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Abstract
Schizophrenia is an endogenous psychosis with a 1% prevalence in world
population. Several pharmacological studies suggest that alterations in the
function of different neurotransmitter systems such as dopamine or gluta-
mate are related to schizophrenic symptoms. This thesis represents mathe-
matical models that are constructed to investigate the dynamical behaviour
of the neurochemical systems in the human brain. These models formu-
late the anatomical properties and physiological processes of synapses, single
brain compartments and large neurochemical pathways involved in the reg-
ulation of behaviour such as the basal ganglia and the limbic system. The
interaction between the neurochemical systems and the electrophysiologi-
cal activities are considered by modelling in different scales. In the synap-
tic scale, it has been shown that the transport of neurotransmitters in the
synaptic cleft is merely governed by electrical forces than diffusion. The
intra-synaptic concentration of neurotransmitters is modelled using partial
differential equations and is coupled to the Hodgkin-Huxley equation (neu-
rochemical modification) to model the effect of neurotransmitter-receptor
binding in the generation of post-synaptic potentials. Considering the mor-
phological and ultra-morphological studies of brain compartments, the aver-
aged electrophysiological activity is modelled by integral equations respecting
these internal structures. A system comprised by nonlinear delay differential
equations is constructed to simulate the dynamical behaviour of neurochem-
ical concentrations, coupled to the local electrophysiological activity of the
compartments, on the brain pathways. By parameter sensitivity analysis,
we have also investigated qualitatively the influence of certain anti-psychotic
agents. Synchronized oscillations are experienced in electrophysiological sys-
tems. The neurotransmitter concentrations also demonstrate an oscillatory
behaviour. The resulting oscillatory dynamics of these processes reveals a
profound view on the relation between the dynamical behaviour of the neu-
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rochemical systems and the occurrence of psychotic states. These facts led
us to establish a hypothesis on this relation, called the oscillation hypoth-
esis of psychosis. Because of the general formulation of the models, these
are not only useful for schizophrenia, but also for the investigations of other
neurological diseases.
Zusammenfassung
Die Krankheit Schizophrenie ist eine endogene Psychose mit einer Pra¨valenz
von 1% in der Bevo¨lkerung. Mehrere pharmakologische Studien setzen die
schizophrenen Symptom-Erscheinungen mit den funktionalen Vera¨nderungen
der verschiedenen Neurotransmitter-Systeme wie zum Beispiel den dopamin-
ergen und glutamatergen Systemen in Verbindung. Diese These repa¨sen-
tiert mathematische Modelle, welche fu¨r die Untersuchung der neurochemis-
chen Prozesse im Gehirn konstruiert sind. Diese Modelle formulieren die
anatomischen Eigenschaften und die physiologischen Prozesse der Synapsen,
der einzelnen Gehirn-Regione sowie der neurochemischen Bahnen, die wie
die Basal Ganglien und das limbische System in der Steuerung des men-
schlichen Verhaltens involviert sind. Die Wechselwirkung der neurochemis-
chen Systeme mit den elektrophysiologischen Aktivita¨ten wurde in allen
Skalen beru¨cksichtigt. Bei der Untersuchung der Synapsen wurde gezeigt,
dass die Diffusionskra¨fte im Vergleich zu den elektrischen Kra¨ften eine eher
schwa¨chere Rolle bei dem Transport der Neurotransmitter im synaptischen
Spalt spielen. Die intra-synpatischen Neurotransmitter-Konzentrationen sind
mit Hilfe partieller Differentialgleichungen modelliert und wurden zum Zweck
der Simulation der Effekte der Neurotransmitter-Rezeptor-Bindung auf die
Erzeugung der post-synaptischen Potentiale mit den Hodgkin-Huxley Gle-
ichungen gekoppelt (neurochemische Modifizierung). Die gemittelte Aktivita¨t
der Gehirn-Regionen wurde mit Integralgleichungen modelliert, die die mor-
phologischen und ultra-morphologi-schen Eigenschaften dieser Regionen bein-
halten. Ein System bestehend aus nicht-linearen retardierten Differential-
gleichungen wurde konstruiert, um das dynamische Verhalten der neuro-
chemischen Konzentrationen gekoppelt mit den elektrophysiologischen Ak-
tivita¨ten der Regionen auf Gehirn-Bahnen zu simulieren. Durch Parameter-
Sensitivita¨tsanalysen wurde auch der Effekt der anti-psychotischen Phar-
maka qualitativ untersucht. Die neurochemischen sowie die elektrophysi-
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ologischen Systeme zeigen oszillatorische Verhaltensmuster. Diese oszilla-
torische Dynamik der Prozesse offenbart eine starke Verbindung zwischen
der Erscheinung psychotischer Symptome und dem Verhalten der neuro-
chemischen Prozesse, welche in der Gestalt einer Hypothese, die Oszilla-
tionshypothese der Psychosen, formuliert wird. Aufgrund der allgemeinen
Formulierung der Modelle sind diese neben der Schizophrenie auch fu¨r die
Untersuchung einiger anderer neurologischer Erkrankungen geeignet.
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Chapter Premier
Introduction
Schizophrenia 1 is a psychiatric diagnosis that describes a family of men-
tal diseases characterized by impairments in the perception or expression of
reality, most commonly manifesting as auditory hallucinations, paranoid or
bizarre delusions or disorganized speech and thinking in the context of signif-
icant social or occupational dysfunction. Onset of symptoms typically occurs
in young adulthood, with approximately 1% of the population affected.
Pharmacological studies on the treatment of psychoses especially schizo-
phrenia suggest that the emergence of psychotic states is directly related
to the abnormal dynamical behaviour of neurotransmitter systems in brain
pathways such as basal ganglia. Hyperactive dopaminergic transmission and
hypo-functionality of glutamate systems in basal ganglia’s network are both
substantial assertions on the role of anomalies of neurotransmitter systems in
producing schizophrenic symptoms (Carlsson, 1988; Carlsson and Carlsson,
1990; Moghaddam and Adams, 1998; Moghaddam, 2003; Moghaddam and
Krystal, 2003; Coyle, 2006).
The quantitative analysis of the dynamics of basal ganglia has been done
in several studies but only restricted to the electrophysiological aspects (Be-
van et al. 2002, Frank 2004, Rubin et al. 2002, 2004). The interactions of
neurochemical within the electrophysiological systems suggest models includ-
ing both. In the present work, mathematical models will be introduced that
simulate the dynamical behaviour of the neurochemical systems correspond-
ing to the related electrophysiological activities, in three scales: the synaptic
level, the level of single compartment activities, and the multi-compartmental
system-level.
This thesis is subdivided into five parts. The most important facts of any
section in these parts are expressed as statement in special box-environments.
The first part is a brief introduction to the physiological and psychiatric as-
1from the Greek roots schizein (”to split”) and phre-n(”mind”)
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pects of schizophrenia. Synaptic processes, important neurochemical brain
pathways, anatomical and physiological properties of the brain compart-
ments, basics on the disease schizophrenia and its neuropathological and
pharmacological aspects are discussed. The reader becomes acquainted with
the physiological and clinical background of schizophrenia which is the foun-
dation of the mathematical models introduced in the second part of this
work. The experienced readers can also skip this part and leap directly to
the mathematical part. The reader is advised to consider the fifth part,
the supplement, for more information on the neurobiological and psychiatric
aspects of the schizophrenia.
The second part is subdivided into three chapters. The first chapter of
this part abstracts the physiological and anatomical structure of the brain
pathways as graphs. These graphs are then analyzed in terms of their topo-
logical and algebraic properties. The dimension of cycle-subspaces are cal-
culated and a cycle-basis is given. From the algebraic point of view, the
automorphism groups and spectrums are calculated and the dynamical gen-
erators of the graphs are characterized. These results are very useful for the
construction of the mathematical models and also for the latter analysis of
the dynamical patterns.
The second chapter of the computational part is the actual modelling
part. In this chapter, the neurochemical systems of the human brain are
mathematically formulated in three scales. In the microscpic scale, synaptic
processes are analyzed and modelled. The dynamical behaviour of the pre-
synaptic membrane is described in other works (Yusim et al. 1999) which
has been reviewed and embedded into our model as a system of ordinary dif-
ferential equations describing the release behaviour of neurotransmitters into
synapses. The behaviour of neurotransmitter concentrations in the synaptic
cleft has also been investigated.
It appears that the dynamics of the neurotransmitters in the synaptic
cleft is merely governed by intra-synaptic electrical fields, generated by the
potential difference of pre- and post-synaptic membranes and the charge of
neurotransmitters, than the diffusion-forcing concentration gradients. This
fact led to two models:
1. A system of coupled partial differential equations consists of a concen-
tration transport equation and an equation describing the dynamics of
the membrane electrical fields as a function of neurotransmitter con-
centration gradients. The spatial alteration of the neurotransmitter
concentration influences the process of de/hyperpolarization of both
synaptic membrane sides and thus the temporal change in the electri-
cal field generated by the membrane potentials. This system qualita-
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tively contains the release, and re-uptake processes and the action of
transporter molecules on the neurotransmitters:
∂E
∂t
= β ∇ρ , βz > 0
∂ρ
∂t
+ div(−α ρE) = frelease(ρ, t)− γex .
2. A modified version of the Poisson-Nernst-Planck equations2:
∂ρ
∂t
+div(−µkT
q
(
∂ρ
∂x
)−µczρ(∂ψ
∂x
)−zαρE) = f(t,∇ρ, ψ) , in (0, T ]×Ω
∆ψ = zρ , in Ω
∂E
∂t
= β ∇ρ , βz > 0 in Ω
ρ = ρ∂Ω , ψ = ψ∂Ω, on (0, T ]× ∂Ω ,
ρ(0, x) = ρ0(x) , in Ω .
The first system has been simulated with Gascoigne (a finite element li-
brary developed in the work-group of Prof. Dr. R. Rannacher, University of
Heidelberg). As expected a fore- and backward transport of neurotransmit-
ters in the synaptic cleft is observed which will be discussed in the third part
of this thesis in detail. The dynamical behaviour of the neurotransmitters in
the synaptic cleft is not observable experimentally in a reasonable resolution.
This makes these investigations more meaningful. Because of the complexity
of the modified Nernst-Planck equations, these will be given and discussed
compactly.
The scale-transition from the synaptic level to the multi-compartmental
model becomes feasible by the models for single brain compartments. Con-
sidering the morphology and ultra-structural morphology of single brain com-
partments, integral equations has been developed to model the upscaled
activity from the synapses to the networks comprised by different kind of
neurons and different connectivity characteristics. The integral equations
describe the integration of information along groups of interneurons with a
given density distribution and internal synaptic connectivity:
2The parameters are taken to be: µ the mobility, z the valency, T the temperature
in Kelvin, k the Boltzmann constant, c a parameter obtained by Einstein-relation; and α
and β are proper multiplicative constants.
18 CHAPTER 1. INTRODUCTION
vt(z) =
∫
Ωh
ρ(z, y) ·
∑
i∈I χi(y)(
∑
x∈Ωi ψ(x, y)ut(x))
|I| g(χ(y)) dy ,
⋃
i
Ωi ⊆ Ωh ,
where χi(y) describes the summation weight depending on the y-location of
Ωi. χ(y) = (χi(y)) is the i-vector of the summation weights. And g : R|I| → R
is the averaging parameter.
In this section the reader will be introduced to experimental methods to
obtain the (for modelling) required morphological and ultra-structural pa-
rameters. Thereafter, the mathematical model will be constructed regarding
to the measurable parameters.
The single compartment model allow the consideration of multi-compartment
systems. Such abstract systems which denote the physiological pathways in
the human brain are spatially extended. Because of the extreme mathe-
matical complexity of systems including the spatial extension and dynamical
behaviour of states, the duration of spatial propagation (τij) and the duration
of synthesis (τ ki ) are replaced by experimentally obtained and physiologically
reasonable time-lags. It follows that the dynamical behaviour of neurotrans-
mitter concentrations along networks such as basal ganglia and the limbic
system can be modelled by systems of nonlinear delay differential equations.
These systems consist of equations describing the local neurotransmitter con-
centration in brain regions (compartments) depending to their projections
and innervations, depending on their dynamical release, re-uptake and syn-
thesis behaviour 3 and also the local electrophysiological activities:
dski (t)
dt
=
∑
j
(−fkij(ski , ui)ski (t)+gkji(ski , γki , uj)skj (t−τij)+σki (gkji, ω(ui))ski (t−τ ki )).
Considering the electrophysiological activity in compartments calculated
by the developed integral equations as an elicitor for the release, re-uptake
and synthesis behaviour of neurotransmitters, the electrophysiological and
neurochemical systems get coupled by this model. This coupling helps to
connect the directly observable electrophysiological activities with pharma-
cological results on the behaviour of neurochemical systems. To achieve
more in this direction, pharmacological parameters describing the effect of
neurotransmitter-antagonization, synthesis inhibition and the blockade of
transporter molecules are embedded into the model and simulated.
3ski denotes the concentration of substance k n the region i. The functions f, g and σ
describe the release, re-uptake and synthesis rates of the neurotransmitters.
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Before the numerical simulation, some fundamental aspects of the mod-
els are analyzed. The influence of synthesis time-delays on the dynamical
patterns is investigated in detail. It reveals that the synthesis-delays can
produce considerable oscillatory effects on the system states depending on
the frequency of the local neurotransmitter synthesis. The influence of the
pharmacological parameters on the dynamical behaviour of the systems is
also investigated due to sensitivity analysis. To obtain the trajectory sensi-
tivity vector, it is necessary to specify the sensitivity equation for the drug-
parameters. The complexity of this equation suggests that the solutions of
this sensitivity equation are not allocable purely analytically. For this reason,
the parameter sensitivity analysis for the time-varying synthesis-parameter
is superseded by numerical simulations of the neurochemical trajectories as
functions of perturbations in the parameter system by the method of inter-
nal numerical differentiation. It reveals that the system is structurally stable
under drug-parameter perturbation chosen from certain ranges. By singular
drug application, the neurochemical/electrophysiological orbits escapes their
normal course temporarily and reverse back to their original course after a
short time period of about 2 seconds.
The third part, the numerical simulations, is subdivided in the same order
as the modelling part by the scales. The intra-synaptic concentration of neu-
rotransmitter is modelled by a system of partial differential equations, which
is simulated with Gascoigne. The results are represented in graphics and
discussed in detail. The single compartment models are simulated for two
special brain nuclei: the corpus striatum and the subthalamic nucleus. These
nuclei represent two categories of brain regions: the corpus striatum consists
of four families of interneurons; the subthalamic nucleus only of one. There
are two methods used to simulate the single compartment models. First, net-
work simulations regarding to the density distribution of interneurons and
their synaptic connectivities reveal oscillatory patterns in electrophysiolog-
ical activity of the corpus striatum. Second, the integral equation of the
neural activity of the subthalamic nucleus is calculated and represented by
a diagram. The oscillatory pattern also appears here. These oscillations are
experimentally expectable as long field potential studies suggest. The next
step is clearly the simulation of the multi-compartment model.
ARCHI, an explicit Runge-Kutta code for solving delay and neutral dif-
ferential equations and parameter estimation problems, is used to simulate
the designed model comprised by a nonlinear system of delay differential
equations. The initial values for the neurotransmitter concentrations are
estimated from micro-dialysis experiments on human. The time-delays are
partly obtained from anatomical studies and are partly calculated based on
anatomical observations. The physiological parameters are also obtained by
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physiological and pharmacological observations on the behaviour of neuro-
transmitters and drugs. The simulations of this model reveal oscillations in
the single compartment’s electrophysiological activity as well as in the local
neurotransmitter concentrations.
The physiological interpretation of these oscillatory patterns is a result
of discussions with neuroscientists (Prof. Dr. A. Carlsson and others) and is
given in part IV. Drug parameter tests in the simulations suggest that the
antagonizing the effects of dopamine as a therapeutic strategy for paranoid
schizophrenia shifts the level and phase of the neurochemical oscillations only
temporarily. The system reverses back to its original state after a short time
period. This behaviour is also clinically observable. The synthesis-inhibitors
in contrast forces such changes for a longer time period. Thus, because the
effect of anti-psychotic drugs leads to changes in the oscillatory patterns,
it is a reasonable hypothesis that the mental states are related to certain
oscillatory patterns. This fact led to the formulation of the main result of this
thesis represented in part VI, called the oscillation hypothesis of psychosis.
After the introduction of the oscillation hypothesis, some pharmacological
and mathematical perspectives are introduced.
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Chapter Two
Neurophysiology of Behaviour
Complex information require adapted and proper media to be processed.
Sensory and motor nerve cells are capable to receive, integrate and relay
the environmental signals. Cellular interactions in clustered or unclustered
population networks (brain regions) and higher projections between these
areas allow the nervous system to process problems of higher complexity
and cognitive information. Thus, to study the information processing in the
brain, we have to investigate the physiology of cellular processes as well as
the structure and functionality of brain compartments as discrete nuclei and
as functional groups.
In this chapter, the principal facts on the neurophysiology of the brain
will be introduced. First, the synaptic processes will be discussed. Then,
the information processing will be investigated on the basis of brain’s macro-
circuits. Following the structure of the macro-circuits, we will discuss the
importance of the brain compartments from functional and neurochemical
point of view for the modelling. The aim is to construct a general schematic
network including the principal neural projections and innervations which
are important for behaviour. The reader can use the supplement for more
information on the neurochemical substances and the anatomy of the brain
compartments.
2.1 Synaptic Processes
Synaptic transmission refers to the propagation of nerve impulses from one
nerve cell to another. This occurs at a specialized cellular structure known
as the synapse, a junction at which the axon of the pre-synaptic neuron ter-
minates at some location upon the post-synaptic neuron. The end of a pre-
synaptic axon, where it is juxtaposed to the post-synaptic neuron, is enlarged
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and forms a structure known as the terminal button. An axon can make con-
tact anywhere along the second neuron: on the dendrites (an axodendritic
synapse), the cell body (an axosomatic synapse) or the axons (an axo-axonal
synapse). At the pre-synaptic ending, an electrical impulse (action poten-
tial) will trigger the migration of vesicles containing neuroactive substances
(neurotransmitters resp. neuromodulators), which are fixated with synapsin
on the actin-filaments and micro-tubuli, toward the pre-synaptic membrane.
These vesicles are equal in the concentration of neuroactive substances but
not in volume. The incoming action potential induces a depolarization (or
hyperpolarization) of the pre-synaptic membrane, thus the Ca2+-channels
will open. The Ca2+-ions flow through the channels from the extracellu-
lar space, this leads to an increased concentration of -ions inside the cell.
The increased concentration of Ca2+-ions inside the cell trigger the vesi-
cles to migrate to the pre-synaptic membrane. The vesicle membrane will
fuse with the pre-synaptic membrane releasing the neurotransmitters into
the synaptic cleft. The release of the neuroactive substances is controlled
by a special machinery of autoreceptors and Ca2+-influx. These molecules
then diffuse across the synaptic cleft where they can bind with receptor sites
on the post-synaptic ending through electrical dipole-dipole binding. When
the transmitter binds to the receptor ion channels are opened either direct
(ionotropic receptors) or indirectly (metabotropic receptors). If the ions de-
polarize the post-synaptic cell-membrane they produce an excitatory post-
synaptic potential wave (EPSP). In general, glutamate and acetylcholine
produce EPSPs in the central nervous system synapses. If the ions hyperpo-
larize the post-synaptic membrane they produce an inhibitory post-synaptic
potential wave (IPSP). The major transmitters producing IPSPs are glycine
and GABA (γ-amino-butyric acid). The generation of an action potential on
the post-synaptic membrane depends from the localization of receptors and
the superposition of the potential waves. If there are enough EPSPs (well
distributed) the post-synaptic membrane will be depolarized to the thresh-
old level and an action potential will be produced, then the signal will travel
along the second neurone. Once the signal has been delivered the transmit-
ter must be removed so that new signals may be received. In some cases
the transmitter is metabolized by an enzyme in the synaptic cleft. In other
cases the transmitters are attracted by pre-synaptic transport molecules, are
recycled and absorbed by the pre-synaptic neurone. In still other cases these
both processes are combined.
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2.2 Information Processing and Behaviour
Complex information require high-grade integrated systems to be proceeded.
Considering the properties of the brain compartments, complex behavioural
or vegetative tasks require the interaction between different compartments.
For any kind of information, such as motor, sensory, or emotional one or more
macro-circuits which consist of a set of brain compartments, will interact
and process the inputs. Here, the most important circuits for motor and
emotional information processing will be discussed, and their interactions
will be investigated.
2.2.1 The Basal Ganglia
The basal ganglia are a richly interconnected set of brain nuclei found in
the prosencephalon and mesencephalon of mammals, birds and reptiles. The
most widely accepted views of basal ganglias functions are based on ob-
servations of human aﬄicted with degenerative diseases that attack these
structures. These observations have led most clinical investigators to view
the basal ganglia as components of a system that is somehow involved in the
generation of goal-directed voluntary movement but in complex and subtle
aspects of that process. Current views based on experimental studies sug-
gest a more general role for the basal ganglia in selection among candidate
movements, goals, strategies, and interpretations of sensory information. The
anatomical connections of the basal ganglia link it to elements of the sensory,
motor, cognitive, and motivational apparatus of the brain.
The basal ganglia are large subcortical nuclear masses considered to be
derivatives of the forebrain. These are connected components of parallel or-
ganized functional basal ganglia-thalamocortical circuits. The elements of
each circuit include discrete, essentially non-overlapping parts of striatum,
globus pallidus, substantia nigra, thalamus and cortex (figure 2.1). In each
case, specific cortical areas send excitatory, glutamatergic projections to se-
lected portions of the striatum (comprising caudate nucleus, ventral striatum
and dorsal striatum), which is generally thought to represent the input stage
of basal ganglia. By virtue of their high rates of spontaneous discharge,
the basal ganglia output nuclei (the internal and ventral segments of globus
pallidus GPi and GPe; substantia nigra pars reticulata SNr) exert a tonic,
GABA-mediated, inhibitory effect on their target nuclei in the thalamus.
Within each circuit, this inhibitory outflow appears to be differentially mod-
ulated by two opposing but parallel pathways that pass from the striatum to
the basal ganglia output nuclei. Each circuit includes a direct pathway to the
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Figure 2.1: The basal ganglia (copyright: www.clinic-clinic.com)
output nuclei, which arise from inhibitory striatal efferent that contain both
GABA and substance P. Activation of this pathway tends to disinhibit the
thalamic stage of the circuit. The direct pathway should be able to mediate
the excitatory glutamatergic input from the cortex to the thalamus via the
striatum and the medial section of pallidum. This, also the existence of only
two GABAergic neuron chains result in thalamic and behavioural stimula-
tion. Each circuit also includes an indirect pathway, which passes first to the
external segment of the globus pallidus (GPe) via striatal projection neurons
that contain both GABA and enkephalin, then from GPe to the subthalamic
nucleus via a purely GABAergic pathway and finally to the output nuclei
via an excitatory, probably glutamatergic, projection from the subthalamic
nucleus. The high spontaneous discharge rate of most GPe neurons exerts a
tonic inhibitory influence on the subthalamic nucleus. Activation of the in-
hibitory GABA/Enkephalin projection from the striatum tends to suppress
the activity of GPe neurons and thereby disinhibit the subthalamic nucleus,
increasing the excitatory drive on the output nuclei and increasing the in-
hibition of their efferent targets within thalamus. The two striatal efferent
systems of each circuit thus appear to have opposing effects upon the basal
ganglia output nuclei and, accordingly, upon the thalamic targets of basal
ganglia outflow (Alexander et al. 1986).
The corticostriatal projections appear to be essentially glutamatergic and
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Figure 2.2: The projection network of the basal ganglia
have an excitatory influence on the striatum. The projections from the dor-
sal and ventral striatal complexes to the thalamus, apparently often with
collaterals projecting on the mesencephalic reticular formation, appear to be
largely inhibitory and possibly GABAergic. This leads some neurologists to
consider the above circuit as a negative feedback loop. In this context the
thalamus could be looked upon as a filter for sensory inputs. This filter is
under the control of the cerebral cortex via corticostriato-thalamic loops. In
this way the cortex is able to protect itself from an overload of sensory in-
formation arising via the sensory pathways to the thalamus, as well as from
hyper-arousal via the afferent pathways to the reticular formation (Carls-
son 1988). The clinical relevance of basal ganglia circuits depends directly
from the balance between the different neurotransmitter concentrations. The
exact balance in the dopamine, acetylcholine and GABA systems is prereq-
uisite for normal motor function. The degeneration of pigmented neurons
in substantia nigra leads to depleted dopamine values in striatum and re-
sult to morbus Parkinson. Also genetic anomalies in the acetylcholine- and
GABAergic systems in striatum could lead to chorea Huntington. There
are also psychophysiologic hypotheses based on the dysfunctionalities in the
dopaminergic and glutamatergic systems which will be discussed now in more
accuracy. In 1963, a specific stimulating action on dopamine (and nora-
drenalin) turnover of the major neuroleptics chlorpromazine and haloperidol
was discovered and proposed to be due to blockade of dopamine (and no-
radrenalin) receptors. When these studies were extended to a large number
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of antipsychotic agents, blockade of dopamine receptors, appeared to be the
common denominator. This led to the notion that blockade of dopamine
receptors is the most essential component in the action of the major antipsy-
chotic agents. The fact that dopaminergic agonists are capable of faithfully
mimicking certain schizophrenic disease states led to propose that dopamine
may be involved in schizophrenia. This theory has played a prominent role
in schizophrenia research for more than four decades. However, some impor-
tant caveats must be considered. First, the hypothesis rests almost entirely
on indirect pharmacological evidence. A disturbance in dopaminergic func-
tions in the brains of schizophrenic patients remains to be demonstrated
beyond doubt. Second, a fair proportion of schizophrenic patients respond
poorly, or not at all, to treatment with anti-dopaminergic drugs. Third,
dopaminergic agonists can only mimic the paranoid form of schizophrenia.
Non-paranoid schizophrenia, and especially negative symptoms, can be mim-
icked more faithfully by glutamatergic NMDA-receptor antagonists. Arvid
Carlsson, one of the leaders in this area, considered the circuits of basal gan-
glia to explain the pharmacological effects of antipsychotic drugs (dopamine
antagonists) and their influence on neurophysiology. Carlsson and Carls-
son (1990) have emphasized the inhibitory influence of the striatum on the
thalamus and thus interpreted the basal ganglia-thalamocortical circuits as
negative feedback loops. Their conclusion was based on the fact that the
mesostriatal dopaminergic pathways are behaviourally stimulating and that
most of neurophysiologists seem to agree that the dopaminergic input to the
striatum has a mainly inhibitory action on striatal projection neurones.
2.2.2 The Limbic System
In 1878, the French neurologist Paul Broca called attention to the fact that,
on the medial surface of the mammalian brain, right underneath the cortex,
there exits an area containing several nuclei of grey matter (neurons) which
he denominated limbic lobe (from the Latin word ”limbus” that implies the
idea of circle, ring, surrounding, etc.) since it forms a kind of border around
the brain stem (in another part of this text we shall write more about these
nuclei). The entirety of these structures, that, years later would receive
the name of ”limbic system”, developed with the emergence of the inferior
(primitive) mammals. This system commands certain behaviours that are
necessary for the survival of all mammals. It gives rise and modulates specific
functions that allow the animal to distinguish between the agreeable and the
disagreeable. Here specific affective functions are developed, such as the one
that induces the females to nurse and protect their toddlers, or the one which
induces these animals to develop ludic behaviours (playful moods). Emotions
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Figure 2.3: The projection network of the limbic system
and feelings, like wrath, fright, passion, love, hate, joy and sadness, are
mammalian inventions, originated in the limbic system. This system is also
responsible for some aspects of personal identity and for important functions
related to memory.
The complex structure of the limbic system affords it to process high-
complex information like the emotional behaviour (figure 2.3). Because of
its connections to extra-limbic structures, the limbic system is also involved
in processing of other information. This will be discussed in the next section.
2.2.3 Generalized Information Processing Pathway
Statement: The limbic system and basal ganglia solely are not sufficient
to process the complex information in the brain. A complex pathway com-
prised by these systems and other brain nuclei is required to precede in-
formation of different kinds simultaneously and to complete complex be-
havioural tasks.
The physiological and anatomical properties of two major brain macro-circuits
have been discussed in the last paragraphs. The neural projections and the
interconnections were restricted to a single system, and the cross-projections
between the systems have been neglected.
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Considering the interconnectivity between single compartments of these
macro-circuits suggest that high-complex information processing such as be-
havioural facial mimics (as a combination of motor and emotional informa-
tion processing) requires a larger network which is comprised by at least
basal ganglia and the limbic system. Such a network allows the brain to pre-
cede information of different kinds simultaneously and to complete complex
behavioural tasks. Realistic mathematical models for the neurochemical pro-
cesses behind mental disorders such as schizophrenia need networks including
all major pathways.
We have constructed a schematic network comprised by basal ganglia,
the limbic system (LBG network) and other important nuclei such as nucleus
raphe with regard to their bilateral projections (2.5). Nucleus Raphe is the
major brain region containing serotonin, which plays an important role in
the generation of optical hallucinations (LSD-effects). The neurotransmitter
systems are embedded on the network such that a classification of network-
projections reveals (figure 2.4).
Figure 2.4: The neurotransmitter matrix of the LBG network
The LBG-network generalizes the common view of information processing
and allows us to analyze the neurochemical and electrophysiological dynam-
ics of the brain in more detail. In the computational part of this work,
a mathematical model comprised by a system of nonlinear delay differen-
tial equations is constructed based on the geometry of the LBG-network to
analyze quantitatively the dynamical influence of different neurotransmitter
systems on behaviour, and especially on the mental states.
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Figure 2.5: The LBG (limbic-basal ganglia) network
32 CHAPTER 2. NEUROPHYSIOLOGY OF BEHAVIOUR
2.3 Brain Compartments
About 100 billions of nerve cell bodies including their fibers, glia cells and
blood vessels build a complex structure called the brain or cerebrum. The
brain compartments are classified either by their developmental history in
telencephalon, diencephalon, mesencephalon, metencephalon and myelen-
cephalon; or by their anatomical properties in cortex, basal ganglia, tha-
lamus, hypothalamus, tectum, tegmentum, cerebellum, pons and medulla
oblongata. Because of the important role of telencephalon in the integration
and processing of complex inputs, especially cognitive, emotional and fine-
regulative information, its anatomical structure in general will be discussed
here. The telencephalon consists essentially of basal nuclei and the cortex
cerebri.
Supported by our interest in large-scale information processing in the
brain, we also discuss the morphology and physiology of the principal com-
partments of the generalized pathway. The knowledge of the structure and
physiology of these compartments will be used in the mathematical modelling
of information processing inside brain nuclei by integral operators.
In this work, we will use results on the morphology and the ultra-structural
properties of the brain compartments based on immunohistochemical and
Golgi-expermients. These results are represented in the supplement. The
reader is advised to consider these results for better understanding of the
mathematical models.
Chapter Three
Schizophrenia and
Schizophrenia-like Disorders
Estimates of the incidence and prevalence of schizophrenia depend on the
criteria for diagnosis and the population surveyed. The annual incidence is
probably between 0.1 and 0.5 per 1000 population. The onset of schizophre-
nia characteristically occurs between the ages 15 to 45. While schizophrenia
occurs equally in men and women, the mean age of onset is about five years
earlier in men (Ha¨fner et al. 1989). The lifetime risk of developing schizophre-
nia is probably between 7.0 and 9.0 per 1000 (Jablensky 1986). The point
prevalence of schizophrenia in European countries is probably between 2.5
and 5.3 per 1000 (Jablensky 1986). Collaborative studies by the WHO have
shown that the prevalence of schizophrenia, when assessed in comparable
ways, is similar to different countries (Jablensky et al. 1992).
Of all the major psychiatric syndromes, schizophrenia is to difficult to
define and describe. The main reason for this difficulty is that, over the past
100 years, many widely divergent concepts of schizophrenia have been held
in different countries and by different psychiatrists. Radical differences of
opinion persist to the present day. If these conflicting ideas are to be made
intelligible, it is useful to start with a simple comparison between two basic
concepts - acute schizophrenia and chronic schizophrenia.
Essentially, the predominant clinical features in acute schizophrenia are
delusions, hallucinations, and interference with thinking. Features of this
kind are often called ’positive’ symptoms. Some patients recover from the
acute illness whilst the others progress to chronic syndrome. In contrast, the
main features of chronic schizophrenia are apathy, lack of drive, slowness,
and social withdrawal. These features are often called ’negative’ symptoms.
Once the chronic syndrome is established, few patients recover completely.
Most of the disagreements about the diagnosis of schizophrenia are con-
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cerned with the acute syndrome. The criteria for diagnosis are concerned
with both the pattern of symptoms and the course of the disorder. There
are disagreements about both, the range of symptoms that are required and
the duration that these symptoms should have been present in order to make
the diagnosis.
3.1 Etiology
Of the predisposing causes, genetic factors are most strongly supported by
the evidence, but the fact that some patients with schizophrenia have no
family history of the disorder suggest that environmental factors are likely to
play a part as well. The nature of these environmental factors is uncertain.
Perinatal neurological damage has been suggested, and so have interpersonal
and social influences. A theory of the pathogenesis of schizophrenia based
on the evidence of abnormalities in brain structure and morphology (the
neurodevelopmental hypothesis) is outlined as follows. Schizophrenia is as-
sociated with a subtle, static structural brain lesion that involves a diffuse
system of periventricular limbic and diencephalic nuclei and their connections
to the dorsolateral prefrontal cortex (Weinberger 1986).
In the present work, the biochemical abnormalities and morphological
changes in the schizophrenic brains are of much more interest. Thus, we
will not further discuss the aetiology and begin with clinical features of this
disease and its biochemical anomalies.
3.2 Clinical Features
3.2.1 The Acute Syndrome
In appearance and behaviour some patients with acute schizophrenia are
entirely normal. Others seem changed and different, although not always in
a way that would immediately point to psychosis. They may be preoccupied
with their health, their appearance, religion, or other intensive interests.
Social withdrawal may occur. Some patients smile or laugh without obvious
reason. Some appear to be constantly perplexed. Some are restless and
noisy, or show sudden and unexpected changes of behaviour. Others retire
from company, spending a long time in their rooms, perhaps lying immobile
on the bed apparently preoccupied in thought.
The speech often reflects an underlying though disorder. In early stages,
there is vagueness in the patient’s talk that makes it difficult to grasp his
meaning. Some patients have problems with dealing with abstract ideas
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(concrete thinking). Other patients become preoccupied with vague pseudo-
scientific or mystical ideas.
When the disturbance is more severe, two characteristic kinds of abnor-
malities may occur. Disorders of the stream of thought include pressure of
thought, poverty of thought, and thought blocking. Thought withdrawal is
sometimes classified as a disorder of the stream of thought, but it is more
usefully considered as a form of delusion.
Loosing of association denotes a lack of connection between ideas. This
may be detected in illogical thinking or talking past the point. In the severest
form of loosing structure and coherence of thinking is lost, so that utterances
are jumbled (word salad). Some patients use ordinary words in unusual ways
(metonymy), and a few new words (neologisms).
Abnormalities of mood are common and are of three main kinds. First,
there may be sustained abnormalities of mood such as anxiety, depression,
irritability, or euphoria. Second, there may be blunting of affect, sometimes
known as flattening of affect. Third, there is incongruity of affect.
Auditory hallucinations are among the most frequent symptoms. They
may take form of noises, music, single words, brief phrases, or whole conversa-
tions. They may be unobtrusive or so severe as to cause great distress. Some
voices seem to give commands to the patient. Some patients hear their own
thought apparently spoken out loud either as they think them (Gedanken-
lautwerden) or immediately afterwards. Some voices seem to discuss the
patient in the third person. Other comment his actions.
Visual hallucinations are less frequent and usually occur with other kinds
of hallucinations. Tactile, olfactory, gustatory, and somatic hallucinations
are reported by some patients.
Delusions are characteristic. Primary delusions are infrequent and are
difficult to identify with certainty. Delusions may originate against a back-
ground of so-called primary delusional mood (Wahnstimmung). Persecutory
delusions are common, but are not specific to schizophrenia. Of great diag-
nostic value are delusions of reference and of control, which are less common.
In acute schizophrenia orientation is normal. Impairment of attention and
concentration is common, and may result in memory impairment. Insight is
usually impaired. Most patients do not accept that their experiences result
from illness, but usually ascribe them to the malevolent actions of other
people. This lack of insight is often accompanied by unwillingness to accept
treatment.
Schizophrenic patients do not necessarily experience all these symptoms.
The most common symptoms are the lack of insight, auditory hallucinations,
and ideas of reference.
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3.2.2 The Chronic Syndrome
The chronic syndrome is characterized by thought disorder and the negative
symptoms of under-activity, lack of drive, social withdrawal, and emotional
apathy. Roughly spoken, in contrast to positive symptoms of acute syn-
drome, the negative symptoms are related to a loss of cognitive and motor
abilities.
The most striking feature of the syndrome is diminished volition, that is
a lack of drive and initiative. A variety of motor disturbances occur but most
are uncommon. Disorders of motor activity are often called catatonic. Stupor
and excitement are the most striking catatonic symptoms. A patient in
stupor is immobile, mute, and unresponsive, although fully conscious. Stupor
may change (sometimes quickly) to a state of uncontrolled motor activity and
excitement. Various disorders of movement occur in schizophrenia such as
stereotypy, mannerism, and ambitendence.
Social behaviour may deteriorate. Self-care may be poor, and particularly
in women, the style of dress and presentation may be careful but somewhat
inappropriate. Some patient collect and hoard objects, so that their sur-
roundings become cluttered and dirty. Other break social conventions by
talking intimately to strangers or shouting obscenities in public.
Speech is often abnormal, showing evidence of thought disorder of the
kinds found in acute syndrome. Affect is generally blunted; when emotion
is shown, it is often incongruous. Hallucinations are common, in any of the
forms occurring in the acute syndromes. Delusions are often systematized. In
chronic schizophrenia, delusions may be held with little emotional response.
Delusions may also be ’encapsulated’ from the rest of patient’s belief.
Because of the over-simplified character of these classifications two points
need to be stressed. First, different features may predominate within a syn-
drome. Second, some patients have features of both syndromes.
Chapter Four
The Neuropathology and
Psychopharmacology of
Schizophrenia
4.1 Pathological Abnormalities of Schizophre-
nia
The existence of neuropathological abnormalities in schizophrenia suggests
deformations in the network structure of schizophrenic brains, and abnormal-
ities in the information processing sequence. Here, we review the recent MRI
findings in schizophrenia based on the work of M. Shenton and co-workers
(Shenton et al. 2001), beginning with ventricle findings to subcortical struc-
tures.
Lateral ventricular enlargement may indicate tissue loss in surrounding
brain regions or it may indicate a failure in development (neurodevelopmen-
tal hypothesis). Over 75% of CT findings (Johnstone et al. 1976; Shelton
et al. 1986) and about 80% of the MRI findings (Buckley 1998; Gur and
Pearlson 1993; Henn and Braus 1999; Lawrie and Abukmeil 1998; McCarley
et al. 1999; Nelson et al. 1998; Pearlson and Marsh 1993, 1999; Pfefferbaum
et al. 1990; Pfefferbaum and Zipursky 1991; Rauch and Renshaw 1995; Raz
and Raz 1990; Seidman 1983; Shelton and Weinberger 1986; Shenton 1996;
Shenton et al. 1997, 2001; Weight and Bigler 1998; Yurgelun-Todd 1999) re-
port enlarged lateral ventricles. Moreover, even studies not reporting lateral
ventricle enlargement have reported enlargement in the temporal horn por-
tion of the lateral ventricular system (Shenton et al. 1992). These findings
are also consistent with several post-mortem findings which have reported
both reduced volume in the amygdala-hippocampal complex and increased
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temporal horn volume (Bogerts et al. 1985; Brown et al. 1986; Colter et al.
1987; Falkai and Bogerts 1986, 1988; Jakob and Beckmann 1989; Jeste and
Lohr 1989; Kovelman and Scheibel 1984).
Over 73% of the MRI studies observed an increased volume of the third
ventricle. The proximity of the third ventricle to the thalamus is likely im-
portant, then an increased liquid volume in third ventricle would lead to a
reduction of thalamic volume, which is of enormous importance in informa-
tion processing and thus to schizophrenia.
It has been suggested that schizophrenia is also related to abnormalities
in the hippocampus (Bogerts 1997; Dwork 1997; Keltner 1996; Zaidel et al.
1997) and amygdala (Bogerts 1997; Breier et al. 1992; Shenton et al. 1992).
The abnormalities of the hippocampus consist of volume changes, cell density
changes, periventricular gliosis, senile degeneration, and normal neuronal
size, shape, position, and/or orientation (Dwork 1997). A study compared
the left and right pyramidal neurons in the hippocampus. Examination of
post-mortem tissue of participant’s brains using neurons digitized from the
central parts of hippocampal subfields CA4, CA3, CA2, and CA1 found that
schizophrenic group had considerably smaller neurons than the normal group
in the left CA1, the left CA2, and the right CA3 fields.
Anatomical abnormalities in the left hippocampal region and the pos-
terior side of the left temporal lobe are correlated with delusions, halluci-
nations, and bizarre behaviour (Bogerts 1997). Most MRI studies combine
the amygdala and hippocampus into the amygdala-hippocampal complex be-
cause it is difficult to separate them on coronal slices. In agreement to the
post-mortem studies, volume reduction in the amygdala-hippocampal com-
plex and parahippocampal gyrus are present in chronic, and first episode
schizophrenia patients (Becker et al. 1990; Bogerts et al. 1990, 1993; Breier
et al. 1992; Chua and McKenna 1995; DeLisi et al. 1988, 1991; Hirayasu et
al. 1998; Kawasaki et al. 1993; Lawrie et al. 1999; Shenton et al. 1992).
About 67% of MRI studies that evaluated superior temporal gyrus (STG)
grey and white matter volume combined report STG volume reductions in
schizophrenia. MRI studies evaluating only the grey matter volume of STG
reported unanimously volume reductions (Holinger et al. 1999; Marsh et al.
1997; Menon et al. 1995; Vita et al. 1995). Studies of electrical stimulations
to more anterior portions of STG have resulted in complex auditory hallu-
cinations and verbal memories (Penfield and Roberts 1959). These findings
are similar to common symptoms of acute schizophrenia which include ver-
bal memory deficits, disordered thinking, and auditory hallucinations. With
respect to correlations with other brain regions, it is interesting to note that
volume reduction in the hippocampus, amygdala, parahippocampal gyrus
and STG is highly intercorrelated (Shenton et al. 1992), suggesting that re-
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gions that are functionally interrelated also evince volume reductions. Wible
and co-workers (1995) showed correlations between left prefrontal grey mat-
ter and left amygdala-hippocampal complex, left parahippocampal gyrus,
and left STG. Moreover, Nestor et al. (1993) observed an association be-
tween poor performance on verbal memory, abstraction, and categorization,
and volume reduction in both the parahippocampal gyrus and posterior STG.
These cognitive deficits are consistent with the function of these brain regions
and their role in associative links in memory, particularly verbal memory.
Nestor et al. (1997) interpreted these findings as indicative of a dysfunc-
tional semantic system in schizophrenia.
The prefrontal cortex is one of the mostly highly complex and evolved
neocortical regions of the human brain, comprising close to 30% of neocortex
in human, with both afferent and efferent connections to all other areas
of cortex, as well as to limbic and basal ganglia structures (Fuster 1989;
Goldman-Rakic et al. 1984; Pandya and Seltzer 1982). This brain region
serves an important modulatory role in all aspects of human functioning.
The MRI studies suggest that differences in the prefrontal cortex may be too
small to detect, but which are nonetheless correlated with reductions in areas
of the temporal lobe that are neuroanatomically and functionally related, as
well as symptoms thought to be associated with frontal lobe functioning
(Wible et al. 1995, 2001).
Despite of the recent evidences suggesting that cerebellum may play a
critical role in higher cognitive functioning and may be implicated in the
neuropathology of schizophrenia, there are no significant differences in its
volume in schizophrenic and control patients.
Post-mortem studies of basal ganglia structures (Heckers et al. 1991) and
68% of MRI studies report increases in volume, but further studies suggest
that the increased volume of basal ganglia structures may be a function of
conventional neuroleptic medications whereas atypical neuroleptics do not
exert the same effect. Recent studies (Shenton et al. 2001) reported smaller
caudate in a group of neuroleptic nave subjects with related schizotypal per-
sonality disorder. However, Gur and co-workers (1998) evaluated basal gan-
glia structures in neuroleptically nave and previously treated patients and
reported no differences in the volume of basal ganglia structures between the
neuroleptically nave group and controls.
Summarising the findings, there are large evidences for volume differ-
ences in ventricle systems, temporal lobe structures (amygdala-hippocampal
complex), and correlated abnormalities with prefrontal cortex. In general,
there are no significant differences in the volume of thalamus, basal ganglia
structures, and cerebellum, which could be also caused by the measurement
difficulties, small ensemble of studies, and influence of antipsychotic agents
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as a disturbing parameter.
4.2 The Dopamine Hypothesis
In 1963, a specific stimulating action on dopamine (and noradrenaline) turnover
of the major neuroleptics chlorpromazine and haloperidol was discovered and
proposed to be due to blockade of dopamine (and noradrenaline) receptors
(Carlsson and Lindqvist 1963). When these studies were extended to a large
number of antipsychotic agents, blockade of dopamine receptors, rather than
adrenergic receptors, appeared to be the common denominator (Andn et al.
1970; Nybck et al. 1970). This led to the notion that blockade of dopamine
receptors is the most essential component in the action of the major antipsy-
chotic agents. There is overwhelming evidence that the major antipsychotic
agents are capable of blocking dopamine receptors. Thus, they have been
shown to antagonize the central action of dopamine and other dopaminergic
agonists, actions such as stimulation of locomotor activity and stereotyped
behaviour, and disruption of a discriminative task, inhibition of firing by
dopaminergic neurons and of dopamine synthesis and turnover, hyperther-
mia and decrease in prolactin secretion. The fact that dopaminergic agonists
are capable of faithfully mimicking certain schizophrenic disease states led
Randrup and Munkvad (1965) to propose that dopamine may be involved in
schizophrenia. All the above observations form the basis for the dopamine
hypothesis of schizophrenia.
Beside the importance of this theory for schizophrenia research and its
therapeutic value, some important caveats must be discussed. First, the
hypothesis rest almost entirely on indirect pharmacological evidences. Our
quantitative analysis of the basal ganglia’s network, where the highest dopamine
concentrations are located, with a view toward to schizophrenia is a possible
investigation of this caveat. Second, dopaminergic agonists can only mimic
the acute schizophrenia. The chronic schizophrenia is better mimicked by
agents acting on the glutamatergic systems, especially located in prefrontal
cortex. Our study reveals that for totally mimicking of schizophrenic symp-
toms a neurotransmitter-interaction model is required.
4.3 The Glutamate Hypothesis
The idea of a glutamatergic abnormality in schizophrenia was first proposed
by Kim, Kornhauber, and colleagues in 1980 (Kim et al. 1980) based on their
findings of low cerebrospinal fluid (CSF) glutamate levels in patients with
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schizophrenia. This theory was not received well because, first, these find-
ings could not be replicated in subsequent studies and, second, our limited
knowledge of the glutamate system at the time suggested that disruptions in
glutamate neurotransmission would result in overt toxicity and gross devel-
opmental abnormalities, something not seen in schizophrenia.
During the last two decades considerable interest has focused on the possi-
ble role of glutamate in schizophrenia (Bunney et al. 1995; Moghaddam and
Adams 1998; Moghaddam 2003; Moghaddam and Krystal 2003). One reason
for this is the discovery that phencyclidine (PCP), that can induce a psy-
chotic condition mimicking schizophrenia, perhaps even more faithfully than
amphetamines, is a powerful antagonist on NMDA receptor. This receptor
is equipped with an ion channel regulating the penetration of calcium and
other cations into the neuron. PCP binds to a specific site in this channel,
thereby blocking the function of the receptor. Different NMDA antagonists
such as MK-801, AP5, and CGS 19755, seem to be psychostimulants, at
least in rodents, and are psychotogenic in humans (Lodge et al. 1989). thus
a deficiency of glutamate function in schizophrenia must be considered.
4.4 The Oscillation Hypothesis
Hypothesis: The local neurotransmitter concentrations on the brain path-
ways oscillate. Sensitivity analysis of the drug-parameter suggest that the
concentrations also oscillate in disease cases. It appears that the mental
states are associated with characteristic neurochemical oscillations.
The foundations of this hypothesis are the neurochemical oscillations re-
vealed by our mathematical investigation of the neurochemical dynamics on
the networks involved in schizophrenia. The neurotransmitter concentra-
tions oscillate in normal as well as in ”diseased” cases. Parameter sensitivity
analysis suggests that the quantitative behaviour of the brain’s biochemical
circuitries depend strongly on the interaction between the different neuro-
transmitter systems. It reveals also that to any mental state a characteristic
oscillation is associated, and schizophrenic moods are possibly related to dis-
turbances of these oscillations (Noori and Ja¨ger 2007). This hypothesis will
be discussed in more detail in the next chapters.
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Part II
Computational Psychiatry
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Chapter Five
Graph Theory and Applications
The human brain consists of a set of compartments which are interconnected
through neural projections. Each compartment is a set of neurons which are
in a characteristic synaptic way interconnected. The internal connectivity
is described through the morphology of these compartments. The fact that
these biological structures are discrete set of compartments (or neurons) and
are connected through projection neurons (or axons) suggests that they could
be considered as graphs. The translation of the neural morphology into
graph structures is accompanied with strong simplifications in the biological
nature of the neural processes but allows us to investigate the processes
quantitatively by mathematical models.
The translation of biological data into abstract mathematical notation is
the main objective of this chapter. The physical realization of graphs called
networks, build the foundation of the construction of dynamical systems de-
scribing the biological processes behind the graph structures. To understand
the construction of such dynamical systems, the theory of networks will be
discussed. First, an introduction to the theory of graphs will be given which
is very useful to work with the right notation. Second, an abstract formula-
tion of the anatomical and physiological facts (known from the part I) will
be introduced. After the mathematical formulation of the problem, the prin-
cipal characteristics of the graphs will be investigated. This investigation
includes the determination of the number of cycles of the graphs and the
determination of generators of the dynamical patterns behind the graphs.
The knowledge of the structural properties of the networks corresponds with
the dynamical behaviour of the states of their vertices. This correspondence
is not investigated in this thesis.
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5.1 An Introduction to Graph Theory
A graph G is an ordered pair of disjoint sets (V,E) such that E is a subset
of the set of unordered pairs of V . If elements of E are ordered pairs of V
then G is called a directed graph. The set V is the set of vertices and E the
set of edges 1. The order of G is the number of vertices (|G|). The size of
G, e(G) ,is the number of edges with 0 ≤ e(G) ≤ n!
2!(n−2)! .
G′ = (V ′, E ′) is a subgraph of G = (V,E) if V ′ ⊆ V and E ′ ⊆ E. If G′
contains all edges of of G that join two vertices in V ′ then G′ is said to be
the subgraph induced or spanned by V ′ and is denoted by G[V ′].
Two graphs G = (V,E) and G′ = (V ′, E ′) are isomorphic if there exists
a bijection φ : V → V ′ such that xy ∈ E iff φ(x)φ(y) ∈ E ′. The set of
vertices adjacent to a vertex x ∈ G is denoted by Γ(x). The degree of x is
d(x) = |Γ(x)|. For directed graphs, we define in-degree and out-degree as the
number of edges incident into and out of a vertex. The minimum degree of
the vertices of a graph is denoted by δ(G); the maximum degree by ∆(G).
A walk W is an alternating sequence of vertices and edges. If a walk
W = x0x1 · · ·xl is such that l ≥ 3, x0 = xl and the vertices xi, 0 < i < l are
distinct from each other and x0 then W is said to be a cycle.
A graph is connected if for any pair {x, y} of distinct vertices there is a
path from x to y.
Let G = (V,E) be a finite connected graph. For xi ∈ V , if Γ(xi) 6= 0,
then xi is a linear function on a proper subset of V . Considering all xi ∈ V
as linear functions on subsets f V , then a linear system appears 2.
A generating set of a graph G is a set consists of solutions of the linear
systems.
A minimal generating system B is called a basis for graph G.
Remarks:
• A basis B for the graph G is not unique;
• If B ∼= B′ , then G ∼= G′ isomorphic;
• If B is a basis for graph G, a finite connected and directed graph
defining a dynamical system. Then the system G can be reduced to B
A similar way to define a basis for a graph is the following. The vertex
space C0(G) of a graph G is the complex vector space of all functions from
1The edge between x and y is denoted by xy.
2see Noori 2007
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V into C. Similarly the edge space C1(G) is the complex vector space of all
functions from E into C. Let V = {v1, · · · , vn} and E = {e1, · · · , em}. The
elements of C0(G) are usually written in the form x =
∑n
i=1 xivi. This sum
is the formal sum of the vertices but if we think of vi as the function V → C
which is 0 everywhere except at the vertex vi, where it is 1, then v1, · · · , vn
is called a basis of C0(G).
There are several matrices naturally associated with a graph and its vector
spaces. The adjacency matrix A = A(G) = (aij) of a graph G is the n × n
matrix given by
aij =
{
1 vivj ∈ E
0 otherwise
It is clear that A represents an endomorphism of C0(G).
The spectrum of a graph G is the set of numbers which are eigenvalues of
A(G), together with their multiplicities. If the distinct eigenvalues of A(G)
are λi, and their multiplicities are m(λi), then we shall write
Spec(G) =
(
λ0 λ1 · · · λs
m(λ0) m(λ1) · · · m(λs)
)
.
The automorphism group of a graph G is the group, Aut(G) of permu-
tations of the vertices preserving adjacency. Each pi ∈ Aut(G) induces an
endomorphism of C0(G) which is described by a permutation matrix P . It
commutes with the adjacency matrix A,
PA = AP .
There is also another useful matrix structure, the incidence matrix, which
we will use to understand the algebraic properties of the cycle-subspaces of
graphs. The incidence matrix D(G) of a graph G, with respect to a given
orientation of G, is the n×m matrix dij whose entries are
dij =

+1 vithe positive end of ej
−1 vithe negative end of ej
0 otherwise
These remarks indicate how the methods of representation theory may
be used to characterize the graphs by their algebraic and analytic properties
through their adjacency and incidence matrices and automorphism groups.
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5.2 Graph-Theoretical Characterization of the
System
In the first part, the LBG-network has been introduced. It consists of four-
teen complex compartments 3 and is comprised mainly by tow subgraphs,
namely the limbic system and the basal ganglia. First, these two subgraphs
will be investigated separately, then their composition into the LBG-network
will be discussed. The graph-theoretical study of these structures reveal
topological properties of the systems which are interesting in their own right
and are also important for the understanding of the dynamical behaviour
behind the structures.
5.2.1 The Structure of the Limbic System G1
Theorem: The limbic system as a graph is 2-dimensional (two minimal
generators) and has an 8-dimensional cycle-subspace.
The limbic system is a graph structure which contains five compartments:
the cortex (v1), the hippocampus (v2), the amygdala (v3), the hypothalamus
(v4), and the thalamus (v5) (figure 5.1). We first begin with the quantitative
analysis of the algebraic properties of the limbic system through its adjacency
matrix, and then we investigate its cycle-space by the kernel of its incidence
matrix. Finally, possible minimal generating sets will be introduced.
The lowest (δ) and highest (∆) in/out-degrees are: δin(G1) = 1, δout(G1) =
1, ∆in(G1) = 4 and ∆out(G1) = 4. The amygdala is the compartment with
the highest in/out-degrees. For further investigations, it is necessary to con-
struct the adjacency and the incidence matrix.
A(G1) =

0 1 1 0 1
0 0 1 0 0
1 1 0 1 1
0 0 1 0 1
1 0 1 0 0
 .
The spectrum of G1 is then given as
Spec(G1) =
(
2.6 −1.4 + 0.2i −1.4− 0.2i 0.1 + 0.4i 0.1− 0.4i
1 1 1 1 1
)
.
3The physiological processes in each compartment will be modelled by multi-kernel
integral operators respectively to its internal morphology.
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Figure 5.1: The directed graph of the limbic system
The existence of complex eigenvalues is caused by the non-symmetric struc-
ture of A(G1) (G1 is a directed graph).
The automorphism group of the limbic system is an 8-dimensional sub-
space of the form:
Aut(G1) = {M ∈ GL(5,R)|M =

λ1 ∗ ∗ ∗ ∗
λ2 ∗ λ3 ∗ ∗
λ4 ∗ λ5 λ3 λ6
∗ ∗ λ7 ∗ ∗
λ8 ∗ λ7 ∗ ∗
} ,
where the ∗ represent linear combinations of the λi-components.
By incidence matrix D(G), we can make some foundamental statements
on the dimension of cycle-subspaces of a graph, and also the number of its
components.
D(G1) =

1 0 0 0 −1 1 0 0 −1 1 0 0
−1 1 0 0 0 0 0 −1 0 0 0 0
0 −1 1 0 0 0 −1 1 1 −1 −1 1
0 0 −1 1 0 0 0 0 0 0 1 0
0 0 0 −1 1 −1 1 0 0 0 0 −1
 .
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If c is the number of components of graph G, n the number of its vertices
and m the number of its edges, then
rank(D(G)) = n − c , co− rank(D(G)) = m − n + c .
The incidence matrix of G1 has rank 4. It means that G1 consists of only
one component. The co-rank of D(G1) is 8. Using our knowledge that the
cycle-subspace of G is the kernel of the incidence matrix of G and the kernel
of the incidence matrix is a vector space whose dimension is equal to the
co-rank of G (Biggs 1993), then the cycle-subspace of the limbic system is
an 8-dimensional vector space with the following basis (figure 5.2):
Figure 5.2: The cycle basis of the limbic system
There are two possible generating sets fulfilling the minimality property
of bases:
B1 = {Cortex , Amygdala} and B2 = {Thalamus , Amygdala}.
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It means that the compartments of the limbic system are all structurally
dependent on the basis set consists of the cortex (resp. the thalamus) and
the amygdala.
5.2.2 The Structure of the Basal Ganglia G2
Theorem: The basal ganglia as a graph is 3-dimensional (three minimal
generators) and has a 6-dimensional cycle-subspace.
The basal ganglia is a graph structure which contains seven compartments:
the cortex (w1), the corpus striatum (w2), the substantia nigra pars compacta
(w3), the globus pallidus externa (w4), the nucleus subthalamicus (w5), the
globus pallidus interna (w6) ,and the thalamus (w7) (figure 5.3). We first
begin with the quantitative analysis of the algebraic properties of the limbic
system through its adjacency matrix, and then we investigate its cycle-space
by the kernel of its incidence matrix. Finally, possible minimal generating
sets will be introduced.
Figure 5.3: The directed graph of the basal ganglia
The in/out-degrees are: δin(G) = 1, δout(G) = 1, ∆in(G) = 2 and
∆out(G) = 3. For further investigations, it is necessary to construct the
adjacency and the incidence matrix.
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A(G2) =

0 1 1 0 0 0 1
0 0 1 1 0 1 0
0 1 0 0 0 0 0
0 0 0 0 1 0 0
0 0 0 1 0 1 0
0 0 0 0 0 0 1
1 0 0 0 0 0 0

.
The spectrum of G2 is given as
Spec(G2) =
(
1.6 0.7 + 0.6i 0.7− 0.6i 0 −1.3 −1 −0.6
1 1 1 1 1 1 1
)
.
The existence of complex eigenvalues is again caused by the non-symmetric
structure of A2 (G2 is a directed graph).
D(G2) =

1 0 0 0 0 −1 0 0 0 0 1 1
−1 1 0 0 0 0 1 −1 1 0 0 0
0 0 0 0 0 0 −1 1 0 0 0 −1
0 −1 1 0 0 0 0 0 0 −1 0 0
0 0 −1 1 0 0 0 0 0 1 0 0
0 0 0 −1 1 0 0 0 −1 0 0 0
0 0 0 0 −1 1 0 0 0 0 −1 0

.
The incidence matrix of G2 has rank 6. It means that G2 consists of only
one component. The co-rank of D(G2) is also 6. The cycle-subspace of the
basal ganglia is an 6-dimensional vector space with the following basis (figure
5.4):
There are eight possible generating sets fulfilling the minimality property
of bases:
B1 = {Cortex, Striatum, Nucleus Subthalamicus};
B2 = {Cortex, Substantia Nigra, Nucleus Subthalamicus};
B3 = {Cortex, Striatum, Globus pallidus externa};
B4 = {Cortex, Substantia Nigra, Globus pallidus externa};
B5 = {Thalamus, Striatum, Nucleus Subthalamicus};
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Figure 5.4: The cycle basis of the basal ganglia
B6 = {Thalamus, Substantia Nigra, Nucleus Subthalamicus};
B7 = {Thalamus, Striatum, Globus pallidus externa};
B8 = {Thalamus, Substantia Nigra, Globus pallidus externa};
5.2.3 The Structure of the LBG-Network G3
Theorem: The LBG-network is 6-dimensional and has a 36-dimensional
cycle-subspace.
It reveals that the cortex (resp. the thalamus) are generators of both path-
ways. Considering figure 2.5, the generalized information processing pathway,
we recognize that both compartments are bridges between the two pathways:
the limbic system and the basal ganglia. Because of the inclusion of some
extra compartments which are not compartments of the limbic system or
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basal ganglia, the structure of the LBG-network is more complicated as the
union of both pathways through cortical and thalamic bridges.
The complexity of the LBG-network reveals also in the structure of the
adjacency matrix and the spectrum:
The spectrum of G3 is given as
Spec(G3) =
(
4.2 −2.3 1.5 1.03i −1.03i 0.9 0.3 −0.5 −1 0
1 1 1 1 1 1 1 1 4 2
)
,
calculated from the following adjacency matrix A(G3)
A(G3) =

0 1 1 1 1 0 1 0 1 1 0 0 0 0
0 0 0 0 0 0 0 1 0 0 0 1 0 0
1 0 0 0 1 0 0 1 1 0 0 1 0 0
1 0 1 0 1 0 0 0 0 0 0 0 1 1
1 0 1 1 0 1 0 0 0 1 1 0 0 0
0 0 0 0 1 0 1 0 0 0 0 0 0 0
0 0 0 0 0 1 0 0 0 0 1 0 0 0
0 1 0 0 0 0 0 0 0 0 0 0 0 0
1 0 1 1 1 1 0 0 0 1 1 1 0 0
0 0 0 1 1 0 0 0 0 0 0 0 0 0
0 0 0 1 1 1 1 0 0 0 0 0 1 0
0 0 0 1 0 0 0 0 0 0 0 0 0 0
0 0 0 1 0 0 0 0 0 0 0 0 0 0
0 0 0 0 1 0 1 0 0 0 0 0 0 0

.
Analysis of the incidence matrix suggests that rank(D(G3)) = 13, which
leads to the fact that the LBG-network has also only one component and is
fully connected. The co-rank of D(G3), which is also the dimension of the
cycle-subspace of G3 is
co− rank(D(G3)) = 49− 14 + 1 = 36 .
Thus, the cycles-subspace of G3 is a 36-dimensional subspace. The inclusion
of brain regions that are not compartments of the basal ganglia and the
limbic system, such as nucleus raphe, and the strong interactions between
both systems, is a possible reason for the increased dimension of the cycle-
subspace. An interesting observation is also that the generating sets of the
LBG-network fulfilling the minimality property for bases are unions of the
bases of the limbic system, the basal ganglia and the hippocampus. The
possible minimal generating sets for the LBG-network consist of:
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The cortex (resp. the striatum), the substantia nigra, the nucleus subtha-
lamicus, the thalamus, the amygdala, and the hippocampus.
Now, we are ready to introduce mathematical models of dynamical pro-
cesses on the graph structures of the basal ganglia, the limbic system and
also the LBG-network. We have classified these structures by their spectra,
their cycle-subspaces and their generating sets.
Remark: The discovered algebraic and topological properties of these struc-
tures are useful to interpret the generation of dynamical patterns on these
networks as functions of the activity of certain compartments (probably on
networks with reduced structures). This correspondence is not investigated
in this thesis but is of great interest for the future research.
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Chapter Six
Electrophysiological and
Neurochemical Modelling
In this chapter, the principal investigations on the modelling of neurochemi-
cal and electrophysiological processes on neural pathways will be introduced.
First, classical models of the synaptic processes such as Hodgkin-Huxley
equations and kinetic Markov models will be discussed. Then, the problem of
neurotransmitter diffusion or active transport in synapses is discussed, math-
ematically analyzed and models will be introduced. Neurochemical modifica-
tion of the Hodgkin-Huxley equations is the main result of our electrophysio-
logical investigations on synaptic processes, which will also be used in higher
scales. After the discussions on the synaptic processes, the physiological pro-
cesses in a single compartment are modelled considering its ultra-structural
and general morphology, by integral equations. Multi compartment models
are the key to attach the neurophysiology with mental diseases. Therefore,
the dynamical behaviour of neurotransmitter systems is analyzed in terms of
their regional concentrations corresponding to the local electrophysiological
acitivities.
6.1 Synaptic Modelling
The Hodgkin-Huxley equations (Hodgkin and Huxley 1952) describe the
change in membrane potential or voltage V as a function of the sodium
(INa+), potassium (IK+), leakage (Ileak), and stimulating (Iinput) currents
across the membrane as well as membrane capacitance C. The most general
form of the Hodgkin-Huxley equations is:
C
dV
dt
= −INa+ − IK+ − Ileak + Iinput .
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Although the Hodgkin-Huxley equations consider the biochemical processes
by including ionic currents, they disregard the action and influence of neu-
rotransmitters in the generation of action potentials. There are several at-
tempts to enhance this problem. Kinetic Markov models connect the ligand-
gating processes and the post-synaptic electrophysiology in this sense. These
models contain general information (such as neurotransmitter concentra-
tions) on the way how neurotransmitters act on receptors at post-synaptic
membranes but they do not include specific properties of the different neu-
rotransmitter systems, which are necessary to investigate the quality of their
influence.
Following a brief review of the Hodgkin-Huxley equations and the kinetic
models, we shall study novel neurochemical modifications of these equations,
which consider the influence of the concentration-values of specific neuro-
transmitters on the process of the generation of action potentials. To get a
nearly complete overview on synaptic processes, we introduce a model for
neurotransmitter transport (diffusion), which also describes the physiolog-
ical processes at pre-synaptic membranes, such as the interaction between
autoreceptors, Ca2+-influx and neurotransmitter release.
6.1.1 Hodgkin-Huxley Equation
The scientific content of the Hodgkin-Huxley equations comes from two
sources First is the observance of Ohm’s law for the individual currents.
The second is the hypothesis that the Na+, K+ and leakage currents are
all independent and therefore sum in the general equation. As each current
obeys Ohm’s law, the current I = g(V −E), where g is the electrical conduc-
tance (reciprocal of the resistance), V is the voltage across the membrane,
and E is the equilibrium potential of the ion in question computed from the
Nernst equation:
E =
RT
zF
ln(
Cout
Cin
) ,
where z is the charge on the ion in question, and Cout and Cin are the re-
spective concentrations of the ion outside and inside the cell. R and F are
respectively the thermodynamics gas constant and the Faraday constant, and
T is the temperature in degrees Kelvin.
The capacitance C arises from the fact that the lipid bilayer of the axon
membrane forms a thin insulting sheet that serves to store electrical charge
in the same way as an electrical capacitor (Hille 1992). Hodgkin and Huxley
discovered empirically that the conductances were not constant but rather
functions of the membrane potential V , and this voltage dependence is the
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key to understanding action potentials. Therefore, they reformulated the
above equation as:
C
dV
dt
= −gNa+m3h(V −ENa+)−gK+n4(V −EK+)−gleak(V −Eleak)+Iinput
dm
dt
=
1
τm(V )
(−m+M(V ))
dh
dt
=
1
τh(V )
(−h+H(V ))
dn
dt
=
1
τn(V )
(−n+N(V ))
where
τi =
1
αi + βi
, i ∈ {m,h, n}
and
αm = 0.1 (V + 25) e
−(V+25
10
−1) , βm = 4 e
V
18
αh = 0.07 e
V
20 , βh = e
−(V+30
10
+1)
αn = 0.01 (V + 10) e
−(V+10
10
−1) , βn = 0.125 e
V
80 .
In the first equation, ENa+ , EK+ , and Eleak are the equilibrium potentials
at which each of the three currents is balanced by ionic concentration differ-
nces across the membrane. Evidently, the Hodgkin-Huxley equations are a
fourth order system of nonlinear differential equations. The additional vari-
ables m, h, and n represent the rates of Na+ conductance channel activation,
Na+ channel inactivation, and K+ channel activation respectively. Nonlin-
earity results from the fact that equilibrium values of these variables, M(V ),
H(V ), and N(V ) are all functions of the membrane potential V , as are the
time constants τm, τh, and τn. Simulation of these equations reveals dynam-
ical patterns, which are very similar to the clamp-experimental observations
(figure 6.1).
If Iinput = 0, the rest state of the model is linearly stable but is excitable;
that is, if the perturbation from the steady state is sufficiently large there is
a large excursion of the variables before returning to the steady state.
If Iinput 6= 0, there is a range of values where regular repetitive firing
occurs; that is the mechanism displays limit cycle characteristic (Murray
1989). Both types of phenomena have been observed experimentally.
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Figure 6.1: Graphical representation of the solutions of the Hodgkin-Huxley equations; (Grey:m; Green:h;
Cyan:n)
6.1.2 Kinetic Markov Models
The behaviour of the synaptic currents can be captured using kinetic mod-
els that describe the transitions between conformational states of these ion
channels. This class of models, of which the Hodgkin-Huxley model is an
instance, are commonly known Markov models. First, we begin formally to
describe state diagram for different types of gating, present the correspond-
ing kinetic equations, and explain how to relate them. Second, the explicit
models for the transmitter release and post-synaptic currents will be intro-
duced (Destexhe et al. 1998). And finally some simulation results will be
presented.
Generally, kinetic models are written as state diagrams
S1 
 S2 
 · · ·
 Sn ,
where S1, · · · , Sn represent the various states of the channel. The transition
between any pair of states can be written as
Si
rij /o
rji
Sj ,
where rij and rji are the rate constants that govern the transition between
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states Si and Sj. The fraction of channel in state Si, si, obeys the relation
dsi
dt
=
n∑
j=1
sjrji −
n∑
j=1
sirij ,
which is the conventional kinetic equation for the various states of the system.
In the case of voltage-dependent channels, the rate constants will depend
on voltage:
Si
rij(V ) /o
rji(V )
Sj .
The voltage dependence of the rate constants can be expressed as
rij(V ) = e
−Uij(V )
RT ,
where Uij(V ) is the free-energy barrier for the transition from state Si to
Sj, R is the gas constant and T is the absolute temperature. The exact
form of Uij(V ) involves both linear and nonlinear components arising from
interactions between the channel protein and the membrane electrical field.
In the case of ligand-gated channels, the transition between unbound and
bound states of the channel depends on the concentration of ligand:
L+ Si
rij(V ) /o
rji(V )
Sj .
Here, L is the ligand, Si the unbound state, Sj the bound state, and rij and
rji rate constants, as defined before.
These models have to be fitted by complex algorithms to the experimental
data.
Following the excellent work of Parnas work-group (Yusim et al. 1999)
on the mechanism of controlled neurotransmitter release, we introduce their
hypothesis and related kinetic models on this subject. Their investigations
lead to the foundation of the theory that
• Depolarization shifts the autoreceptor from a high affinity state (RH)
to a low affinity state (RL), and repolarization induces the reverse
transition;
• The autoreceptor R must be bound to the neurotransmitter (•) before
it can become associated with the exocytotic apparatus (Ex), and Ex
will soon detach from the unbound autoreceptor;
• Association of a (bound) autoreceptor with Ex blocks it, making it
unable to induce release.
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This hypothesis is supported by the following experiments. Electrically
evoked release of ACh was enhanced by antagonists (hyoscine, scopolamine
or atropine) of muscarinic ACh receptors (mAChRs) in guinea pig ileum
(Morita et al. 1982; Peteris and Ogren 1988), rat urinary bladder (DAgostino
et al. 1986), rat or mouse phrenic nerve (reviewed by Wessler 1989) and using
methoctramine in frog neuromuscular junction (Slutsky et al. 1999). The
same effect was found in a glutamergic system, using APV as an antagonist
of glutamergic synapses in crayfish (Parnas et al. 1994).
Since decreased transmitter binding decreases the amount of Ex associ-
ated with an autoreceptor, the experimental finding that decreased transmit-
ter binding increases release is quite direct evidence that Ex is blocked when
it associates with a bound autoreceptor.
Statement: Depolarization acts in two parallel ways; one is to open
voltage-dependent Ca2+ channels, and another is to free the exocytotic
apparatus from the blocking autoreceptor. This liberation of the exocytotic
apparatus from the autoreceptor must occur if release is to proceed; free
exocytotic machinery acts together with Ca2+ to induce release.
Having described the essence of how the control mechanism works, we turn
now to a mathematical formulation of an integrated model for the control
of release 1. We begin with differential equations that describe the pro-
cesses that determine the intracellular Ca2+ concentration Cain, together
with equations that describe the joint actions of Cain and the free exocytotic
machinery Ex in inducing release.
The assumptions which are employed concerning calcium are quite con-
ventional: entry occurs via voltage-dependent calcium channels and calcium
is removed by saturating processes. For evoked release, Cain is determined
by adding to the resting level, Car , the depolarization-dependent calcium
entry diminished by the calcium removal process. The kinetics are thus given
by (Lustig et al. 1990)
dCain
dt
= Entry(t) − Removal(t) ;Cain(0) ≥ Car ,
where Entry(t) and Removal(t) are the entry and removal rates at time t,
respectively. The phenomenological equations that describe the entry and
removal rates are
1These paragraphs are based (in sense and text) on the paper Yusim et al. (1999)
and have only to be considered as an introduction into the current research in the area of
kinetic modelling of synapses
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Entry(t) =
EmaxCho(t)Cae
Ke(φ)CCae
,
Removal(t) =
Rmax(Cain(t) − Car)
KrC(Cain(t) − Car) .
Here, Cae denotes the extracellular Ca
2+ concentration, Emax represents
the maximal possible entry per open channel, Cho(t) describes the concen-
tration (per unit area) of open channels as a function of time. The half-
saturation coefficient Ke is assumed to be an increasing function of depo-
larization φ. The maximum rate of removal Rmax and the half-saturation
parameter Kr for the removal rate are not voltage dependent. Channel ki-
netics is given by the kinetic scheme
Cho
kφc /o
kφop
Chc ,
which leads to the following differential equations
dCho
dt
= kφopChc − kφcCho , Chc + Cho = ChT ,
where ChT denotes the total concentration of the channels and Chc and
Cho, respectively, denote the concentrations of closed and open channels.
The superscript φ denotes voltage dependence.
In the present model, the combined action of Ex and Cain yields a com-
plex Q. Cooperative action of four Q molecules with a vesicle V activates V
to V ∗ and leads to release L:
Ex + Cain
c1 /o
c−1
Q ,
4Q + V
c2 /o
c−2 V
∗ c3 // L // recovery .
Following Lustig (1989), it has been assumed that when recovery occurs the
four molecules participating in the release of a single vesicle will be returned
to the pool of control molecules. Yusim et al. (1999) postulated that the
molecules participating in release will return to Ex, i.e.,
L
c4→ 4 Ex .
We now present the kinetic differential equations for the autoreceptor, for
Ex, and for the joint effect of Ex and Cain on release:
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dRH
dt
= −(k3 + b2Tr)RH + k−3RL + b−2R•H ,
dRL
dt
= −(k−3 + b3Tr + b4Ex)RL + k3RH + b−3R•L + b−4RL ∧ Ex ,
dR•H
dt
= −(k2 + b−2 + a2Ex)R•H + k−2R•L + b2TrRH + a−2R•H ∧ Ex ,
dR•L
dt
= −(k−2 + b−3 + a3Ex)R•L + k2R•H + b3TrRL + a−3R•L ∧ Ex ,
dRL ∧ Ex
dt
= −(b−4 + a4Tr)RL ∧ Ex+ b4ExRL + a−4R•L ∧ Ex ,
R•H ∧ Ex
dt
= −(k1 + a−2)R•H ∧ Ex+ k−1R•L ∧ Ex+ a2R•HEx ,
R•L ∧ Ex
dt
= −(k−1+a−3+a−4)R•L∧Ex+k1R•H∧Ex+a3R•LEx+a4TrRL∧Ex ,
dEx
dt
= −(a2R•H + a3R•L + b4RL)Ex+ a−2R•H ∧ Ex
+a−3R•L ∧ Ex+ b−4RL ∧ Ex− c1ExCain + c−1Q+ 4c4L ,
dQ
dt
= −c−1Q− 4c2V Q4 + c1ExCain + 4c−2V ∗ ,
dV ∗
dt
= −(c−2 + c3)V ∗ + c2V Q4 ,
dL∗
dt
= c3V
∗ − c4L .
The simulations of these equations reveal graphs which are qualitatively
similar to the experiments (figure 6.2: Yusim et al., 1999).
In the case of post-synaptic currents, detailed models based on activa-
tion by a very brief increase in transmitter concentration must capture three
principal aspects of receptor gating kinetics:
• Activation/binding: The time course of the rising phase of the synaptic
current can be determined either by the rate of opening after neuro-
transmitter is bound to the receptor of, at low concentrations, by the
amount of neurotransmitter present;
• Deactivation/unbinding: The time course of decay can be determined
by either deactivation following transmitter removal or desensitization;
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Figure 6.2: Dependence of the evoked release on membrane potential. (a) Experimental results concerning
the dependence of the time course of release at two levels of depolarization (Parnas et al. 1989). Graphs are
normalized, each to its peak amplitude. (b) Theoretical results corresponding to (a). High depolarization
(solid line) is represented by k1 = k2 = k3 = 8, low depolarization (dashed line) is represented by
k1 = k2 = k3 = 2. (c) Experimental results concerning the diminution of quantal content by post-pulse
hyperpolarization (Arechiga et al. 1990). (d) Theoretical results corresponding to (c). Depolarization
pulse: k1 = k2 = k3 = 2m/s. Hyperpolarizing pulse: k−1 = k−2 = k−3 = 0.9m/s. (copyright: Yussim et
al. 1999)
• Desensitization: Synaptic receptor-gated channels can be closed by en-
tering a desensitized state. It can prolong the decay time and shorten
the rise time.
The Markov kinetic models for synaptic currents are constructed in the
same way as for the release procedure of neurotransmitters, considering the
mentioned receptor states. The kinetic models are capable to be fitted to the
experiments very accurately, but the differences between the various neuro-
transmitter groups are neglected. These models also disregard the spatial
extension of the synaptic cleft, and also possible transmitter transport pro-
cesses in this area and diffusion in the extracellular space.
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6.1.3 Diffusion or Active Synaptic Transport?
Statement: The electrical flux is 103 times stronger than the diffusion flux
in the synaptic cleft.
The qualitative and quantitative description of the motion of neurotransmit-
ters in the synaptic cleft (sc) reveals to be one of the most difficult problems
in the modelling of synapses. Synapses usually are about a few nm wide
and have diameters of about 20 − 25µm. These dimensions make it nearly
impossible to get experimental data on the intra-synaptic processes, such as
the motion of neurotransmitters from the pre-synaptic to the post-synaptic
membranes. There are several suggestions on the physiology of this proce-
dure. For some researchers, it is obvious that the gradient of neurotransmitter
concentration in the sc leads to a passive diffusion, which is best modelled
by diffusion equations in heterogeneous media. The existence of only a few
thousand molecules in a very small area in the process of motion makes this
idea at least from the mathematical point of view useless. The existence of
electrical fields in the synapses generated by the membrane potentials, the
polarity of the neurotransmitters and also the dipole-dipole interaction of
neurotransmitters with receptors suggest that the motion of neurotransmit-
ters is probably caused by such temporal electrical fields.
To ensure that a special inclusion of the electrical fields is also physi-
ologically treatable, we compared the order of magnitude of the diffusion
flux (−D ∂c
∂x
) for 105 dopamine molecules with the electrical current den-
sity (σ · E) generated by the electrical potential difference between the pre-
and post-synaptic membranes. The investigation suggested that the order
of magnitude of the current density preponderates the diffusion flux’ on a
factor of 103.
Jdiff < < JEM .
It justifies our ambitions to consider the motion of neurotransmitters in the
intra-synaptic area as an active electrical transport and to model it with
methods of electrodynamics and statistical mechanics. We would like to un-
derline the fact that the above consideration does not preclude the possibility
of extracellular diffusion which is in fact often observed and is physiologically
relevant (Bach-y-Rita 2001; Vizi 2000).
The hypothesis of intra-synaptic active electrical transport could be also
supported by the physiology of neurotransmitter-transporters like hDAT and
the functionality of autoreceptors. The function of both structures depends
strongly on the membrane potentials (Sonders et al. 1997; Parnas et al.
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2000). Ample electrophysiological evidence shows that activation of autore-
ceptors in dopaminergic cells in the substantia nigra and ventral tegmental
area causes the cells to hyperpolarize through the G-protein-mediated open-
ing of K+ channels (Lacey 1993). Experiments by Sonders and colleagues
(1997) suggest that in regions of dopaminergic neurons in which hDAT and
D2 receptors are colocalized, hyperpolarization attributable to autoreceptor
activation by DA will increase the DAT turnover rate and thus accelerate
the clearance of extracellular DA. The stability of this process is guaranteed
by the fact that the DA-activated K+ conductance would act to offset the
depolarizing action of the transport-associated current, and thereby cancel
the small, positive feedback effect that DA uptake might contribute toward
promoting Ca2+-dependent vesicular DA release.
Statement: The neurotransmitters are transported merely by the intra-
synaptic electrical field from the pre- to the post-synaptic membrane. The
concentration gradient of neurotransmitters in the synaptic cleft changes the
polarity of the intra-synaptic electrical field. Higher neurotransmitter con-
centration at the post-synaptic membrane leads to its de/hyperpolarization
because of the higher probability of neurotransmitter-receptor bindings.
To mathematically model the motion of neurotransmitters in a changing elec-
trical field which interacts with the local concentration of the neurotransmit-
ters, we utilize well-known methods and formulations from electrodynamics
and statistical mechanics. Let us remind the continuity equation and equa-
tion for electrical force in a field 2:
∂ρ
∂t
+ div(ρv) = 0 ,
F = −q · E .
The velocity of the neurotransmitters has the negative direction of the elec-
trical fields and is directly proportional to their values.
F = −qE = mvd
τ
,
vd is the drift velocity and τ the time between collisions. Thus, the prod-
uct of the electrical field and the concentration has been taken to describe
the current density, similar to the Nernst-Planck-equations. The release of
neurotransmitters in the sc (frelease(ρ, t)) and the nonsynaptic diffusion of
2ρ denotes the density of particles and v their velocity; q the electrical charge of a
particle in a field with the strength E.
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neurotransmitters (γex) produce an inhomogeneity in the continuity equa-
tion. These considerations modify the continuity equation to the form:
∂ρ
∂t
+ div(−αρE) = frelease(ρ, t)− γex , α = const. .
We also mentioned that the temporal change of electrical field depends
on the alterations of the local concentration of neurotransmitters. This could
be modelled by:
∂E
∂t
= β ∇ρ , β = const. , βz > 0
Resume: Experiments on the dependency of neurotransmitter dynamics
from the membrane potentials, the comparison of order of magnitudes of
diffusion and electrodynamical processes, and already existing ideas from
physics, led us to derive the following model for the motion of neurotrans-
mitters in the synaptic cleft:
∂E
∂t
= β ∇ρ , βz > 0
∂ρ
∂t
+ div(−αρE) = frelease(ρ, t)− γex .
The initial boundary problem is determined by Dirichlet boundary condi-
tions for ρ and E, with a potential decline on the side-boundaries. Iterative
methods provide solutions for the above system. The iterations are necessary
because of the integro-differential structure of the equations.
The above model is also advantageous to connect the pre- and post-
synaptic processes together and hence, the synaptic processes could be mod-
elled as a unit. The electrophysiological and neurochemical processes on
synaptic membranes will be modelled by a biochemical modification of the
Hodgkin-Huxley equations and kinetic models in the next section; and the
interconnection with the active transport through the changes in electrical
field strength will be discussed.
Statement: Although the diffusion flux is 1000-times smaller than the
electrical flux, it is not fully insignificant. This fact suggests to apply a
modification of the Poisson-Nernst-Planck equations to model the transport
in the synaptic cleft.
Similar to the concept of the ion transport through membranes, we use the
Poisson-Nernst-Planck equations to model the transport of neurotransmitters
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inside the synaptic cleft. There are two major electrical fields that influence
the motion of neurotransmitters, the density electrical field gradψ obtained
by the Poisson-equation, and the external membrane field E which depends
on the concentration gradient of neurotransmitters in the cleft. The reason
for this dependency is on the pre-synaptic membrane the existence of trans-
porter molecules and on the post-synaptic membrane side, the generation of
action potentials as a function of neurotransmitter concentration (the more
neurotransmitters at the post-synaptic membrane the more receptors are
activated). The sum of these potentials is the effective electrical potential
in the synapses. Beside the electrical fields, the existing neurotransmitter
concentration gradient between the pre- and post-synaptic membrane after
the release of neurotransmitters generates also a flux directed to the post-
synaptic side.
Let Ω be a bounded domain of the d-dimensional Euclidean space Rd,
d ≤ 3, and [0, T ] a bounded time-interval. We Supposing that the boundary
∂Ω of Ω is the union of two disjoint parts ∂Ω1 and ∂Ω2, then the following
initial boundary value problem describes the dynamics of neurotransmitter
concentrations in the synaptic cleft:
∂ρ
∂t
+ div(−µkT
q
(
∂ρ
∂x
)− µczρ(∂ψ
∂x
)− zαρE) = f(t,∇ρ, ψ) , in (0, T ]× Ω
∆ψ = zρ , in Ω
∂E
∂t
= β ∇ρ , βz > 0 in Ω
ρ = ρ∂Ω , ψ = ψ∂Ω, on (0, T ]× ∂Ω ,
ρ(0, x) = ρ0(x) , in Ω ,
where the parameters are taken to be: µ the mobility, z the valency, T the
temperature in Kelvin, k the Boltzmann constant, c a parameter obtained
by Einstein-relation and α a multiplicative constant.
We have to remark that E describes the electrical field of the synaptic
membranes. It also depends on external influences such as incoming action
potentials. Thus, its dynamical behaviour is investigated separately.
It is a very difficult problem to investigate the existence and uniqueness
of the above equations with arbitrary fields E. By imposing the following
hypotheses, there exists a unique solution of similar problems for known
external fields E (Gajewski, 1985):
• ρ0 ∈ L+2 = {g ∈ L2|g(x) ≥ 0inΩ}.
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• The mobilities have the form µ = m +M(|∇ψ|, x), 0 < m = const..
The functions x → M(s, x) for s ≥ 0 are measurable. Furthermore
there are constants M1 and M2 such that for all s, s1 ≥ 0
|M(s, x)s| ≤M1 , |M(s, x)s−M(s1, x)s1| ≤M2|s− s1| in Ω .
• The boundary ∂Ω is the union of two (d − 1)-dimensional parts ∂Ω1
and ∂Ω2. ∂Ω1 is closed in ∂Ω.
• 0 ≤ σ ∈ L∞(∂Ω), mes(∂Ω1 ∪ suppσ) > 0. ∂Ω1, ∂Ω2 and σ are such
that the map g → ψ with: −∆ψ = g in Ω; Bψ = 0 on ∂Ω; Bψ = ψ
on ∂Ω1 and Bψ =
∂ψ
∂ν
+ σψ on ∂Ω2; is an isomorphism of Lr onto W
2
r
(d < r < 6).
• There exist functions P ∈ W 2r and R ∈ W 1r such that BP = ψ∂Ω and
R = ρ∂Ω on ∂Ω1 and R ≥ c > 0 in Ω¯.
6.1.4 Biochemical Modifications of the Hodgkin-Huxley
Equations
Statement: In chemical synapses the neurotransmitter-receptor binding
causes the depolarization of membranes. The higher the neurotransmitter
concentration (up to a certain threshold) the oftener this binding and the
higher the probability of the generation of post-synaptic potentials. The
gating parameters of the Hodgkin-Huxley equations express this probabil-
ity. By including the quadratic value of the neurotransmitter concentration
in the equations for gating parameters and neurotransmitter-specific ion
channels, the HH-equations become neurochemically modified.
In the last sections, we discussed the existing mathematical methods for
the generation of action potentials, the neurotransmitter-receptor kinetics
(especially interesting for pre-synaptic processes), and we have developed an
active transport model for neurotransmitters in the synaptic cleft caused by
electrical fields which are generated by membrane potentials. In this section
we modify the Hodgkin-Huxley equations neurochemically, by making them
dependent from the special properties of neurotransmitters.
In general, the Hodgkin-Huxley equations are based on Ohm’ law and the
fact that ionic diffusion through ion channels leads to de-/hyperpolarization
of the membranes. Any neurotransmitter acts on proper receptors which
interact with special ion channels. Let us consider for a moment the GABAA-
receptors as an example. The binding of GABA on these receptors causes
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confirmation changes of neighboring Cl−-channels. Other neurotransmitters
interact in a similar way with various but specific ion channels.
It is obvious that the generation of action potentials at the post-synaptic
membranes depends also from the concentration of neurotransmitters at the
post-synaptic membrane. Then, if there are not enough neurotransmitters
to bind on receptors, the membrane depolarization could not be achieved.
These observations are the foundation of the modified Hodgkin-Huxley
equations. We will embed the concentration of neurotransmitters ck(x, t)
3 in
the equation for the gating parameters pk, then it expresses the probability
of ligand-gating. The relation between different neurotransmitters and ion
channels will also be used in terms of currents through special ion channels,
denoted by index r, it means that the main equation does not only include
the Na+ and K+ ion currents but also other related ion channels for certain
neurotransmitters. We can formulate these modifications by the following
model:
dpk
dt
= ξ · (ck(x, t))2(1− pk) − ς · pk ,
Irk = g¯
r
k · pk · (uk −Hrk) ,
Cm
dui
dt
= −
∑
k
(
∑
r
Irk) + Ileak .
These equations correspond directly with the active transport equations
of the last section. The concentration of neurotransmitters ck(x, t) is the
value of ρk(x, t) in a volume dV or in the one-dimensional case in a line dx:
ck(x, t) =
∫
ρk(x, t)dx .
The electrical potential uk which can be calculated from the above equations
is also related to the active transport equations, namely by E. The membrane
potentials generate the electrical field with the strength E, also:
ui(pre, post) ←→ E .
These correspondences unify the models for different synaptic processes as
one connected process. Kinetic models represent the release of neurotrans-
mitters, caused by an arriving action potential and dependent from the mem-
brane potential by the action of autoreceptors. The active transport model
describe the temporal and spatial changes in intra-synaptic concentration of
neurotransmitters in dependence to membrane potentials and the temporal
3Index k denotes the kind of neurotransmitters; The quadratic value of concentration
is embedded to make the parameters more sensitive to its changes.
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changes in membrane potentials coupled to the changes in neurotransmitter
concentrations. The modifications of the Hodgkin-Huxley equations close
the whole process by modelling the generation of post-synaptic action poten-
tials as a function of neurotransmitter concentrations as dependent from the
special properties of neurotransmitters.
6.2 Single Compartment Models
The brain does not integrate information in the synaptic scale but it has
developed connected regions called Nucleus which process a high amount of
synaptic information. To understand the physiology of this integration pro-
cess, it is necessary to understand the neuronal architecture of the regions
and classify them by their morphological and ultra-morphological proper-
ties. The morphology and ultra-structural morphology of the nuclei are often
studied by neurohistochemical methods, such as Golgi-studies and immuno-
histochemical investigations. The immunohistochemical studies reveal the
appearance of certain neurotransmitter systems in a structure; Golgi-studies,
on the other hand, reveal information about the form of neurons expressing
the obtained neurotransmitter systems and their interconnections. In gen-
eral, the topology of the structure is then obtained. The knowledge about
the appearance of different neurons and the synaptic interactions between
different kinds of neurons inside a nucleus allow us to abstract its structure
through networks.
The experiments on the topology of brain regions suggest that these struc-
tures could be subcategorized as heterogeneous media. There are various
mathematical methods describing dynamical processes in heterogeneous me-
dia, such as asymptotic analysis, homogenization, and integral equations.
Here, we decided to embed the network structure in two scales into an inte-
gral operator, which is supposed to describe the electrophysiological integra-
tion processes inside a nucleus. The idea is to use the mentioned experiments
by modelling the synaptic interactions of different neurons in a small network
structure, a neuron-complex set, which we call a n-cell. Assembling a con-
venient number of n-cells by considering the large scale interaction between
the n-cells, we get a model how a nucleus integrates a number of incoming
electrophysiological synaptic inputs, which are already modelled (figure 6.3).
We will begin with an introduction of the experimental methods, which
are of interest for the analysis and modelling of single compartment integra-
tion processes. In the second part of this section, we construct a mathemat-
ical model for these processes, roughly explained in the above paragraphs.
Collecting the models up to the present, we will then be ready to build up the
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Figure 6.3: Composition of n-cells
desired multi-compartment model for information processing in the human
brain.
6.2.1 Morphological Study of the Brain Compartments
Immunohistochemical Experiments:
The immunocytochemical method is widely used to display certain com-
ponents of neurons. Those components allow statements about their molecu-
lar composition, especially of proteins and neurotransmitter origin. To make
this statements specific, antibodies are required which are directed against
structures or substances.
The structure can be directly or indirectly identified through the charac-
teristics of the antibodies.
• Direct Method: The most simple way to proof the existence of an anti-
gen is to use a specific antibody, which is coupled to a fluorescence
artificial or to an enzyme. The binding between the fluorescence or en-
zyme coupled antibody and the antigen can be observed either through
a fluorescence microscope or could be verified by light-microscopes after
an enzymatic reaction. The low amount of non-specific impregnations
and the fast implementation are the advantages of the direct over the
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indirect methods. The disadvantages are the low sensibility and the
high amount on primary antibodies which are required for the proce-
dure.
• Indirect Method: An antigen-specific unconjugated antibody binds to
the antigen (primary antibody). Fluorescence resp. enzyme conju-
gated secondary antibodies against the primary antibodies are used to
visualize the bindings.
Golgi-Impregnations:
Golgi-impregnation is a great method to display neuronal branches and
bifurcations, that was developed by the Italian pathologist Camillo Golgi in
1873 (Golgi 1873). The quality of the Golgi-impregnation is quit impressive.
Neurons are displayed as black subjects on a light background. Although the
neurons usually do not get impregnated completely, the neuronal branches,
dendrites, collaterals, and even spines are represented clearly. Within this
method, we are able to understand the topology of neurons, by terms like
the shape of dendritic branches, maximal length of dendrites, and the co-
ordination of spines. We will use this topological information to consider a
brain compartment as a network with different kind of vertices, which are
classified by their topological properties.
6.2.2 Modelling the Internal Information Processing
by Integral Operators
Statement: The integration of the activity in a brain compartment de-
pends on the density distribution and the interconnectivity of its interneu-
rons as well as the topology of the compartment.
For one network cell, the model consist of an integral operator which includes
discrete kernels in general. ρ(z, y) describes the distribution of the z-neurons
4 in the 3-dimensional space Ωz 3 y. The range of this function is estimated
by Golgi-studies on the morphology of brain compartments. As an example,
we characterized the distribution of four different families of neurons in the
corpus striatum qualitatively (figure 6.4).
The function ψ(x, y) describes the synaptic connection-affinity of different
neurons on a fixed network structure of a n-cell (fundamental domain). Its
4The z-neurons denote the family of neurotransmitters which are considered.
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Figure 6.4: The spatial distribution of striatal neurons
possible values could be obtained by ultra-structural morphology experiments
of brain compartments, which have also a sensibility to special z-neurons.
Within these functions our operator is:
v(t, z) =
∫
Ωz
ρ(z, y) · (
∑
x∈Ω
ψ(x, y)u(t, x))dy .
Considering a family of fundamental domains - instead of only one local n-cell
structure - then the above integral operator has to be generalized. Thereby,
one has to consider the interconnections between different fundamental do-
mains as well as the correct way of the potential superposition. These facts
leads to the averaged multi-layer-network integral operator:
v(t, z) =
∫
Ωh
ρ(z, y) ·
∑
i∈I χi(y)(
∑
x∈Ωi ψ(x, y)u(t, x))
|I| g(χ(y)) dy ,
⋃
i
Ωi ⊆ Ωh .
χi(y) describes the summation weight depending on the y-location of Ωi.
χ(y) = (χi(y)) is the i-vector of the summation weights. And g : R|I| → R is
the averaging parameter.
It reveals that for u(y)i :=
∑
i∈I χi(y)(
∑
x∈Ωi ψ(x, y)u(t, x)), the product
ρ(z, y) · u(y)i ≡ const. , ∀y .
Simulations showing the effect of this transition procedure are represented in
the third part.
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6.3 Multi Compartment Models
We have introduced mathematical models of synaptic processes, which have
been transformed by integral equations into higher scales. The level of single
compartments is our first approach to interpret the integration of synaptic
signals as neural information. If we want to connect the behaviour with
the physiology, it is necessary to design mathematical models, which realisti-
cally represent the interactions between different brain compartments. These
models have to include the neurochemical as well as the electrophysiological
processes. Considering both processes allows us to study and characterize
the influence of drugs on the behaviour by perturbations in the dynamical
patterns generated by our models and to validate our results with experi-
ments which are often from the electrophysiological point of view, such as
EEG and long field potentials (LFPs).
To embed the interactions between brain compartments into a mathe-
matical model, we first require information on the topology of the brain.
Therefore, we begin with a discussion of the topological properties of the
brain such as distances between different brain regions and their spatial rela-
tions, then information need time to be transported from one compartment
to other ones. We will introduce a well-known idea to translate spatial dis-
tances by temporal differences.
We will then represent the main part of this work, namely a neurochem-
ical multi compartment model of the human brain. It only contains general
anatomical and physiological assumptions. Parameters will be introduced
which allow the inclusion of characteristics of neurological and psychiatric
diseases as well as the influence of drugs. From mathematical point of view,
it is a system of coupled nonlinear delay differential equations of local neuro-
transmitter concentrations and electrophysiological activities, which gets its
input from our models for synapses and single compartments.
6.3.1 Spatial Propagation and Time-Delays
EEG studies suggest that the information processing of very simple motor
activities takes about 100 ms. The reason for this duration is not only the
integration of information in the compartments, it is also the time, which is
required for the propagation of the signals along neural projections between
the compartments. The simplified assumption that the propagation has a
constant velocity along any neural projection and innervation in the whole
brain allow us to substitute the spatial distances by applicable time intervals.
In other words, we will substitute distances by time-delays. It means that the
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rate of change of the neurochemical systems depends not only on their present
state, but also on their past history. The general form of such dynamical
systems is:
dx
dt
= f(x(t), x(t− τi), t) .
The neurochemical dynamical system which we attempt to construct will
describe the changes of neurotransmitter concentrations in the brain regions
coupled with the local electrophysiological activities. As we have seen be-
fore the macroscopic electrophysiological activity is a function of synaptic
potentials which are interacting with synaptic neurotransmitter dynamics.
Coupling these complex coherencies into a dynamical system enforces the
equations to have nonlinear right hand sides. It is expected that such non-
linear delay-differential equations reveal oscillatory behaviour.
Our propose to design a mathematical model consist of a coupled system
of nonlinear delay differential equations to describe the neurochemical pro-
cesses adds up if and only if solutions exist and are stable. Therefore, we
introduce a theorem (Driver 1962) on the existence and uniqueness of solu-
tions of a delay-differential system. We have to remark that because of the
nonlinearities of the equations and the number of delay parameters, analysis
of the system reveals highly non-trivial problems which bust the scope of this
thesis.
Theorem [Existence and Uniqueness]
Let the (right-hand side) functional F (t, ψ(.)) be (i) continuous in t,
and (ii) locally Lipschitz with respect to ψ, and let φ be any member of
C([α, t0] → D). Then there exists a unique solution, y(t) = y(t; t0, φ) on
[α, β) where t0 < β ≤ γ, and if β < γ and β cannot be increased, then for
any compact set A ⊂ D there is a sequence of numbers t0 < t1 < t2 < · · · → β
such that
y(tk) ∈ D − A for k = l, 2, · · · ,
i.e. y(t) comes arbitrarily close to the boundary of D or else y(t) is un-
bounded.
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6.3.2 The Dynamics of Neurotransmitter Concentra-
tions
Statement: The neurotransmitter dynamics on the brain pathways de-
pend on the connections of the compartments. Its value depends on the
outgoing dynamical behaviour (release), the incoming dynamical behaviour
(re-uptake), the regulatory mechanisms (synthesis) and the local electri-
cal potential, which is a function of neurotransmitter concentrations. The
spatial extension of the brain regions are expressed by time-delays.
Considering the network structure and neurotransmitter interactions in the
LBG-network, and the knowledge on the criteria for the existence and stabil-
ity of nonlinear delay differential equations, we are now able to construct an
applicable mathematical model. Any equation of this model shall describe
the time development of the concentration of a certain neurotransmitter sys-
tem in a brain compartment, which we denote by ski
5. The following tables
clarify our notation for compartments and substances.
These model equations comprise a large coupled system of time develop-
ments of extracellular neurotransmitter concentrations at different compart-
ments, which depends on the neurotransmitter averaged release behaviour,
averaged uptake procedure to the original compartment, and the synthesis of
5The low index denotes the region of consideration; The up index denotes the neuro-
transmitter system.
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the neurotransmitters. The uptake process depends on the spatial distances
and the duration of information integration in single compartments, thus it
includes time-lags τij = τji, which shall be estimated by metric data of the
brain. The synthesis machinery reacts not instantaneously on the release-
uptake dynamics. Hence, it also includes time-lags τ ki which depend on the
compartment and neurotransmitter properties.
Initial values for the neurotransmitter concentrations are estimated by ex-
tracellular neurotransmitter concentrations obtained from microdialysis ex-
periments (Ungerstedt 1984; Globus et al. 1988; Wassle and Chun 1988;
Sunol et al. 1988; Meyerson et al 1990; Ronne-Engstrom 1992; Kanthan
1995; Hutchinson et al. 2000; Hutchinson et al. 2002).
The release function frelease = f
k
ij(s
k
i , ui) from i to j is a function of arriv-
ing potentials at the compartment i and the amount of existing neurotrans-
mitter concentration in the same compartment. It is a bounded, continuous
and differentiable function which is the solution of systems differential equa-
tions (Parnas et al. 1989; Destexhe et al. 1994; Aharon et al. 1994; Destexhe
et al. 1998; Yusim et al. 1999; Parnas et al. 2000; Sela et al. 2005). Its
boundedness is because of the boundedness of neurotransmitter concentra-
tion values as well as the existence of autoreceptors which control the release
procedure. The re-uptake process includes a bounded, continuous and differ-
entiable function guptake = g
k
ji(s
k
i , γ
k
i ) which depends clearly on the value of
released neurotransmitters, and also on the synaptic metabolization factor
γki . The time-lags are in the ms scale. The synthesis process depends clearly
on the value recycled neurotransmitters, and also on the frequency of the
arriving action potentials ω(ui). These facts suggest the general form of the
equations:
dski (t)
dt
=
∑
j
(−fkij(ski , ui)ski (t)+gkji(ski , γki , uj)skj (t−τij)+σki (gkji, ω(ui))ski (t−τ ki )).
The neurochemcial system consists of a large system of equations of the
above form which are given explicitly in the following paragraphs. Instead
of reducing this system to a smaller one at the beginning, the system is com-
prised as general as possible to avoid the possibility of neglecting important
dynamical behaviour of any compartments.
The Cortex:
ds11(t)
dt
= −f 1{12,13,14,15,16,18,19}(u1(s23, s14, s15, s48))s11 + g121(u2(s11, s27))s12(t−τ12) +
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g131(u3(s
1
1, s
1
4, s
2
5, s
4
8))s
1
3(t− τ13) + g151(u5(s11, s33, s14, s16, s48, s69, s510))s15(t− τ15)+
g161(u6(s
1
1, s
4
5, s
5
10))s
1
6(t− τ16) + g181(u8(s11, s23))s18(t− τ18) +
g191(u9(s
1
1, s
2
5, s
3
8))s
1
9(t− τ19) +
f 141(u4(s
1
1, s
2
5, s
3
8, s
6
9, s
5
10, s
2
11, s
2
12))s
1
4(t) + σ
1
1(
∑
g1j1, ω(u1))s
1
1(t− τ 11 ) ;
ds21(t)
dt
= −g213(u1(s23, s14, s15, s48))s21(t−τ13) − g215(u1(s23, s14, s15, s48))s21(t−τ15) +
f 221(u2(s
1
1, s
2
7))s
2
2(t) + f
2
51(u5(s
1
1, s
3
3, s
1
4, s
1
6, s
4
8, s
6
9, s
5
10))s
2
5(t) ;
ds41(t)
dt
= −g418(u1(s23, s14, s15, s48))s41(t− τ18) + f 481(u8(s11, s23))s48(t) ;
The Nucleus Subthalamicus:
ds12(t)
dt
= −f 127,211(u2(s11, 227))s12(t) + f 112(u1(s23, s14, s15, s48))s11(t) +
g172(u7(s
1
2, s
2
3))s
2
7(t− τ72) +
g1112(u11(s
1
2, s
2
3, s
4
8))s
1
11(t− τ211) + σ12(
∑
g1j2, ω(u2))s
1
2(t− τ 12 ) ;
ds22(t)
dt
= f 272(u7(s
1
2, s
2
3))s
2
7(t) − g227(u2(s11, s27))s22(t− τ72) ;
The Corpus Striatum:
ds13(t)
dt
= −g131(u3(s11, s14, s25, s48))s13(t− τ13) + f 113(u1(s23, s14, s15, s48))s11(t) +
−g134(u3(s11, s14, s25, s48))s13(t− τ34) + f 142(u4(s11, s25, s38, s69, s510, s211, s212))s14(t) ;
ds23(t)
dt
= −f 2{31,35,37,38,311}(u3(s11, s14, s25, s48))s23(t) + g213(u1(s23, s14, s15, s48))s21(t−τ13) +
g273(u7(s
1
2, s
2
3))s
2
7(t−τ27) + g283(u8(s11, s23))s28(t−τ38) + g2113(u11(s12, s23, s48))s211(t−τ113)
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+ f 253(u5(s
1
1, s
3
3, s
1
4, s
1
6, s
4
8, s
6
9, s
5
10))s
2
5(t) + σ
2
3(
∑
g2j3, ω(u3))s
2
3(t− τ 23 ) ;
ds33(t)
dt
= −f 335(u3(s11, s14, s25, s48))s33(t) + g353(u5(s11, s33, s14, s16, s48, s69, s510))s35(t−τ35) +
σ33(g
3
53, ω(u3))s
3
3(t− τ 33 ) ;
ds43(t)
dt
= −g438(u3(s11, s14, s25, s48))s43(t− τ38) + f 483(u8(s11, s23)s48(t) ;
The Thalamus:
ds14(t)
dt
= −f 1{41,43,45,412}(u4(s11, s25, s38, s69, s510, s211, s212))s14(t) +
g134(u3(s
1
1, s
1
4, s
2
5, s
4
8))s
1
3(t− τ34) + g154(u5(s11, s33, s14, s16, s48, s69, s510))s15(t− τ54) +
g1124(u12(s
1
4, s
5
10))s
1
12(t− τ412) +
f 114(u1(s
2
3, s
1
4, s
1
5, s
4
8))s
1
1(t) + σ
1
4(
∑
g1j4, ω(u4))s
1
4(t− τ 14 ) ;
ds24(t)
dt
= −g245(u4(s11, s25, s38, s69, s510, s211, s212))s24(t− τ45) −
g2411(u4(s
1
1, s
2
5, s
3
8, s
6
9, s
5
10, s
2
11, s
2
12))s
2
4(t− τ411) −
g2412(u4(s
1
1, s
2
5, s
3
8, s
6
9, s
5
10, s
2
11, s
2
12))s
2
4(t− τ412) +
f 254(u5(s
1
1, s
3
3, s
1
4, s
1
6, s
4
8, s
6
9, s
5
10))s
2
5(t) + f
2
112(u11(s
1
2, s
2
3, s
4
8))s
2
11(t) +
f 2122(u12(s
1
4, s
5
10))s
2
12(t) ;
ds34(t)
dt
= −g348(u4(s11, s25, s38, s69, s510, s211, s212))s34(t− τ48) +
f 384(u8(s
1
1, s
2
3))s
3
8(t) ;
ds54(t)
dt
= −g5410(u4(s11, s25, s38, s69, s510, s211, s212))s54(t− τ410) +
f 5104(u10(s
2
5, s
1
6, s
3
8))s
5
10(t) ;
ds64(t)
dt
= −g649(u4(s11, s25, s38, s69, s510, s211, s212))s64(t− τ49) +
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f 694(u9(s
1
1, s
2
5, s
3
8))s
6
9(t) ;
The Amygdala:
ds15(t)
dt
= −g151(u5(s11, s33, s14, s16, s48, s69, s510))s15(t− τ51) −
g154(u5(s
1
1, s
3
3, s
1
4, s
1
6, s
4
8, s
6
9, s
5
10))s
1
5(t− τ54) +
f 115(u1(s
2
3, s
1
4, s
1
5, s
4
8))s
1
1(t) + f
1
41(u4(s
1
1, s
2
5, s
3
8, s
6
9, s
5
10, s
2
11, s
2
12))s
1
4(t) ;
ds25(t)
dt
= −f 2{51,54,59}(u5(s11, s33, s14, s16, s48, s69, s510))s25(t) +
g215(u1(s
2
3, s
1
4, s
1
5, s
4
8))s
2
1(t−τ15) + g241(u4(s11, s25, s38, s69, s510, s211, s212))s24(t−τ14) +
g295(u9(s
1
1, s
2
5, s
3
8))s
2
9(t− τ59) + f 235(u3(s11, s14, s25, s48))s23(t) +
σ25(
∑
g2j5, ω(u5))s
2
5(t− τ 25 ) ;
ds35(t)
dt
= f 335(u3(s
1
1, s
1
4, s
2
5, s
4
8))s
3
3(t)− g353(u5(s11, s33, s14, s16, s48, s69, s510))s35(t−τ35) ;
ds45(t)
dt
= −f 456(u5(s11, s33, s14, s16, s48, s69, s510))s45(t) + g465(u6(s11, s45, s510))s46(t−τ65)−
g458(u5(s
1
1, s
3
3, s
1
4, s
1
6, s
4
8, s
6
9, s
5
10))s
4
5(t− τ58) + f 485(u8(s11, s23)s48(t) +
g2105(u10(s
2
5, s
1
6, s
3
8))s
4
10(t− τ510) + σ45(g465, ω(u5))s45(t− τ 45 ) ;
ds55(t)
dt
= −g5510(u5(s11, s33, s14, s16, s48, s69, s510))s55(t− τ510) +
f 5105(u10(s
2
5, s
1
6, s
3
8))s
5
10(t) ;
ds65(t)
dt
= −g659(u5(s11, s33, s14, s16, s48, s69, s510))s65(t− τ59) +
f 695(u9(s
1
1, s
2
5, s
3
8))s
6
9(t) ;
The Hippocampus:
ds16(t)
dt
= −f 1{65,610}(u6(s11, s45, s510))s16(t) − g161(u6(s11, s45, s510))s16(t− τ16) −
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f 116(u1(s
2
3, s
1
4, s
1
5, s
4
8))s
1
1(t) + σ
1
6(
∑
g1j6, ω(u6))s
1
6(t− τ 16 ) ;
ds46(t)
dt
= f 456(u5(s
1
1, s
3
3, s
1
4, s
1
6, s
4
8, s
6
9, s
5
10))s
4
5(t) − g465(u6(s11, s45, s510))s46(t−τ65) ;
ds56(t)
dt
= −g5610(u6(s11, s45, s510))s56(t− τ610) + f 5106(u10(s25, s16, s38))s510(t) ;
The Globus Pallidus pars externa (GPe):
ds17(t)
dt
= −g172(u7(s12, s23))s17(t− τ27) + f 127(u2(s11, s27))s12(t) ;
ds27(t)
dt
= −f 2{72,711}(u7(s12, s23))s27(t) − g273(u7(s12, s23))s27(t− τ37) +
f 237(u3(s
1
1, s
1
4, s
2
5, s
4
8))s
2
3(t) + g
2
27(u2(s
1
1, s
2
7))s
2
2(t− τ27) +
g2117(u11(s
1
2, s
2
3, s
4
8))s
2
11(t− τ117) + σ27(
∑
g2j7, ω(u7))s
2
7(t− τ 27 ) ;
The Substantia Nigra pars compacta (SNc/VTA):
ds18(t)
dt
= −g181(u8(s11, s23))s18(t− τ18) + f 118(u1(s23, s14, s15, s48))s11(t) ;
ds28(t)
dt
= −g283(u8(s11, s23))s28(t− τ38) + f 238(u3(s11, s14, s25, s48))s23(t) ;
ds38(t)
dt
= −f 3{84,89,810}(u8(s11, s23))s38(t) + g348(u4(s11, s25, s38, s69, s510, s211, s212))s34(t−τ48) +
g389(u9(s
1
1, s
2
5, s
3
8))s
3
9(t− τ89) + g3108(u10(s25, s16, s38))s310(t− τ810) +
σ38(
∑
g3j8, ω(u8))s
3
8(t− τ 38 ) ;
ds48(t)
dt
= −f 4{81,83,85,811}(u8(s11, s23))s48(t) + g318(u1(s23, s14, s15, s48))s41(t− τ18) +
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g438(u3(s
1
1, s
1
4, s
2
5, s
4
8))s
4
3(t− τ38) + g458(u5(s11, s33, s14, s16, s48, s69, s510))s45(t− τ58) +
g4118(u11(s
1
2, s
2
3, s
4
8))s
4
11(t− τ811) + σ48(
∑
g4j8, ω(u8))s
4
8(t− τ 48 ) ;
The Nucleus Raphe:
ds19(t)
dt
= −g191(u9(s11, s25, s38))s19(t− τ18) + f 118(u1(s23, s14, s15, s48))s11(t) ;
ds29(t)
dt
= −g295(u9(s11, s25, s38))s29(t−τ59) + f 259(u5(s11, s33, s14, s16, s48, s69, s510))s25(t) ;
ds39(t)
dt
= −g398(u9(s11, s25, s38))s39(t− τ89) + f 389(u8(s11, s23))s38(t) ;
ds69(t)
dt
= −f 6{94,95}(u9(s11, s25, s38))s69(t) + g649(u4(s11, s25, s38, s69, s510, s211, s212))s64(t−τ49) +
g659(u5(s
1
1, s
3
3, s
1
4, s
1
6, s
4
8, s
6
9, s
5
10))s
6
5(t− τ59) + σ69(
∑
g6j9, ω(u9))s
6
9(t− τ 69 ) ;
The Hypothalamus:
ds110(t)
dt
= −g1106(u10(s25, s16, s38))s110(t− τ610) + f 1610(u6(s11, s45, s510))s16(t) ;
ds310(t)
dt
= −g3108(u10(s25, s16, s38))s310(t− τ810) + f 389(u8(s11, s23))s38(t) ;
ds410(t)
dt
= −g2105(u10(s25, s16, s38))s410(t−τ510) + f 4510(u5(s11, s33, s14, s16, s48, s69, s510))s45(t) ;
ds510(t)
dt
= −f 5{104,105,106,1012}(u10(s25, s16, s38))s510(t) + g5610(u6(s11, s45, s510))s56(t−τ610 +
g5410(u4(s
1
1, s
2
5, s
3
8, s
6
9, s
5
10, s
2
11, s
2
12))s
5
4(t− τ410) +
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g5510(u5(s
1
1, s
3
3, s
1
4, s
1
6, s
4
8, s
6
9, s
5
10))s
5
5(t− τ510) +
g51210(u12(s
1
4, s
5
10))s
5
12(t− τ1012) + σ510(
∑
g5j10, ω(u10))s
5
10(t− τ 510) ;
The Globus Pallidus pars interna (GPi/SNr):
ds111(t)
dt
= −g1112(u11(s12, s23, s48))s111(t− τ112) + f 1211(u2(s11, s27))s12(t) ;
ds211(t)
dt
= −f 2114(u11(s12, s23, s48))s211(t) − g2113(u11(s12, s23, s48))s211(t− τ311) +
f 2311(u3(s
1
1, s
1
4, s
2
5, s
4
8))s
2
3(t) + g
2
411(u4(s
1
1, s
2
5, s
3
8, s
6
9, s
5
10, s
2
11, s
2
12))s
2
4(t− τ411) +
f 2711(u7(s
1
2, s
2
3))s
2
7(t) + g
2
117(u11(s
1
2, s
2
3, s
4
8))s
2
11(t− τ711) +
σ211(
∑
g2j11, ω(u11))s
2
11(t− τ 211) ;
ds411(t)
dt
= −g4118(u11(s12, s23, s48))s411(t− τ118) + f 4811(u8(s11, s23))s48(t) ;
The Cerebellum:
ds112(t)
dt
= −g1124(u12(s14, s510))s112(t−τ124) + f 1412(u4(s11, s25, s38, s69, s510, s211, s212))s14(t) ;
ds212(t)
dt
= −f 2124(u12(s14, s510))s212(t) + g2412(u4(s11, s25, s38, s69, s510, s211, s212))s24(t−τ412) +
σ212(g
2
412, ω(u12))s
2
12(t− τ 212) ;
ds512(t)
dt
= −g51210(u12(s14, s510))s512(t− τ1210) + f 11012(u10(s25, s16, s38))s510(t) ;
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6.3.3 System Parameters and the Influence of Drugs
Statement: The influence of anti-psychotic drugs can be modelled by time-
dependent parameters. The antagonists inhibit the generation of post-
synaptic potentials, thus the antagonist are modelled as parameters re-
ducing the effect of neurotransmitter concentrations in the modified HH-
equation. The synthesis-inhibitors can be introduced directly in the syn-
thesis part of the equations of the multi-compartment model as reduce-
parameters.
We have constructed a mathematical model which describes in a realistic way
the physiological processes in the brain at three different level and intercon-
nect these levels together. To make this model also useful for pharmacological
and thus, clinical application, it is necessary to embed parameters into the
system which represent the influence of drugs on the system. There are two
major possibilities to introduce the action of drugs into our system.
First, parameters describing the action of agonists and antagonists at
post-synaptic membranes shall be introduced at synaptic level. The param-
eter ϑki (t) operates on the intrasynaptic concentration of neurotransmitters
which is responsible for de-/hyperpolariaztion of post-synaptic membranes
through gating parameters.
dpk
dt
= ξ · (ϑk(t) · ck(x, t))2(1− pk) − ς · pk .
If ϑk(t) tends to zero, a lower amount of neurotransmitters will be avail-
able to produce polarizing effects on the post-synaptic membranes. It means
that for 0 ≤ ϑk(t) < 1, ϑk(t) represents the action of an antagonist on the
receptors. For ϑk(t) > 1, the parameter describes the action of agonists in
synapses. These kind of parameters are also capable to mimic the influence
of blockers of transporter molecules, because of the strong interaction be-
tween the intrasynaptic neurotransmitter concentration and the activity of
neurotransmitter transporter proteins.
Second, parameters representing the action of neurotransmitter synthesis-
inhibitors shall be embedded into the system at macroscopic model, by op-
eration on the synthesis functions of the multi-compartment model. These
parameters denoted by δki (t) are scalar factors on σ
k
i which decrease (or in-
crease) the magnitude of neurotransmitter synthesis.
dski (t)
dt
=
∑
j
(−fkij(ski , ui)ski (t) + gkji(ski , γki , uj)skj (t− τij) +
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δki (t) · σki (gkji, ω(ui))ski (t− τ ki )).
The combination of these two parameters allow us to investigate the phys-
iological influence of common anti-psychotic and also anti-epileptic drugs on
the human brain as a set of compartments. It is quit simple to include
release/re-uptake effecting parameters into the system in the same way as
introduced above.
In the next chapter, we will analyze the influence of these parameters
on the local and global properties of the system. It contains information on
the stability behaviour of the system in dependency to the drug parameters
and the parameter sensitivity analysis, a standard method to obtain the
importance factor of a parameter in a dynamical system.
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Chapter Seven
Analysis of the Dynamical
Patterns
7.1 Delay Induced Dynamics
Statement: The synthesis-delays influence the dynamics of the neurotrans-
mitter concentrations by oscillations depending on the frequency of the local
synthesis rate.
There are two different categories of time-delays in our model. The first group
τij denotes the duration of signal propagation along neural projections from
the brain compartment i to the brain compartment j. This group of delays
clearly influences the electrophysiological processes as well as the neurochem-
ical state of any compartment. Because of the large number of time-delays
and equations, it is not possible to represent analytically lucid explanation
on their dynamical influence on the system within this thesis. Thus, we con-
centrate on the second category of time-delays, namely the synthesis-delays
τ ki . Our attempt is to analyze whether/how these delays influence the neu-
rochemical dynamics for very small re-uptake functions (gkji → 0).
Thus, we consider a simplified version of the neurochemical equations.
Assuming that the compartments are not interconnected to singulate a re-
gion, then any equation gets the form:
dski (t)
dt
= −fkij(ski )ski (t) + σki (ski , ω(ui))ski (t− τ ki ) .
The release and synthesis functions are obtained by systems of differential
equations. To reduce the complexity of this investigation, we approximate
these function with regard to their physical nature.
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The facts that the neurotransmitter concentration and synthesis rate are
inversely proportional and the direct (but controlled) relation between rela-
tion between the collective release behaviour and neurotransmitter concen-
trations suggest that the dynamical behaviour of the above equation could
be approximated by equations of the following form:
x˙(t) = −ax(t)2 + bω(t)x(t− τ)
x(t)
,
where a, b are proportionality factors of the release and synthesis rates, and
ω(t) is the frequency of regional depolarizations. Let us assume that ω(t) 6= 0.
It follows then clearly the existence of a τ -periodic solution in the second part
of the above equation
x(t) = x(t− τ) .
Depending on the values of a and b and also the behaviour of ω(t), this
τ -periodic part changes the course of the neurochemical trajectories. The
shape of these trajectories is in the case of a > b and ω(t) = const., horizon-
tally asymptotic decreasing with small damping oscillations after decreasing.
If ω(t) is piecewise nonlinear increasing and b is large enough, then the os-
cillations dominate the behaviour of the solutions.
The above analysis suggests that the influence of synthesis-delays depends
strongly on the regional depolarization-frequencies and is in general non-
negligible. Following numerical simulations will also confirm this hypothesis.
7.2 Parameter Sensitivity Analysis
Statement: The influence of the anti-psychotic drug parameters on the
dynamical behaviour of the system is negligible after a certain time-period.
The system reverse back to its original state after a perturbation, in other
words the system is structurally stable.
1
The mathematical problem to be solved in sensitivity theory is the calculation
of the change in the system behaviour due to parameter variations. There
are several ways to define quantities for the characterization of the parameter
sensitivity of a system. We will first summarize these definitions (Frank
1978,Tomovic and Vukobratovic 1972), and then calculated the sensitivity
functions of our system related to parameters ϑki (t) and δ
k
i (t).
1The concept of structural stability was first introduced by Andronov (Andronov 1966).
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Let the behaviour of the dynamic system be characterized by a quantity
ψ = ψ(α), called a system function, which among other dependencies, is a
function of the parameter vector α = (α1 · · ·αn)t. Let the initial parameter
vector be denoted by α0 and the initial system function by ψ0. Then
Definition
The absolute sensitivity function is defined as
Sj :=
∂ψ(α)
∂α
|α0 = Sj(α0) .
Definition
The parameter induced error of the system function is
∆ψ :=
n∑
j=1
Sj ∆αj .
Definition
The maximum error of the system function is
|∆ψ| :=
n∑
j=1
|Sj| |∆αj| .
Consider the general actual vector state equation of a continuous, possibly
nonlinear system
x˙ = f(x, α, t, u) ,
where α is a time-varying parameter according to α(t) = α0 + δα(t). The
first variation δα is subject to the requirements of uniform boundedness and
integrability. α0 and  are constant with respect to time;  > 0 is a small
number.
It is assumed that the solution of the above state equation can be written
as
x(t, ) = x0(t) + δx(t) ,
where x0(t) is the initial value of the state equation. The first variation δx
allows for the characterization of the sensitivity of the system in a manner
similar to the sensitivity function. This follows from the fact that the relation
between the parameter-induced error and δx is given by
x− x0 = δx .
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Using the initial values, the nonlinear system can be written as
x˙0 + δx˙ = f(x0 + δx˙, α0 + δα, t, u) .
Expanding the right-hand side of this equation into a Taylor series at the
initial point (x0, α0), we obtain
x˙0 + δx˙ = f(x0, α0, t, u) + 
∂f(x, α, t, u)
∂x
|α0δx +

∂f(x, α, t, u)
∂α
|α0δα + R() .
Let us assume that for th term R() containing all higher-order terms in 
the following limit exists:
lim→0[R()
1

] = 0 .
Introducing the initial values, one obtains
δx˙ = 
∂f(x, α, t, u)
∂x
|α0δx + 
∂f(x, α, t, u)
∂α
|α0δα + R() .
If we now divide both sides by  and then take the limit  = 0, we have
δx˙ =
∂f(x, α, t, u)
∂x
|α0δx +
∂f(x, α, t, u)
∂α
|α0δα .
The initial condition vector δx0 of the above differential equation is zero since
x0 is not a function of α. The result can be written as
δx˙ =
∂f
∂x
|α0δx +
∂f
∂α
|α0δα , δx0 = 0 .
This is the general sensitivity equation of a continuous, possibly nonlinear
system with time-varying parameters.
In the following paragraphs, we will investigate our nonlinear systems, for
sensitivity behaviour related to the time-varying parameters ϑki (t) and δ
k
i (t).
Statement: Most of the anti-psychotic drugs have temporally limited
receptor-binding periods. The number of active anti-psychotic substances
decreases in a certain time period after their indication.
The parameters ϑ(t) and δki (t) are descending, continuous, positive functions
in time defined by exponential functions:
δki : R → R+ , δki (t) = e−θ
k
i /t + at+ b , δki (0) = 1 ,
ϑki : R → R+ , ϑki (t) = e−κ
k
i /t + ct+ d , ϑki (0) = 1 ,
for some κki , ς
k
i > 0 and constants a, b, c, d, which depend on the local neu-
rotransmitter properties of the considered brain compartments.
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Similar models on the decrement of drugs in the human body are intro-
duced also in other works (Nocedal 2006).
We begin with the sensitivity analysis of the synaptic models related to the
parameter ϑki (t). The (partial) antagonists as well as agonists of the neuro-
transmitters act in the synapses by influencing the ligand-binding procedure
to alter the process of de-/hyperpolarization at the membranes. This action
could be described by perturbations in the dynamics of the gating parameters
of the modified Hodgkin-Huxley equations:
dpk
dt
= ξ · (ck(x, t))2(1− pk) − ς · pk .
For the influence in a certain compartment i the equation becomes:
dpk
dt
= ξ · ϑk(t) · (ck(x, t))2(1− pk) − ς · pk .
The sensitivity equation of the differential equation of gating parameters
in dependency to an unknown intrasynaptic neurotransmitter concentration
c(x, t) is
δp˙k = (ξck(x, t)
2 − ζ)δp + 2ξck(x, t)2δϑk .
Figure 7.1: The trajectories of the membrane potentials with (red) and without (blue) drug indication.
It appears that the system is structurally stable under parameter small perturbations (βki ∈ [0, 0.61)).
Minimal variations of this perturbation range lead to substantial dynamical alterations of the system.
It appears that the antagonists change the phase and amplitude of the
oscillations for a certain time period, then the system reverses back to its
initial oscillations (structural stability). It means that the influence of the
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drug parameters after a certain time is negligible, which is physiologically
acceptable.
The sensitivity behaviour of the synthesis-parameter δki (t) is more diffi-
cult. Reminding the general form of the DDEs in the model:
dski (t)
dt
=
∑
j
(−fkij(ski , ui)ski (t)+gkji(ski , γki , uj)skj (t−τij)+σki (gkji, ω(ui))ski (t−τ ki )).
The influence of synthesis-inhibitors on this equation is modelled by multiply-
ing the last part of the right-hand-side of the equation with δki (t) = e
−κki /t.
Here, we use the method of internal numerical differentiation [IND] (Bock
1981) to obtain the sensitivity of the multi-compartment system (delay-
differential equations) regarding to the parameters κki . ”The main idea of
IND is to differentiate the approximative solution of the initial value prob-
lem which is generated adaptively by an integration method of variable order
and increment control.” To investigate the variation problem of the param-
eter sensitivity function, we integrate the perturbed system with the same
discretization-scheme as the normal system and the build their difference
quotient. The simulation-results are represented in the following (Figures
7.2, 7.3).
The DDE-system of the multi-compartment model appears to be structurally
stable under drug-perturbation parameters. However, these parameters are
not negligible. They significantly change the dynamical behaviour of the
system for a certain time period. In fact, this result is qualitatively com-
patible with the clinically observed drug-influence on the neurophysiological
systems.
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Figure 7.2: The difference of the normal and disturbed (blue: weak perturbation parameter κ1th = 0.4; red:
strong perturbation κ1th = 0.9) dopamine-concentration trajectories of the substantia nigra. It appears
that the dopaminergic system is stable under perturbations in the synthesis of glutamate in thalamus.
The alteration in the dynamical behaviour of the system tends to zero for t→∞.
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Figure 7.3: The difference of the normal and disturbed (blue: weak perturbation parameter κ1th = 0.4; red:
strong perturbation κ1th = 0.9) glutamate-concentration trajectories of the thalamus. The glutamatergic
system reveal strong sensitivity to synthesis-inhibitor parameters. Nevertheless, it is considerable that the
system is structurally stable. The amplitudes of the oscillation of the difference function oscillate to zero
for t→∞ (damped oscillation).
Part III
Numerical Simulations
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Chapter Eight
Synaptic Processes
We have developed two mathematical models to simulate the dynamical be-
haviour of neurotransmitter concentrations in the synaptic cleft. Because of
the experimental difficulties to observe this behaviour, such models reveal
physiological and pharmacologically important information on this subject.
In this chapter, we will use the finite element library Gascoigne by Prof. Dr.
R. Becker and Prof. Dr. M. Braack (http://www.gascoigne.de/) to simulate
the first model. The simulation toolkit Gascoigne is developed for incom-
pressible, compressible, non-reacting and reacting flows in two and three
dimensions. It combines error control, adaptive mesh refinement and a fast
solution algorithm based on multigrid methods. The discretization of the
underlying partial differential equations is done by stabilized finite elements
on locally refined meshes.
The second model was a modified version of Poisson-Nernst-Planck equa-
tions with Dirichlet boundary conditions. For known external fields and some
assumptions for the boundaries, we used the work of Gajewski (Gajewski,
1985) on the existence and uniqueness of the solution. We focus here only
on the numerical simulation of the first model. This model is quit similar
to the modified Poisson-Nernst-Planck equations and will be simulated using
the method of vanishing viscosities. Because of the importance of the extra-
synaptic neurotransmitter concentration for the validation of our model, as a
result of the potential decline at side-boundaries, we will give a short discus-
sion on the estimation of its value by our model at the end of this chapter.
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8.1 Intrasynaptic Concentrations of Neuro-
transmitters
Resuming the main facts on our model, it is a coupled system of partial
differential equations with Dirichlet boundary condition and given initial
values. We use the method of vanishing viscosity to adapt the last equation
for numerical methods used in Gascoigne:
∂E
∂t
= β ∇ρ ,
∂ρ
∂t
+ div(−αρ · E)− ∆ρ = frelease(ρ, t)− γex , → 0 .
This allows us to use the simulation toolkit Gascoigne to simulate the model.
We simplified the geometrical shape of the synaptic cleft to a rectangle with
prolonged length. The release of neurotransmitters was given to be asym-
metrically.
The simulations suggest that the intra-synaptic concentration of neuro-
transmitters is transported by the electrical field inside the synaptic cleft,
from the pre- to the post-synaptic membrane. After arriving on the post-
synaptic membrane, the polarity of the electrical field changes that forces
the neurotransmitters to be back-transported (re-uptake) to the pre-synaptic
membrane (figure 8.1). This behaviour is physiologically expected. It is also
observable that an amount of the neurotransmitter concentration tends to
the side-boundaries (diffusion to the extra-synaptic space), which will explain
the observation a fractional amount of the released neurotransmitters in the
extra-synaptic space.
This simulated concentration of neurotransmitters can directly be em-
bedded into the modified Hodgkin-Huxley equations to produce a realistic
effect of the neurotransmitters on the electrophysiological system. It is also
very useful for the optimization of anti-psychotic drug-dosage.
Result: The mathematical model for intra-synaptic concentrations reveals
an expected behaviour. The electrical field and the concentration gradient
interact. There exists a fractional amount of neurotransmitters that diffuse
out to extra-synaptic space.
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Figure 8.1: The intra-synaptic concentration of neurotransmitters in three time steps. 1) The neuro-
transmitters are released asymmetrically from the pre-synaptic membrane into the synaptic cleft. 2) The
neurotransmitter concentration is transported by the existing electrical field inside the membrane to the
post-synaptic membrane. 3) The neurotransmitter concentration gradient at the post-synaptic membrane
side changes the polarity of the intra-synaptic electrical field followed by the activation of transporter
molecules on the pre-synaptic membranes, which forces the re-uptake of neurotransmitters.
8.2 Estimations of Extrasynaptic Neurotrans-
mitter Concentration Values
As we have seen, a certain amount of neurotransmitters diffuses to the extra-
synaptic space during the synaptic processes. The extra-synaptic concen-
tration of neurotransmitters is experimentally observable by micro-dialysis
and voltammetry studies. By understanding the fractional level of extra-
synaptic diffusion in relation to the released concentration, we can estimate
an average realistic value for intra-synaptic neurotransmitter concentrations
by parameter estimation methods. This knowledge is helpful for the quanti-
tative analysis of the effectivity of the neurotransmitter synthesis-inhibitors
which happens to be of therapeutic importance in schizophrenia.
Remark: For a realistic validation with observed extra-synaptic con-
centrations further modelling steps are required. The existence of several
neighboring synapses, and the complex topology of the brain reveal some
problems that are not discussed here.
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Chapter Nine
Examples for the Single
Compartment Model
The aim of this chapter is to numerically investigate the behaviour of a
compartment by known dynamics of single neurons. We just represent our
method through two examples: the corpus striatum and the subthalamic
nucleus. First, we remind on the main morphological and ultrastructural
properties of the compartments, namely the spatial distribution of the differ-
ent neural populations, the neurochemical classification and the interconnec-
tion between the neurons. Second, the simulation results will be discussed
and compared with the experiments. It reveals that both examples show
oscillatory dynamics which was expected.
9.1 The Corpus Striatum
The neuronal populations of the striatum could be divided into four classes:
Spiny projection neurons (about 96% of the whole neural population) are
GABAergic neurons, which get external inputs from cortical areas and sub-
stantia nigra pars compacta. These neurons also get inputs from the dopamin-
ergic, GABAergic and acetylcholinergic interneurons. Large aspiny neurons
(cholinergic), GABAergic interneurons and dopaminergic neruons comprise
the rest population of straital neurons. The cholinergic interneurons get ex-
ternal inputs from thalamus and substantia nigra pars compacta; and internal
inputs from the GABAergic interneurons. They project to the dopaminergic
and projection neurons. The action of the cholinergic interneurons antipodal
to the action of the dopaminergic neurons. The cholinergic neurons inhibit
the activity of the projection neurons of the direct pathway (mostly D1 sys-
tem) and disinhibit the activity of the indirect pathway neurons (D2 system).
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The interactions between the different neural populations is much precisely
represented in the figure 9.1.
Figure 9.1: Schematic ultra-structural morphology of the primate’s striatum, including the neurochemical
synaptology. The green/orange arrows denote inhibitory/excitatory afferents. The dashed arrows are
external efferents to the striatal neurons. Hereby, St1A and St1B denote the spiny projection neurons
which project to GPe and GPi/SNr. St2 denotes the dopaminergic interneurons, St3 the GABAergic
interneurons, and St4 the acetylcholinergic neurons.
Considering the structure of figure 9.1 as the internal structure of the n-
cells which we introduced in the last chapter and the specific distribution of
neural population, we are able to simulate the propagation and summation of
the electrophysiological activity in the striatum based on the activation of a
single neuron. The special network structure of the n-cells suggests a specific
activity transmission. It reveals that the activity transmission induced by
a constantly activated neurons is approximately radial and oscillatory. The
constant activity of a single neuron produces activation-waves on the striatal
populations (figure 9.2).
Such neurons are simplified versions of the tonic activated cholinergic in-
terneurons. Activations of neurons of other classes suggest similar activation
waves along the striatal populations. We assume that these oscillations are
correlated with the LFP studies of basal ganglia which also suggest oscilla-
tions in control patients (Boraud et al. 2005).
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9.2 The Subthalamic Nucleus
Based on cellular and dendritic morphology neurons in the subthalamic nu-
cleus appear to be of one main type, which nonetheless show a variance in
the dimension of the cell soma and dendritic ramifications (Kita et al. 1993;
Yelnik and Percheron 1979). In rats, the cell somata are ovoid or polygo-
nal with a medium size ranging 11 − 18µm in diameter. Most subthalamic
neurons extend 3 − 4 primary dendrites which taper and branch into sec-
ondary and tertiary dendrites. Dendrites show infrequent spines, which, if
present, are located on more distal parts of the dendrites. The dendrites
spread in varying patterns within the nucleus. In general, dendrites appear
to distribute roughly equally in an ovoid area in both the frontal and sagittal
planes, thus showing a greater extension in the rostro-caudal dimension than
in the dorsal and ventral dimension. Subthalamic neurons across species
appear to be similar in morphologic type, although the planar distribution
patterns of the dendrites vary from species to species. This presumably re-
flects different geometries of the different inputs in different species (Gerfen
and Wilson 1996).
Neurons in the subthalamic nucleus appear to be of one neurochemical
type in that most are immunoreactive for glutamate.
Using the integral operator introduced in the last chapter, it reveals that
the electrophysiological activity of a large population of neurons in subthala-
mic nucleus is a phasic summation of the single activations and has bursting
effects (figure 9.3).
Both examples show oscillatory activity of large neural populations com-
prising compartments by single/multiple activation of the neurons. It is to
be expected that by taking a realistic number of neurons, the results of our
model directly fit the experimental results.
Result: The electrophysiological activity of the single compartments is
of oscillatory nature and depends on the morphological structure of the
compartments.
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Figure 9.2: The oscillatory dynamics of the activity of striatal neurons by a single constant activation
with a realistic spatial distribution of the neurons.
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Figure 9.3: The internal electrophysiological activity of the subthalamic nucleus with respect to its mor-
phology.
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Chapter Ten
Simulations of the
Multi-Compartment Systems
Following Baker and Paul (1993), we describe a Runge-Kutta method for
delay differential equations of the form
u′(t) = F (t, u(t), u(t− τ(t))) t ≥ t0 ,
subject to the initial condition u(t) = ψ(t) for tmin ≤ t ≤ t0. The extension
to equations with more than one delay is clear. The particular DDE method
to be described can be associated with a choice of continuous Runge-Kutta
triple {c, A, b(θ)}. The method may be motivated as an adaptation of the
basic Runge-Kutta method for y′(t) = f(t, y(t)), as follows:
The approximate solution u˜(t) is sought on the interval [t0, T ] through
the computation of its values {u˜n ≡ u˜(tn)} on the mesh Γ := {t0, t1, · · · , tN}
and either the internal stage-values {Uni} or the internal derivative approx-
imations {U ′ni} associated with points {tni}. Suppose that the solution has
advanced to the point t = tn and, assuming that γ(tni) ≤ tn, that a continu-
ous extension u˜(t) to u(t) is available for t ∈ [t0, tn]. Its form is supposed to
be
u˜(tk + θHk) = u˜k +Hk
∑
l
bl(θ)U
′
kl 0 ≤ θ ≤ 1 (k = 0, 1, · · · , n− 1) .
Our numerical strategy for the DDE now reduces to invoking the numerical
solution by a Runge-Kutta process of a related equation of the form y′(t) =
f(t, y(t)), in which
f(t, y(t)) = F (t, y(t), u˜(t− τ(t))) .
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The formula motivating the method is given by u˜n ≡ u˜(tn) ≈ u(tn) where
u˜0 = u(t0),
u˜n+1 = u˜n +Hn
ν∑
i=1
biU
′
ni ,
U ′ni = F (tni, Uni, u˜(γni)) ,
with
Uni = u˜n +Hn
i−1∑
j=1
aijU
′
ni , γni = tni − τ(tni) ,
where u˜(γni) = ψ(γni) if γni < t0, whilst
u˜(γni) = u˜(tj + θniHj) = u˜j +Hj
∑
k
bk(θni)U
′
jk
in the case that γni = tj + θniHj for 0 ≤ θni ≤ 1 and j ∈ {0, 1, · · · , n}.
If we solve for the values {U ′ni}, we now have the equations
U ′ni = F (tni, u˜n +Hn
i−1∑
j=1
aijU
′
nj, u˜(γni)) ,
with the relevant expression for u˜(γni) expressed as above. In the case that
γni > tn, the argument in the value u˜(γni) lies to the right of tn, and outside of
the current range of u˜(·). Thus, the explicit Runge-Kutta formulae become
implicit equations for {U ′ni}. Maintaining an explicit method imposes the
restriction that
γni ≤ tn ∀i .
For the class of DDEs which we are interested in (without singularities and
vanishing time-lags), a strategy to avoid the Runge-Kutta formulae becoming
implicit is to reduce the stepsize Hn until the restriction on γni is satisfied.
For the numerical investigation of our neurochemical model comprised
by a system of nonlinear delay differential equations, we chose the solver
ARCHI. ARCHI is an explicit Runge-Kutta code for solving delay and neu-
tral differential equations and parameter estimation problems developed by
the Manchester Centre for Computational Mathematics, which uses the de-
scribed method to construct smooth solutions for systems of delay differential
equations.
In the following section, we introduce the initial functions and delay pa-
rameters of our system. These values are taken by neurosurgical experiments
such as microdialysis, intracellular studies on different brain compartments
and estimations of the delay parameters based on the neuroanatomical facts.
The last section includes all numerical results on the neurochemical dynamics
obtained from our mathematical model.
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10.1 Initial Functions and Delay Ranges
To simulate a system of delay differential equations, we first need to obtain
the initial functions and the time-delays. For the current initial value prob-
lem, we assume that the initial functions correspond to the initial concen-
tration values which were obtained experimentally by micro-dialysis experi-
ments. The mentioned initial values for the neurotransmitter concentrations
are estimated by extracellular neurotransmitter concentrations obtained from
microdialysis experiments (Ungerstedt, 1984; Globus et al. 1988; Wassle and
Chun, 1988; Sunol et al., 1988; Meyerson et al, 1990; Ronne-Engstrom, 1992;
Kanthan, 1995; Hutchinson et al., 2000; Hutchinson et al., 2002).
The time-delays are mostly estimated by morphological studies on the
neuronal characteristics of the brain compartments, their projections and
innervations. The experimentally unknown values have been estimated by
mathematical calculations based on the anatomical and morphological prop-
erties of the brain pathways. The connection delay parameters are repre-
sented in a table in this section.
10.2 Results
The neurochemical and electrophysiological systems have been simulated
with and without considering time-lags. In both cases the trajectories of neu-
rotransmitter concentrations and electrical potential differences reveal stable
oscillatory pattern (figures 10.1,10.2,10.3,10.4,10.5,10.6). In the case of simu-
lations of delay-differential equations, the initial function has been chosen to
be constants the same as the initial values of the variables. These show the
qualitative behaviour of the neurochemical and electrophysiological systems
and the emergence oscillatory pattern.
Parameter sensibility tests (different orbital colors) suggest that the os-
cillatory behaviour of the orbits remains stable. Perturbations in the release
parameters on the feedback loop of subthalamic nucleus (STN) and globus
pallidus pars externa (GPe) show significant changes in the oscillation char-
acteristics of basal ganglia, especially in the synchronization of the dopamin-
ergic oscillations on the nigrostriatal feedback loop. The simulation results
suggest that the interaction between different neurotransmitter systems is of
great importance for the generation and characterization of the oscillatory
patterns.
These oscillations are caused by the nonlinearities of the system and also
the delays in signal processing and propagation. Oscillations of basal gan-
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Connection Parameter Source
CTX-STN τ = 2.5ms Fujimoto and Kita (1993)
CTX-St τ = 10ms Gerfen and Wilson (1996)
CTX-Th τ = 15ms Estimate based on the innervation distances
CTX-Amy τ = 2ms Estimate based on the innervation distances
CTX-HC τ = 1ms Estimate based on the innervation distances
CTX-SNc τ = 12ms Estimate based on the innervation distances
CTX-Raphe τ = 18ms Estimate based on the innervation distances
STN-GPe τ = 2ms Kita and Kitai (1991)
STN-GPi τ = 1.5ms Nakanishi et al. (1987)
St-Th τ = 4ms Estimate based on the innervation distances
St-Amy τ = 8ms Estimate based on the innervation distances
St-GPe τ = 5ms Kita and Kitai (1991)
St-SNc τ = 6ms Estimate based on the innervation distances
St-GPi τ = 4ms Nakanishi et al. (1987)
Th-Amy τ = 10ms Estimate based on the innervation distances
Th-SNc τ = 3ms Estimate based on the innervation distances
Th-Raphe τ = 5ms Estimate based on the innervation distances
Th-HT τ = 1.5ms Estimate based on the innervation distances
Th-GPi τ = 4ms Estimate based on the innervation distances
Th-Cb τ = 20ms Estimate based on the innervation distances
Amy-HC τ = 1ms Estimate based on the innervation distances
Amy-SNc τ = 6ms Estimate based on the innervation distances
Amy-Raphe τ = 12ms Estimate based on the innervation distances
Amy-HT τ = 4ms Estimate based on the innervation distances
HC-HT τ = 5ms Estimate based on the innervation distances
SNc-Raphe τ = 3ms Estimate based on the innervation distances
SNc-HT τ = 6ms Estimate based on the innervation distances
SNc-GPi τ = 5ms Estimate based on the innervation distances
Cb-HT τ = 18ms Estimate based on the innervation distances
Table 10.1: Connection delay parameters
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Figure 10.1: The nigrostriatal dopamine concentrations in relation to the electrophysiological activity of
striatum; Different colors reveal perturbation in neurotransmitter release parameters.
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Figure 10.2: The nigrostriatal dopamine concentrations in relation to the GABA concentration in striatum;
Different colors reveal perturbation in neurotransmitter release parameters; Three cases of dynamical
pattern emerge: A) stable cylindrical trajectories [dark blue], B) Damping trajectories [pink], C) unstable
trajectories [cyan]. The cases A and B show reversal behaviour after small parameter perturbations.
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Figure 10.3: The electrophysiological activity of corpus striatum [Simulation with time-lags].
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Figure 10.4: Synchronized electrophysiological oscillations in thalamus [Simulation with time-lags].
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Figure 10.5: The oscillatory pattern of the cortical glutamate concentration [Simulation with time-lags].
118 CHAPTER 10. MULTI-COMPARTMENT SIMULATIONS
Figure 10.6: The GABA concentration in Globus pallidus pars externa [Simulation with time-lags].
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glia’s electrophysiological system are also observed in LFP (local field po-
tentials) studies in control patients and also in animals (Cassim et al. 2002
Magill et al. 2004; Boraud et al., 2005).
The qualitative behaviour of the solutions of the system depends strongly
on the dynamics of each neurotransmitter system. The interactions amongst
the neurotransmitter systems are also studied experimentally (Konradi et
al. 2002; Chesselet, 2002). Beside the strong neurochemical sensibility, the
system is able to reverse to its original stable states after small dynamical
disturbances. This fact suggest an interpretation in the sense of circular and
temporal emergence of illness symptoms.
Thalamus as a part of the network is also able to control the interval of
oscillation-phases, -frequencies and -amplitudes of its efferent. Changes in
the oscillatory behaviour of basal ganglia, a clustered part of this network,
influence the scale of control-limits of thalamic efferent. In this sense, one
can talk about a thalamic filter (Carlsson et al. 1999) and consider basal
ganglia as the calibrator of this filter.
The reaction of the system on neuroleptics-like parameters has been nu-
merically investigated. By singular application of pure dopamine antagonists
in striatal D2-receptor, it reveals that a short-time change in the oscillation
characteristic emerges (figure 13.5). This behaviour suggests that changes in
the dynamical pattern of neurochemical systems in basal ganglia, especially
in the nigrostriatal system, are related with mental states.
Resume: The neurochemical concentrations reveal oscillatory dynamics.
This dynamical behaviour is correlated to the local electrophysiological ac-
tivity of the compartments. The drug-parameters change the activity pat-
tern, in terms of phase and level of the oscillation, for a short time-period
that is also clinically observable in the same way.
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Figure 10.7: The short-time change in the oscillatory pattern of electrophysiological activity of striatum
after a singular indication of dopamine D2-antagnoists [Simulation with time-lags].
Part IV
Physiological Discussion
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Chapter Eleven
Oscillatory Dynamics and the
Physiology of Behaviour
This chapter is supposed to represent the connection between the results of
our mathematical model and the observable physiological processes behind
psychotic states. Based on the well-known anatomical facts and the conse-
quences of the oscillatory dynamics of neurotransmitter concentrations, we
recognized special pathways as to be fundamental for the generation of men-
tal behaviour. These hypotheses are also supported by our investigations
on the influence of drug-parameters on the system. The results of these
investigations suggest also a correlation between the characteristics of the
physiological oscillations and the neurochemical states of the system, which
are in the own right directly correlated to mental states. These correlations
led us to the idea of the ”Oscillation Hypothesis of Schizophrenia” which will
be introduced in detail.
11.1 Functional Anatomy of Schizophrenia
Several pharmacological and neurophysiological studies (Bhatia and Marsden
1994; Carlson 1980; Carlsson 1988; Carlsson 1995; Dean and Hussain 2001;
Glenthoj and Hemingson 1999; Grunder et al. 2006; Heinz 2000; Hirvonen
et al. 2006; Hollerman et al. 2000; Levy and Dubois 2006; Mehler-Wex
et al. 2006; Middleton and Strick 2000; Ono et al. 2000; Saint-Ogr et al.
1995; Schmitt et al. 2005; Sedvall 1990; Stathis et al. 2007; Talvik et al.
2006; Wilson 2004) assign basal ganglia an important role in the physiology
of schizophrenia. The high density of dopamine receptors in the striatum,
the interactions between dopaminergic system with other neurotransmitter
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systems, and the sensitive reaction of mental state as a consequence of alter-
ations in dopaminergic activities are the foundations of the above correlation
between basal ganglia’ physiology and schizophrenia.
There are also strong evidences for the influence of the glutamatergic
system and its interactions with dopaminergic system on the mental states
(Carlsson and Carlsson 1990; Javitt 2007; Moghaddam and Krystal 2003;
Larnelle et al. 2003; Stone et al. 2007; Wu et al. 2003). These hypotheses
are not in contradiction to the correlation between the basal ganglia and
schizophrenia. The cortical glutamatergic projections to the basal nuclei
represent the majority of the external inputs into the basal ganglia structures
which correlate the glutamatergic activities with these subcortical structure
in support to the above correlation.
The clinical relevance of the basal ganglia circuits depends directly on
the balance between different neurotransmitter systems. Beside basal gan-
glia, the influence of the limbic system is also of interest in the physiological
investigation of the schizophrenia. The fact that other neurotransmitter sys-
tem than dopaminergic and glutamatergic systems such as 5 − HT -system
in nucleus Raphe led to the inclusion of a couple of new compartments into
the area of investigation. Our graph-theoretical analysis suggests that the
resulting network, the LBG-network, is represented by a set of compartments
containing dopamine, glutamate and GABA. These compartments (cortex,
substantia nigra pars compacta, subthalamic nucleus, thalamus, amygdala
and hippocampus) suppose to generate the dynamical patterns of the mam-
malian brain and are independent. Numerical simulations also suggest that
the reciprocal influence of the limbic and basal ganglia structures is not neg-
ligible. Thus, we suggest the LBG-network to be correlated more than any of
its substructures (the basal ganglia and the limbic system) to the schizophre-
nia.
Concluding, the graph-theoretical analysis, the numerical simulations and
the well-known physiological aspects of the schizophrenia suggest that
• The synaptic behaviour of the neurotransmitter in the sense of their in-
hibitory/excitatory effects on the synaptic membranes differs in general
from their influence in the network-scale on regional activities1.
• The neurochemical system of the human brain reveals oscillatory be-
haviour which depends on the physiological state of the system (i.e. the
oscillations change their properties in the case of disease and lesions),
but it remains also in the healthy brains.
1This is also correlated with the results Wu et al. 2000, on the inhibitory glutamate
regulation of evoked DA-release in striatum.
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• Small perturbations in the neurochemical dynamics instabilize the or-
bits which have the dynamical property to revert back to its initial
stable moods or to jump to other stable moods. These properties are
associated with the real act of information processing in the human
brain. Roughly spoken, a man needs time to get on with a problem or
the problem changes his mood irrecoverable but not irreversible. This
also suggest an interpretation in the sense of circular and temporal
emergence of illness symptoms.
• There are certain brain compartments which mainly produce the dy-
namical behaviour of the brain. These are: the cortex, the substantia
nigra pars compacta, the subthalamic nucleus, the thalamus, the amyg-
dala and the hippocampus. Thalamus as a generator, is a relay-filter
for cortical afferents to protect the cerebral cortex from signal over-
load and to control the interval of oscillation-phases, -frequencies and
-amplitudes of its efferents. Other generators determine the oscillation
characteristics which are correlated to mental states.
• Because of the strong reciprocal influence of the limbic and the basal
ganglia structures, it is assumable that the LBG-network correlates
more intensive with schizophrenia than its substructures.
11.2 Oscillation Hypothesis of Schizophrenia
The foundation of the ’Oscillation Hypothesis’ of psychosis is the oscilla-
tory nature of neurotransmitter dynamics. We have analyzed numerically
the influence of typical anti-psychotic drugs on the system. It appears that
the exhibition of these family of D2-antagonists changes the oscillation char-
acteristics for a certain time interval but the states then reverse back to
its original oscillation state. These parameter test have been done without
considering any anomalies in the LBG-network. This situation happens to
be phenomenologically similar to the real case of the action of typical anti-
psychotic drugs on schizophrenic patients.
By singular application of pure dopamine antagonists in striatal D2-
receptor, it reveals that a short-time change in the phase of the oscillations
emerges. The phasic changes are not restricted to the dopaminergic system
but the glutamatergic system has been also altered in a similar way.
Changes in the oscillatory behaviour of the neurochemical system caused
by anti-psychotic drugs, which influence the psycho-behaviour, reveal a phys-
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iological relationship between mental states and the neurochemical oscilla-
tions. This suggests that mental disorders (e.g. schizophrenia) (-as well as
neurological diseases (e.g. Chorea Huntington)), could be caused by anoma-
lies in the phases of the neurochemical oscillations. It establishes a direct
correspondence of oscillation-characteristics with mental states. In this case,
the symptoms of mental disorders due to temporal changes of phases and
amplitudes of basal ganglia’s neurochemical oscillations. Considering the
mental states as classes of quasi-stable states and the fact that changes of
sensibility and precision of thalamic filtration induce state transitions, then
the symptoms are evidenced with certain disturbances in neurotransmitter
systems which force the whole system to jump from its initial state to other
stable states or snatch its ability to revert back rapidly to the initial state.
Since, the psychotic symptoms are produced internally by the brain, so
one can consider them as signals with abnormal oscillatory behaviour which
are usually filtered by thalamus. These series of correlations between abnor-
mal oscillatory behaviour and the temporal mental state, led to the ”Oscil-
lation Hypothesis of Schizophrenia”:
Any mental state is associated to a characteristic
neurochemical oscillation in the brain.
Chapter Twelve
Pharmacological and
Mathematical Perspectives
The correlation between mental states and oscillation characteristics of neu-
rochemical dynamics reveals new perspectives in the design of effective anti-
psychotic drugs. Computational investigations of the combinatorial influ-
ence of drug-parameters on the dynamical behaviour of the system suggest
new purchases for the pharmacological combination-therapy strategies in the
treatment of schizophrenia. Here, we discuss the impact of this method by
clinically interpreting the computational results on the dopamine’s synthesis-
inhibition. The qualitative effects of the synthesis-parameters on the dynam-
ics of the neurochemical system led us to the idea that the combination of
synthesis inhibitors and partial antagonists will produce the optimized effect
on the mental appearance.
12.1 On the Role of Synthesis-Inhibitors
Beside the computed effects of typical anti-psychotic drugs on the neuro-
chemical oscillations which led us to the formulation of the oscillation hy-
pothesis of schizophrenia, we also numerically investigated the influence of
neurotransmitter synthesis-rate parameters and their perturbations on the
dynamics of our system. The dopamine synthesis has been studied in more
detail. The results were very fascinating and valuable.
It appears that the dopamine synthesis-inhibitors are able to fundamen-
tally change the oscillation characteristics of the whole neurochemical sys-
tem, but especillay the dopaminergic system of the nigrostriatal complex.
The synthesis-inhibitors decrease significantly the level of dopaminergic os-
cillations and alter their amplitudes. These effects are of long durance.
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As a consequence of the oscillation hypothesis, there is a relationship
between these alterations and mental states. This fact is also supported by
recent pharmacological experiments (Huttunen et al. 2007; Fohey et al. 2007;
Stone et al. 2007). Changes in the dopamine level for a long time interval
and in the oscillation amplitudes suggest that dopamine synthesis-inhibitors
should be considered as powerful and effective therapeutics in the treatment
of schizophrenia.
The effects produced by perturbations in the synthesis behaviour of other
neurotransmitter systems are also very interesting. The absence of experi-
mental references on the possible relevance of the non-dopaminergic synthesis
factors in the pharmacology of schizophrenia withdraws us the physiological
interpretation on the computed results on the dynamical influence of these
factors on the system.
12.2 Mathematical Perspectives
There are some mathematical problems revealed here which explode the
framework of this thesis. Although, these problems are of great interest
for further investigations. The following items list these crucial problems:
• The transition between different scale has to be further investigated.
• Understanding the correspondence between the structural and alge-
braic properties of a graph and the dynamical behaviour on it.
• Analysis of the existence, uniqueness and stability behaviour of the
solutions for transcendent delay differential equations with multiple
delays such as the multi-compartment model introduced in 6.3.
• Development and implementation of better (more accurate and effec-
tive) simulation tools and solvers than ARCHI by multi-step methods.
(ARCHI is a Runge-Kutta based solver)
• Study the delay induced dynamics in more general situations as dis-
cussed here.
Part V
Supplement
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Chapter Thirteen
Neurobiological Supplement
13.1 Neurotransmitters and Neuromodulators
The molecular spectrum of neuroactive substances ranges from ordinary in-
termediates of amino acid metabolism, like glutamate and GABA, to highly
effective peptides, proteohormones and corticoids. Neurotransmitters are the
most common class of chemical messengers in the nervous system. A neu-
roactive substance which fulfills the following criteria can be classified as
Neurotransmitters (von Bohlen und Hallbach and Dermietzel 2006):
• It must be of neural origin and accumulate in the pre-synaptic termi-
nals, from where it is released upon depolarization;
• The released neurotransmitters must induce post-synaptic effects upon
its target cells, which are mediated by neurotransmitter-specific recep-
tors;
• The substance must be metabolically inactivated or cleared from the
synaptic cleft by re-uptake mechanisms;
• Experimental application of the substance to nervous tissue must pro-
duce effects comparable to those induced by naturally occurring neu-
rotransmitter.
The neurotransmitters are synthesized in the cytosol of the pre-synaptic cells
and are active transported into vesicles. There are three main categories of
neurotransmitters in the central nervous system: acetylcholine, amino acids
and decarboxilated amino acids (catecholamines, serotonin, histamine and
GABA).
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Acetylcholine [[2-(acetyloxy)ethyl]trimethylammonium]: Acetylcholine
(ACh) was the first neurotransmitter discovered. It plays a significant role
in synaptic transmission in the central and peripheral nervous system. Ach
is a simple molecule synthesized from choline and acetyl-CoA through the
action of choline acetyltransferase. Neurons that synthesize and release ACh
are termed cholinergic neurons. ACh receptors are ligand-gated cation chan-
nels composed of four different polypeptide subunits arranged in the form
[(a2)(b)(g)(d)]. Two main classes of ACh receptors have been identified on
the basis of their responsiveness to the toadstool alkaloid, muscarine, and
to nicotine, respectively: the muscarinic receptors and the nicotinic recep-
tors (Dale-classification). Both receptor classes are abundant in the human
brain. Nicotinic receptors are further divided into those found at neuromus-
cular junctions and those found at neuronal synapses. The activation of ACh
receptors by the binding of ACh leads to an influx of Na+ into the cell and
an eﬄux of K+, resulting in a depolarization of the post-synaptic neuron and
the initiation of a new action potential 1.
Amino Acids [(2S)-2-aminopentanedioic acid]: Glutamate represents a
principal part of the category of amino acids. It is an excitatory neurotrans-
mitter and has both kinds of receptors, ligand-binding receptors [AMPA /
kainate] and G-protein coupled receptors [NMDA]. Glutamate neurons are
particularly prominent in the cerebral cortex. They project to a variety
of subcortical structures: these include the hippocampus, the basolateral
complex of the amygdala, the substantia nigra, the corpus striatum, the
thalamus, the red nucleus (nucleus ruber) and the pons. Various intrinsic
glutamatergic pathways have been described in the hippocampus and also
glutamatergic projections from hippocampal formation to the hypothalamus,
the nucleus accumbens and the lateral septum.
Decarboxilated Amino Acids:
• Dopamine [4-(2-aminoethyl)benzene-1,2-diol]: It was thought for a
long time that dopamine was simply an intermediate product in the
synthesis of norepinephrine. However, it has been shown that dopamine
is a prominent neurotransmitter in the brain with several potential
functions and a distinct distribution. Dopamine has been found to
be enriched, for example, in the substantia nigra and in the striatum,
whereas norepinephrine is absent from these brain regions. The differ-
ential distribution of dopamine is suggestive of a specific function for
1The cholinergic interneurons in corpus striatum which interact with the dopaminergic
terminals from the substantia nigra are of great importance in this work.
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this A)neurotransmitter in neuroregulative processes. With respect to
the peripheral nervous system, dopamine has long considered to consti-
tute the precursor of the other catecholamines. However, dopaminergic
neurons were found (Bell 1989) to occur in peripheral nerves. Conse-
quently, dopamine has also been regarded as a transmitter in peripheral
nervous tissues.
Dopamine, like other neurotransmitters, is not capable of crossing the
blood-brain barrier. However, the precursors of dopamine, phenylala-
nine and tyrosine are able to cross it. The biosynthesis of dopamine
takes place within nerve terminals. Dopamine is synthesized by hy-
droxylation of tyrosine to DOPA and the decarboxylation of DOPA to
dopamine.
Most dopaminergic receptors are located post-synaptically, but some
are located pre-synaptically in the substantia nigra (pars compacta),
the hypothalamus, the corpus striatum and the structures of the limbic
system. Stimulation of the pre-synaptic dopaminergic receptors results
in activation or inhibition of the release and synthesis of dopamine (au-
toreceptors). The autoreceptors are found at nerve terminals, as well
as on the soma and on the dendrites of most dopaminergic neurons.
Stimulation of autoreceptors located at the nerve terminals results in
an inhibition of dopamine release and synthesis, whereas stimulation of
somatodendritic autoreceptors decreases the firing rate of the dopamin-
ergic neurons. In general, autoreceptors regulate the release and syn-
thesis dynamics of dopamine.
The dopaminergic receptors are divided into the D1 and D2 groups.
The D1 group consists of D1 and D5 receptors, which are positively
linked to adenylate cyclase. The D2 group consists of D2, D3 and D4
receptors and each of these receptor types exists in different isoforms.
The dopaminergic autoreceptors belong to the family of D2 receptors.
From a clinical point of view, dopamine attracted considerable interest
since it became evident that this monoamine is involved in several
major brain disorders, like Parkinsonism and Schizophrenia.
• Serotonin [5-Hydroxytryptamine]: The name serotonin is an acronym
composed of serum and tonus because of its vasotonic properties. Sero-
tonin is a monoamine, with similar functional features as D-lysergic acid
diethylamide (LSD, a prominent hallucinogenic drug), mainly located
in the nucleus raphe with diffuse innervations. A relatively high density
of serotonergic projections occurs in the cerebral cortex, the hippocam-
pus, the amygdala, the basal ganglia, the lateral geniculate nucleus, the
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suprachiasmatic nucleus, the tectum opticum, the substantia gelatinosa
and in the ventral horn of the spinal cord.
Neurons provide the only source for serotonin in the central nervous
system. The precursor of serotonin is the essential amino acid tryp-
tophan and the availability of tryptophan represents the rate-limiting
factor in the synthesis of serotonin.
The largest group of serotonin receptors belongs to the superfamily of
G protein-coupled receptors. To date, seven subtypes of 5-HT receptors
have been distinguished (5−HT1 to 5−HT7) on the basis of cloning
data. A further subdivision of the seven subclasses has been achieved
by classifying them on the basis of their structural and pharmacological
properties.
• Histamine [4-(2-aminoethyl)-1,3-diazole]: The principal storage sites
of histamine are basophilic leucocytes and mast cells, which release
histamine as part of their reaction to allergens. Other sources include
the epidermis, the intestinal mucosa and the central nervous system.
Histaminergic neurons are predominantly located in the tuberal area
of the posterior hypothalamus (tuberomammillary nucleus). From this
nucleus, the histaminergic neurons project diffusely into several brain
areas; and their axonal collaterals give rise to projections, for example
to the forebrain, the cerebellum and the mesencephalon. A dense his-
taminergic innervation is also obvious in thalamic areas as well as in
the nucleus accumbens. Histaminergic projections have been found also
in the cerebral cortex and in the hippocampus. Three different recep-
tor subtypes, termed H1, H2 and H3, bind histamine specifically. The
three receptor subtypes can be distinguished by their different binding
patterns and different biological effects.
• γ-Amino Butyric Acid (GABA): Several amino acids have dis-
tinct excitatory or inhibitory effects upon the nervous system. The
amino acid derivative, γ-aminobutyrate, also called 4-aminobutyrate,
(GABA) is a well-known inhibitor of pre-synaptic transmission in the
central nervous system, and also in the retina. The formation of GABA
occurs by the decarboxylation of glutamate catalyzed by glutamate
decarboxylase (GAD). GAD is present in many nerve endings of the
brain as well as in the β-cells of the pancreas. Neurons that secrete
GABA are termed GABAergic. GABA exerts its effects by binding to
two distinct receptors, GABAA and GABAB. The GABAA receptors
form a Cl−-channel. The binding of GABA to GABAA receptors in-
creases the Cl−-conductance of pre-synaptic neurons. The anxiolytic
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drugs of the benzodiazepine family exert their soothing effects by po-
tentiating the responses of GABAA receptors to GABA binding. The
GABAB receptors are coupled to an intracellular G-protein and act by
increasing conductance of an associated K+-channel. In several places,
GABAergic cells occur at high densities. A prominent example is the
corpus striatum, where nearly 96% of the cell somata are GABAer-
gic. Additional brain areas, identified as exhibiting GABAergic cells in
large amounts and densities are the globus pallidus, the substantia ni-
gra (pars reticularis) and the cerebellum. GABAergic interneurons are
most frequent in the thalamus, the hippocampus and in the cerebral
cortex.
In contrast to neurotransmitters, neuromodulators can be divided into
several subclasses. The largest subclass is composed of neuropeptides. Addi-
tional neuromodulators are provided by some neurobiologically active gaseous
substances and some derivatives of fatty acid metabolism. The main differ-
ences between neurotransmitters and neuromodulators are in their size and
duration of post-synaptic activity.
13.2 Ionic Channels and the Generation of
Action Potentials
Neuronal signalling depends on rapid changes in the electrical potential differ-
ence across nerve cell membranes. During an action potential the membrane
potential changes quickly, up to 500 V/s. These rapid changes in potential
are made possible by ion channels, a class of integral proteins that traverse
the cell membrane. These channels have three important properties: first,
they conduct ions, second, they recognize and select among specific ions,
and third, they open and close in response to specific electrical (Voltage-
gated), mechanical (pressure or stretch) and chemical (transmitter-gated)
signals. The idea of the existence of a narrow region in the channels acts like
a molecular sieve led to an explanation of channel selectivity. At this selec-
tivity filter, an ion sheds most of its waters of hydration and forms a weak
chemical bond with charged or polar amino acid residues that line the walls
of the channel. Since the shedding of waters of hydration is energetically un-
favourable, an ion will permeate a channel only if the energy of interaction
with the selectivity filter compensates for the loss of waters of hydration.
Permeant ions remain bound to the selectivity filter for a short time, after
which the electrochemical gradient propels the ion through the channel. This
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idea was extended from the original pore theory first by Loren Mullins, and
later by George Eisenman and Bertil Hille.
Figure 13.1: The crystal structure of the potassium-ion channel (copyright: www.nsls.bnl.gov)
The kinetics of ion flow through a channel is characterized by the size
and voltage-dependence of the channels conductance. The conductance is
determined by measuring the current that flows through the open channel in
response to a given electrochemical driving force. The net electrochemical
driving force is determined by two factors: the electrical potential difference
and the concentration gradient of the permeant ions across the membrane.
In some channels, the current flow through the open channel is a nonlinear
function of driving force.
Each channel protein has two or more conformational states that are rel-
atively stable. Each of these stable conformations represents a different func-
tional state. For example, each allosteric channel has at least one open state
and one close state, and may have more than one of each. The transition of
a channel between closed and open states is called gating. Some ion channels
are regulated by the non-covalent binding of chemical ligands. These ligands
may be neurotransmitters or hormones in the extracellular environment that
bind to the extracellular side of the channel, or they may be intracellular
second messengers that are activated by transmitters. The second messenger
may act inside of the channel either directly, by binding to the channel, or in-
directly, by initiating protein phosphorylation that is mediated by enzymes,
called protein kinases. This covalent modification of the channel is reversed
by dephosphorylation, a reaction catalyzed by protein phosphatases. Cova-
lent modification results in relatively long-lasting changes in the functional
states of ion channels called modulatory changes. Because ion channels are
13.2. IONIC CHANNELS AND ACTION POTENTIALS 137
integral membrane proteins, some are subject to the influence of two other
classes of allosteric regulators: the electric field across the membrane and
the mechanical stretch of the membrane. Under the influence of allosteric
regulators, ion channels can enter one of three functional states: closed and
activatable; open; closed and non-activatable.
Another interesting subject of investigation is the physiology behind the
changes in conformation of a channel after a given stimulus. For transmitter-
gated channels, the change in free energy of the ligand bound to its site on
the channel as compared to the ligand solution leads to channel opening.
For voltage-gated channels, the opening and closing is associated with a
movement of a charged region of the channel through the electric field of
the membrane. Changes in the membrane voltage tend to move this charged
region back and forth through the electric field, and thus drive the channel
between closed and open states. For mechanically activated channels the
energy associated with membrane stretch is thought to be transferred to the
channel through the cytoskeleton.
Every neuron has a separation of electrical charge across of its cell mem-
brane consisting of a thin cloud of positive and negative ions spread over the
inner and outer surfaces of the membrane. A nerve cell at rest has an excess
of positive charges on the outside of the membrane and an excess of negative
charges on the inside. This separation of charge is maintained because the
lipid bilayer acts as a barrier to the diffusion of ions. The charge separation
gives rise to an electrical potential difference across the membrane. The po-
tential difference, or voltage, is called the resting membrane potential. It is
directly proportional to the charge separation across the membrane. In most
neurons the resting membrane potential ranges from about 60 to 70 mV.
The term resting membrane potential applies to the potential across the
membrane when the cell is at rest. The more general term membrane poten-
tial refers to the electrical potential difference across the membrane at any
moment in time; at rest or during signalling. The charge separation across
the membrane is disturbed whenever there is a net flux of ions into or out of
the cell, thus altering the polarization of the membrane. A reduction of the
charge separation is called depolarization; an increase in charge separation is
called hyperpolarization. Passive depolarizing or hyperpolarizing responses
of the membrane potential to current flow are called electrotonic potentials.
Hyperpolarizing responses are purely passive. Small depolarisations are also
passive. However, at a critical level of depolarization, called the threshold,
the cell responds actively with an all-or-none action potential.
The distribution of ionic channels on the post-synaptic membrane is of
great significance for the local generation of action potentials. In the case
of transmitter-gated channels, the critical level of depolarization is achieved
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by the superposition of excitatory and inhibitory potential waves on the
membrane. The superposition of waves is depending on the localization of
the initial point of generation of the potential waves and also on their relative
distances.
Back to the physiology of the generation of voltage-dependent action po-
tentials, Hodgkin and Katz proposed that the depolarization that initiates
an action potential causes a transient change in the membrane that briefly
switches its predominant permeability from K+ to Na+. These permeabil-
ity changes occur because of the opening of voltage-sensitive channels in the
membrane that allow Na+ to move down its concentration gradient into the
cell. These Na+-channels are normally kept closed by a voltage-sensitive
gating mechanism. Depolarization opens these Na+-channels, allowing in-
creased Na+ influx into the cell, thereby producing the rising phase of the
action potential. The falling phase of the action potential is caused by the
subsequent closing of the Na+-channels, which reduces Na+ influx, and by
the opening of voltage-gated K+-channels, which allows increased K+ eﬄux
from the cell. According to the ionic hypothesis developed by Hodgkin and
Huxley (Hodgkin and Huxley 1952), the action potential is produced by the
movement of ions across the membrane through voltage-gated channels. This
movement, which occurs only after the channels are opened, changes the dis-
tribution of charges on either side of the membrane. An influx of Na+, and
in some cases Ca2+, reverses the resting charge distribution, after which K+
eﬄux repolarizes the membrane by restoring the initial charge distribution.
Most of the ion-channels are opened primarily when the membrane potential
is near the action potential threshold, and thus have profound effects on the
firing patterns generated by the neuron.
13.3 Anatomy of the Brain compartments
The Cerebral Cortex: The cerebral cortex is a folded sheet of cells that
varies from 2 to 4 mm in thickness. The cortex that is visible on the external
surface of the brain is called the neocortex because it is the part of cortex
most recently acquired in evolution. The neocortex is by far the largest
component of the human brain. The most striking morphological feature of
the neocortex is that its neurons are arranged in several well-defined layers.
The other parts of the cortex arose earlier in vertebrate evolution and are
called the allocortex. The allocortex lies deep within the temporal lobe near
the zone where olfactory input reaches the cerebral cortex.
The cell bodies of cortical neurons have a variety of shapes, but in general
two main types can e distinguished in all areas of the cortex: pyramidal
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cells and several types of non-pyramidal cells. Pyramidal cells are so called
because they have a cell body shaped like a pyramid, with the apex gives rise
to a dendrite that runs toward the outermost layer of the cortex, intersecting
the overlying layers roughly at right angles. The base of the cell body, which
may be 30µm across, gives rise to several dendrites that course laterally
within the layer containing the cell body. The non-pyramidal cells usually
have round, smaller cell bodies, often stellated in shape, seldom measuring
more than 10µm in diameter. Their dendrites may arise from all aspects of
the cell body. The axons of pyramidal and non-pyramidal cells also differ.
Although the axon of a pyramidal cell may have several collateral branches
that terminate near the cell body, the main trunk of the axon enters the
white matter and terminates either in another area of the cortex or at a
more distant site in the central nervous system. In contrast, the axon of a
non-pyramidal cell branches perfusely in the region near the cell body and
rarely extends beyond this region.
Because of these differences, pyramidal cells are projection neurons and
non-pyramidal cells are responsible for local intern information processing.
Individual layers of the cortex do not contain equal proportions of pyramidal
and non-pyramidal cells, and the type of the cell that predominates in a layer
provides an important clue about the function of that layer.
The neocortex is divided into six layers, numbered sequentially from the
surface next to the pia matter to the white matter underlying the cortex.
Layer I contains only a few neuron bodies. It is composed largely of ax-
ons that run laterally through the layer and glia cells. The axons that run
through layer I synapse on the apical dendrites of cells lying in deeper layers
and presumably interconnect local cortical areas. Layer II, which contains
mostly small pyramidal neurons, and Layer III, which contains larger pyra-
midal cells, provide much of the output to the other cortical regions. Layer
IV is rich in non-pyramidal cells and receives most the afferent input from
the thalamus. Layer V has the largest pyramidal cells; these cells give rise
to long axons that leave cortex and descend to the basal ganglia (corticos-
triatal projection neurons), the brain stem, and the spinal cord. Layer VI
also contains pyramidal cells, many of which project back to the thalamus.
Neurons of Layers IV and VI build the thalamocortical feedback loop.
The characteristic pattern of layering in different cortical areas was clearly
shown by K. Brodmann (Brodmann 1907), who examined the organization
of the cells and fibers in the cortex. He divided the human cerebral cor-
tex into about 50 cytoarchitectural areas according to cell size, cell density,
the number of layers in each region, and the density of myelinated axons.
He assigned a number to each structural area, most of which have discrete
functions (figure 13.2).
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Figure 13.2: Cytoarchitectural classification of the human cerebral cortex by K. Brodmann. Brodmann’s
areas have consistently been found to correspond to distinctive functional fields, each of which has a
characteristic pattern of connections. Area 4, the primary motor cortex, occupies most of the precentral
gyrus. The primary somatic sensory cortex includes areas 1,2, and 3 in the postcentral gyrus. Area 17
is the primary visual cortex. Areas 41 and 42 comprise the primary auditory cortex. The prefrontal
association cortex and the parietal-temporal-occipital association cortex are also composed of a number
of distinct cytoarchitectonic areas. (copyright: Kandel et al. 2000)
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For example, the primary visual cortex, the area that receives direct input
from the lateral geniculate nucleus, corresponds to Brodmanns area 17. He
also correctly identified the boundaries of the primary motor and somatosen-
sory areas and suggested that there may be many separate functional zones
within individual association areas. Recent research has shown that there
are, in fact, more functional zones in the association cortex than even Brod-
mann recognized.
The Cerebellum: The cerebellum constitutes only 10% of the brain, yet
it contains more than half of all the neurons. These neurons are arranged
in a highly regular manner that results from repetition of the same basic
circuit module. Despite its structural regularity the cerebellum is divided
into several distinct regions, each of which makes connections with different
areas of the brain. These features suggest that all areas of the cerebellum
perform similar functions but that each area performs that function on a
different set of inputs. The cerebellum is not necessary for perception or for
the contraction of muscle. Even though the cerebellum contains both sensory
and motor components, its complete removal does not impair either sensory
perception or muscle strength. Rather, the cerebellum regulates movement
and posture indirectly by adjusting the output of the major descending motor
systems of the brain.
A striking feature of the cerebellar surface is the many parallel transverse
convolutions that run from one side to the other. Two deep transverse fissures
divide the cerebellum into three major lobes. The primary fissure, located on
the upper surface, divides the cerebellum into anterior and posterior lobes.
The posterolateral fissure on the underside of the cerebellum separates the
large posterior lobe from the small flocculonodular lobe (figure 13.3).
The cerebellum is organized into three functional regions, each with dis-
tinct anatomical connections to the brain and spinal cord: the vestiobulocere-
bellum, the spinocerebellum, and the cerebrocerebellum. These three regions
correspond roughly to anatomical subdivisions that have evolved successively
in phylogeny. Each region receives its main inputs from a different source
and sends its outputs to a different part of the brain.
There are three layers to the cerebellar cortex; from outer to inner layer,
these are the molecular, the purkinje, and granular layers. The function of
the cerebellar cortex is essentially to modulate information flowing through
the deep nuclei. Mossy and climbing fibers carry sensorimotor information
into the deep nuclei, which in turn pass it on to various premotor areas, thus
regulating the gain and timing of motor actions. Mossy and climbing fibers
also feed this information into the cerebellar cortex, which performs various
computations, resulting in the regulation of Purkinje cell firing. Purkinje
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Figure 13.3: Regional organization of the cerebellum
neurons (GABAergic) feed back into the deep nuclei via a potent inhibitory
synapse. This synapse regulates the extent to which mossy and climbing
fibers activate the deep nuclei, and thus control the ultimate effect of the
cerebellum on motor function. The synaptic strength of almost every synapse
in the cerebellar cortex has been shown to undergo synaptic plasticity. This
allows the circuitry of the cerebellar cortex to continuously adjust and fine-
tune the output of the cerebellum, forming the basis of some types of motor
learning and coordination.
The Hypothalamus: The hypothalamus is extensively interconnected
with a ring of cortical structures that are part of the limbic system. The
hypothalamus can be grossly divided in the lateral medial direction into
lateral, medial, and periventricular regions. It can also be divided in the
anterior-posterior direction into anterior, middle, and posterior regions. The
lateral region has long fibers that project to the spinal cord and cortex, and
also has extensive short-fiber, multisynaptic ascending and descending path-
ways. Most prominent of these fiber systems is the medial forebrain bundle,
a major tract that runs through the lateral hypothalamus and continues ros-
trally to end in the telencephalon. Many aminergic neurons originating in
the brain stem project to neocortical regions by way of fibers in the medial
forebrain bundle and its rostral continuation in the cingulum bundle. The
medial region of the hypothalamus is separated from the lateral region by
the descending columns of the fornix. It contains most of the well-delineated
nuclei of the hypothalamus, including (1) the preoptic nuclei and suprachi-
asmatic nuclei in the anterior region; (2) the dorsomedial, ventromedial, and
paraventricular nuclei in the middle region; and (3) the posterior nucleus and
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Figure 13.4: Medial view showing the positions of the main hypothalamic nuclei (copyright: Kandel et al.
2000)
mammilary bodies in the posterior region (figure 13.4).
The periventricular region consists of those parts of the hypothalamus
immediately bordering the third ventricle. The basal portion of the medial
region and the periventricular region contain many of the small (parvicellu-
lar) hypothalamic neurons that secrete the substances that control the release
of anterior pituitary hormones.
Each nucleus of the hypothalamus typically subserves a variety of func-
tions. This is most clearly seen in the paraventricular nucleus, a highly dif-
ferentiated structure that contains anatomically discrete regions of neurons
containing specific peptides and combinations of peptides.
Most fiber systems of the hypothalamus are bidirectional. Projections
to and from areas caudal to the hypothalamus are carried in the medial
forebrain bundle, the mammillotegmental tract, and the dorsal longitudinal
fasciculus. Rostral structures are interconnected to the hypothalamus by
means of the mammillothalamic tract, fornix, and stria terminalis. There
are two exceptions to the rule that fibers are bidirectional in the hypotha-
lamus. The hypothalamohypophyseal tract contains only descending axons
of paraventricular and supraoptic neurons, which terminate primarily in the
posterior pituitary. The hypothalamus also receives one-way afferent con-
nections directly from the retina. There fibers terminate primarily in the
suprachiasmatic nucleus, which is involved in generating light-dark cycles.
Histamine has been shown to be a transmitter in invertebrates, and bind-
ing sites for certain kinds of antihistaminic drugs have been localized to neu-
rons in the vertebrate brain. This putative vertebrate transmitter substance
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is concentrated in the hypothalamus. This knowledge allows us to embed
histaminergic pathways into our simplified network of the limbic system.
The Corpus Amygdaloideum: The amygdala as a component of the
limbic system coordinates the actions of the autonomic and endocrine sys-
tems and is involved in emotions. The amygdala is composed of many nuclei
that are reciprocally connected to the hypothalamus, hippocampal formation,
neocortex, and thalamus. It gives rise to two major efferent projections: the
stria terminalis and the ventral amygdalofugal pathway. The stria terminalis
innervates the bed nucleus of the stria terminalis, the nucleus accumbens,
and the hypothalamus. The ventral amygdalofugal pathway provides input
to the hypothalamus, dorsal medial nucleus of the thalamus, and rostral cin-
gulate gyrus. The amygdala in turn receives an important afferent input
from the olfactory bulb and also inputs from the other afferent systems.
Despite its extensive olfactory input, the amygdala is not essential for
olfactory discrimination. Lesions and electrical stimulations of the amygdala
produce a variety of effects on autonomic responses, emotional behaviours,
and feeding. It has been also implicated in the process of learning, par-
ticularly those tasks that require coordination of information from different
sensory modalities, or the association of a stimulus and an affective response.
The output of amygdala, as well as afferent input that is triggered as a conse-
quence of the activity of autonomic effectors, feeds back to cortical structures,
such as the prefrontal cortex, and results in a conscious emotional experience.
Amygdala is of central importance from the pharmacological point of
view, then the GABA receptors to which benzodiazepines bind are concen-
trated in the limbic system, specifically in the amygdala.
The Hippocampus: Like amygdala, hippocampus is also a part of the
limbic system. The hippocampus is involved in memory storage. Its function
in the process of memory storage is clarified by the fact that Alzheimer disease
which is the most common form of dementia is often observed to be carried
with a neural degeneration in hippocampus.
The hippocampus forms a principally uni-directional network with input
from the entorhinal cortex (EC) that forms connections with the dentate
gyrus (DG) and CA3 pyramidal neurons via the perforant path (PP [Lateral
and Medial]). CA3 neurons also receive input from the DG via the mossy
fibers (MF). They send axons to CA1 pyramidal cells via the Schaffer col-
lateral pathway (SC), as well as CA1 cells in the contralateral hippocampus
via the associational commissural pathway (AC). CA1 neurons also receive
input directly from the perforant path and send axons to the subiculum (Sb).
These neurons in turn send the main hippocampal output back to the EC,
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Figure 13.5: The network structure of the hippocampus (copyright: www.bris.ac.uk)
forming a loop (figure 13.5).
Thus, the hippocampus receives its major input from the entorhinal cor-
tex by the way of the perforant path. The entorhinal cortex in turn receives
its input from areas of the association cortex and thereby provides a link
between neocortex and the limbic system. Fibers from the entorhinal cortex
that reach the hippocampus by means of the perforant pathway pass through
subiculum, an area of cortex that receives major output from the hippocam-
pus and has extensive reciprocal connections with many areas of the brain,
including several areas of the neocortex. The subiculum is the origin of those
fibers in the fornix that innervate the hypothalamus. The fornix also con-
tains axons of hippocampal pyramidal cells that innervate non-hypothalamic
structures.
The Thalamus: The thalamus relays sensory input to the primary sen-
sory areas of the cerebral cortex, as well as information about motor be-
haviour to the motor areas of the cortex. It prevents also an overflow of
cortical afferents. A major result of this work is also the fact that thalamus
also filters cortical afferent signals of abnormal characteristics which will be
discussed later.
The thalamus is composed in part of distinct sensory nuclei that receive
input about different sensory modalities, including somatic sensation, audi-
tion, and vision. The thalamus also mediates motor function by transmitting
information from the cerebellum and basal ganglia to the motor regions of the
frontal lobe the primary motor cortex and higher-order motor areas. In ad-
dition, the thalamus is involved in autonomic reactions and the maintenance
of consciousness. Almost all the thalamic nuclei project to and receive input
from the cerebral cortex. Thalamocortical connections are made through the
internal capsule, a large fiber bundle that carries most of the axons running
to and from the cerebral hemisphere. The internal capsule contains not only
the rostral continuation of the somatic afferent pathway and the projection
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Figure 13.6: The major nuclei of the thalamus as seen on the left side of the brain (copyright: Kandel et
al. 2000)
fibers from the various nuclei of the thalamus, but also the fibers descending
from the cortex to the brain stem and spinal cord.
A Y-shaped sheet of fibers called the internal medullary lamina separates
the thalamic nuclei into six groups: Lateral, Medial, Anterior, Intralaminar,
Midline and Reticular (figure 13.6).
Each lateral nucleus receives restricted sensory or motor input and projects
to and receives input from a specific region of sensory, motor, or association
cortex, especially from and to the cingulate gyrus, a portion of the limbic
system in the cerebral cortex and parietal lobe. The lateral nuclei are relay
nuclei that are divided into two tiers, ventral and dorsal.
The medial nuclei are also relay nuclei. The largest component of the
medial group is the medial dorsal nucleus.
The anterior nuclei participate in emotion by relaying information from
the hypothalamus to the cingulate gyrus.
The intralaminar, reticular, and midline nuclei are diffuse-projection nu-
clei. The intralaminar nuclei lie within the internal medullary lamina; the
largest of these cell groups is the centromedian nucleus. Cells in this nu-
cleus have axons that terminate in several cortical areas in the frontal lobe
and in two major components of the basal ganglia, the caudate nucleus and
putamen. These projections make this nucleus of special interest for our
investigations. Then, thalamus become a central vertex in the generalized
network of the brain and therefore, one of the generators of the dynamical
patterns of neurochemical substances.
The Corpus Striatum: The striatum is a subcortical part of telen-
cephalon and a major input nucleus of the basal ganglia. The dorsal striatum
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forms a continuous and large mass, topographically separated by the inter-
nal capsule into the caudate nucleus medially, the putamen laterally and the
fundus below, linking the two preceding ventrally; but a single entity. It
consists of four neuronal types:
• Spiny neurons relatively close from the pyramidal neurons of the cortex
due to the presence of spines with spine apparatus (acanthodendritic
neurons), and make up 96% of the striatum;
• Leptodendritic neurons (2%) with large, poorly bifurcated, arborisation
looking like pallidonigral neurons;
• Spidery cholinergic interneurons (1%) morphologically entirely different
from those observed in rodents (which must lead to very careful inter-
specific correlations).In primates they are the tonically Active Neurons
(TANs). These briefly stop firing in concomitance to behaviourally
salient situations and reward-related events;
• GABAergic interneurons, which are fast-spiking/low threshold spiking,
and express dopamine receptors.
The striatum is spatially organized according to several levels. The dorsal
striatum is a single entity closed and continuous with a toric topology. The
observable anatomical subdivisions of the dorsal striatum (caudate nucleus
and putamen) essentially induced by the internal capsule do not completely
overlap with now accepted anatomic-functional subdivisions. The selective
distribution of the axonal terminal arborisations of cortical sources differen-
tiate the sensorimotor striatum, mainly putaminal but located in its dorsal
part and in the lateroinferior part of the caudate. A great part of the remain-
ing of the volume (essentially caudate) receiving from axonal endings from
the frontal, parietal, temporal cortex forms the associative striatum. The
separation between these two territories is rather clear-cut and observable
using calbindin immunochemistry. A third entity, the most inferomedial,
raises more problems as there is no general agreement about its border with
the associative striatum.
The most important afferent in terms of quantity of axons is the corticos-
triatal connection. Many parts of the neocortex innervate the dorsal stria-
tum. The cortical pyramidal neurons projecting to the striatum are located
in the lamina V. They end mainly on the spines of the spiny neurons. They
are (glutamatergic), exciting striatal neurons. Another well known afferent is
the nigrostriatal connection arising from the neurons of the substantia nigra
pars compacta. While cortical axons synapse mainly on spine heads of spiny
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neurons, nigral axons synapse mainly on spine shafts. The thalamostriatal
afferent essentially comes in primates from the central region is glutamater-
gic. The participation of truly intralaminar neurons is much more limited.
The striatum receives afferents from other elements of the basal ganglia such
as the subthalamic nucleus (glutamatergic) or the external globus pallidus
(GABAergic).
The main efferent target of the striatum is the pallidonigral set. The
basal ganglia core is made up of the striatum and its direct targets through
the striato-pallidonigral bundle. The striato-pallidonigral bundle is a very
dense bundle of a few myelinated axons giving the whitish aspect to the set.
This comprises successively the external globus pallidus (GPe), the internal
globus pallidus (GPi), the pars compacta of the substantia nigra (SNc) and
the substantia nigra pars reticulata (SNr). This set is made up of the same
genus of neurons. Its neurons are inhibited by GABAergic synapses from
the dorsal striatum. Among these targets, one does not send axons outside
the system (GPe, thus a regulator). Another sends axons to the superior
colliculus. Two others are the bases of basal ganglia system output to the
thalamus forming two separate channels: one through the internal segment
of the globus pallidus to VO and from there to the cortical SMA and another
through the substantia nigra to VA and from there to the frontal and the
oculomotor cortex (figure 13.7).
Metabotropic dopamine receptors are present both on spiny neurons and
on cortical axon terminals. Second messenger cascades triggered by activa-
tion of these dopamine receptors can modulate pre- and post-synaptic func-
tion, both in the short term and in the long term. The striatum is best
known for its role in the planning and modulation of movement pathways
but is also involved in a variety of other cognitive processes involving execu-
tive function. In humans the striatum is activated by stimuli associated with
reward, but also by aversive, novel, unexpected or intense stimuli, and cues
associated with such events.
The high concentration of dopamine receptors in striatum is a major rea-
son for it involving in several neurological diseases such as Chorea Hunting-
ton, Morbus Parkinson, and also schizophrenia. Thus, the synaptic dynamic
of its neurotransmitter systems, its upscaled dynamical behaviour as a nu-
cleus, and its interactions in the brain macro-circuits will be quantitatively
analyzed and interpreted through this work.
The Globus Pallidus: The globus pallidus (or pallidum) is derived
from the diencephalon and lies medial to the putamen and lateral to the
internal capsule. It is divided into internal and external segments. The in-
ternal segment (GPi) receives inputs from corpus striatum, substantia nigra
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Figure 13.7: Striatal structure and connections with the medial and lateral globus pallidus (MPS, LPS)
pars compacta, and nucleus subthalamicus. The efferent of GPi reach tha-
lamus and enclose the basal ganglias feedback loop. The external segment
(GPe) builds a feedback loop with nucleus subthalamicus, which is of major
importance in the information processing by basal ganglia.
The Nucleus Subthalamicus: The principal type of neuron found in
the subthalamic nucleus has rather long dendrites devoid of spines. The den-
dritic arborisations are ellipsoid, replicating in smaller dimension the shape
of the nucleus. The dimensions of these arborisations (1200, 600 and 300 m)
are similar across many speciesincluding rat, cat, monkey and manwhich is
unusual. However, the number of neurons increases across evolution as well
as the external dimensions of the nucleus. Due to the bending of dendrites at
the border, the subthalamic nucleus is a close nucleus, able to receive infor-
mation only in its space. The principal neurons are glutamatergic, which give
them a particular functional position in the basal ganglia system. In humans
there are also a small number (about 7.5%) of GABAergic interneurons that
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participate in the local circuitry.
The subthalamic nucleus receives its main input from the lateral pallidum
( external segment of the globus pallidus) (84.2% of its axons), not so much
through the ansa lenticularis as often said but by radiating fibers crossing the
medial pallidum first and the internal capsule (see figure). This afference is
GABAergic, inhibiting the neurons of the subthalamic nucleus. Excitatory,
glutamatergic inputs come from the cerebral cortex (particularly the mo-
tor cortex), and from the pars parafascicularis of the central complex. The
subthalamic nucleus also receives neuromodulatory inputs, notably dopamin-
ergic axons from the substantia nigra pars compacta.
The axons of subthalamic nucleus neurons leave the nucleus dorsally. The
efferent axons are glutamatergic (excitatory). Except for the connection to
the striatum (17.3% in macaques), most of the subthalamic principal neurons
are multi-targets and directed to the other elements of the core of the basal
ganglia. Some send axons to the substantia nigra medially and to the medial
and lateral nuclei of the pallidum laterally (3-target, 21.3%). Some are 2-
target with the lateral pallidum and the substantia nigra (2.7%) or the lateral
pallidum and the medial (48%). Less are single target for the lateral pallidum.
In the pallidum, subthalamic terminals end in bands parallel to the pallidal
border. When all axons reaching this target are added, the main afference of
the subthalamic nucleus is, in 82.7% of the cases, clearly the medial pallidum
(internal segment of the globus pallidus).
The first intracellular electrical recordings of subthalamic neurons were
performed using sharp electrodes in a rat slice preparation (Nakanishi et al.,
1987). In these recordings three key observations were made, all three of
which have dominated subsequent reports of subthalamic firing properties.
The first observation is that, in the absence of current injection or synaptic
stimulation, the majority of cells were spontaneously firing. The second
observation is that these cells are capable of transiently firing at very high
frequencies. The third observation concerns non-linear behaviour, when cells
are transiently depolarized after being hyperpolarized below 65mV. They are
then able to engage voltage-gated calcium and sodium currents to fire bursts
of action potentials.
Several recent studies have focused on the autonomous pace making abil-
ity of subthalamic neurons. These cells are often referred to as ”fast-spiking
pacemakers” since they can generate spontaneous action potentials at rates
of 80 to 90Hz in primates.
Strong reciprocal connections link the subthalamic nucleus and the ex-
ternal segment of the globus pallidus. Both are fast-spiking pacemakers.
Together, they are thought to constitute the ”central pacemaker of the basal
ganglia” with synchronous bursts.
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The connection of the lateral pallidum with the subthalamic nucleus is
also the one in the basal ganglia system where the reduction between emit-
ter/receiving elements is likely the strongest. In terms of volume, in humans,
the lateral pallidum measures 808 mm, the subthalamic nucleus only 158
mm. This translated in numbers of neurons represents a strong compression
with loss of map precision.
The systemic position of this circuit is particular in the basal ganglia
system that may be revealed by contrast versus outputs subsystems. There
are two output paths starting from the striatum. The first has a first relay
in the medial pallidum (GABAergic inhibitory) and the second in the nigra
reticulata (GABA). These two output subsystems do not send regulatory
messages to other elements of the basal ganglia system: striatum, lateral
pallidum or subthalamic nucleus. The lateropallido-subthalamic subsystem is
particular in that it does the reverse. It does not send axons to the thalamus
and from there to the cortex. All efferent axons of the subsystem are indeed
returning inside the basal ganglia system. This topologically makes it a
regulator. Some axons from the lateral pallidum go to the striatum. The
activity of the medial pallidum is influenced by afferences from the lateral
pallidum and from the subthalamic nucleus. The subthalamic nucleus sends
axons to another regulator: the pedunculo-pontine complex.
The Substantia Nigra: The substantia nigra lies in the midbrain and
has two zones. The ventral pale zone, the pars reticulata (SNr), resembles
the globus pallidus cytologically. A dorsal, darkly pigmented zone, the pars
compacta (SNc), is composed of dopaminergic neurons whose cell bodies
contain neuromelanin. The dark pigment, a polymer derived from dopamine,
gives the substantia nigra its name, because in human this part of the brain
appears black in cut sections. Because of the striking similarities in cytology,
connectivity, and function of GPi and SNr, these two nuclei can be considered
as a single structure arbitrarily divided by the internal capsule.
The substantia nigra receives afferents from cortex and corpus striatum
and projects dopaminergic pathways to the limbic system, GPi/SNr, thala-
mus, and striatum. The nigrostriatal feedback loop is of great importance in
the generation of psychotic salience and in the general information processing
in basal ganglia.
Because of the very high dopamine concentration in substantia nigra and
the richness of dopaminergic projections into different circuits like the lim-
bic system and basal ganglia, substantia nigra is probably involved in a lot
of neurological and psychological diseases, also in learning processes, and
addiction.
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The Raphe Nuclei: The raphe nuclei are traditionally considered to
be the medial portion of the reticular formation, and they appear as a ridge
of cells in the center and most medial portion of the brain stem. In order
from caudal to rostral, the raphe nuclei are known as the nucleus raphe ob-
scurus, the raphe magnus, the raphe pontis, the raphe pallidus, the nucleus
centralis superior, nucleus raphe dorsalis, nuclei linearis intermedius and lin-
earis rostralis. The raphe nuclei can be of particular interest to neurologists
and psychologists since many of the neurons in the nuclei (but not the ma-
jority) are serotonergic. Serotonin seems to be the culprit in many of our
modern psycho-pharmaceutical problems, such as anorexia, depression, and
sleep disorders.
13.4 On the Antipsychotic Agents
Antipsychotic drugs have been used clinically for 50 years. Reserpine and
chlorpromazine were the first drugs found to be useful in schizophrenia. Al-
though chlorpromazine is still sometimes used for the treatment of psychoses,
these forerunner drugs have been superseded by many newer drugs.
A number of chemical structures have been associated with antipsychotic
properties. The drugs can be classified into the following groups:
• Phenothiazine derivatives: Three subfamilies of phenothiazines, based
primarily on the side chain of the molecule, were once the most widely
used of the antipsychotics. Aliphatic derivatives (e.g. Chlorpromazine)
and piperidine derivatives (e.g. Thioridazine) are the least potent.
Piperazine derivatives are more potent in the sense that they are effec-
tive in lower doses. The piperazine derivatives are also more selective
in their pharmaceutical effects;
• Thioxanthene derivatives: This group of drugs is exemplified primarily
by thiothixene. In general, these compounds are slightly less potent
than their phenothiazine analogues;
• Butyrophenone derivatives: This group, of which haloperidol is the
most widely used, has a very different structure from those of the
preceding groups. Diphenylbutylpiperidines are closely related com-
pounds. These agents tend to be more potent and to have fewer auto-
nomic effects;
• Miscellaneous Structures: The newer drugs have a variety of struc-
tures and include pimozide, molindone, loxapine, clozapine, olanzapine,
risperidone and ziprasidone.
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The first phenothiazine antipsychotic drugs, with chlorpromazine as the
prototype, proved to have a wide variety of central nervous system, auto-
nomic, and endocrine effects. These actions were traced to blocking ef-
fects at a remarkable number of receptors. These include dopamine and
a-adrenoceptor, muscarinic, H1 histaminic, and serotonine (5−HT2) recep-
tors. After dopamine was recognized as a neurotransmitter, various exper-
iments showed that its effects on electrical activity in central synapses and
on production of cAMP by adenylyl cyclase could be blocked by most an-
tipsychotic drugs. This evidence led to the conclusion in the early 1960s that
these drugs should be considered dopamine antagonists. The antipsychotic
action is now thought to be produced by their ability to block dopamine in
the mesolimbic and mesofrontal systems. Recently, partial antagonists has
been developed to reduce the motor side effects of the antipsychotic drugs of
the first generation expressed above.
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Chapter Fourteen
Psychiatric Supplement
14.1 Historical Evolution of the Concept of
Schizophrenia
The existence of a schizophrenia-like syndrome can be found in literature
dating back to antiquity. Historical accounts of mania and melancholia cer-
tainly are found in ancient Greek writings. Even earlier ancient writings of
Mesopotamia contain evidence of psychiatric illness, with clear descriptions
of schizophrenia-like syndromes that included paranoid delusions.
In the first century, AD, Celsus proposed a classification of mental disor-
ders into three separate categories: delirium, melancholia, and a third that
remained unnamed, but was subdivided into two forms with and without
hallucinations. Galen, who lived from 122-199 AD, while not describing a
separate schizophrenic-like illness, stated that fanatic imaginations could oc-
cur during melancholia. Nevertheless, it was not until the late 18th and
early 19th century, that the modern descriptions of ’schizophrenia’ began to
emerge.
Morel introduced the term ’demence praecox’ in the mid 19th century to
refer to the condition of an adolescent patient, originally bright and active,
who gradually became gloomy, silent and withdrawn. In 1863 Kahlbaum
described a condition which he termed ’katatonia’ as pathologically charged
motor tension, while a distinct syndrome of auditory hallucinations and per-
secutory delusions, he termed ’basania typical’.
Kraepelin’s contribution, then in 1898, only shortly after psychiatry it-
self became known as a separate entity, was the integration of these sepa-
rate symptoms into a clinically distinct disorder. He defined the syndrome,
’dementia praecox’, as a psychosis with an early age of onset and chronic
deterioration in mental functioning, in contrast with the manic-depressive
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psychoses, which were characterized by recurrent episodes of illness.
The term ’schizophrenia’ (split-mind), was actually introduced by E.
Bleuler, in 1908 to describe this syndrome as a ’splitting or incongruity’
of mental functions. By splitting he meant a dissociation between thought
and affect, leading to illogical thought connections, thus creating the typical
schizophrenic though disorder. He suggested that the aetiology was phys-
ically and likely to be of multiple aetiologies. In his classic monograph,
’Dementia Praecox of the Group of Schizophrenias’ (1911), he further ex-
panded on Kraepelin’s concepts and emphasized that there were two clusters
of symptoms that appeared to characterize the disorders. He defined primary
symptoms as those specifically characteristic of the disorder (disturbances of
association, affectivity, ambivalence, and autism), while the secondary symp-
toms (e.g. hallucinations, delusions) may be found in other disorders as well.
The relative importance of this grouping of symptoms to the diagnosis and
aetiology of schizophrenia remains an issue today.
14.2 Schizophrenic Subtypes
The variety of the symptoms and course of schizophrenia has led to several
attempts to define subgroups. Patients with hebephrenic schizophrenia often
appear silly and childish in their behaviour. Affective symptoms and thought
disorders are prominent. Delusions are common and not highly organized.
Hallucinations are also common, and are not elaborate.
Catatonic schizophrenia is characterized by motor symptoms, by changes
in activity varying between excitement and stupor. In paranoid schizophrenia
the clinical picture is dominated by paranoid delusions. The patient may
appear normal until the abnormal beliefs are uncovered.
Simple schizophrenia is characterized by the insidious development of odd
behaviour, social withdrawal, and declining performance at work.
14.3 Schizophrenia-like Disorders
Whatever definition of schizophrenia is adopted, there will be cases that
resemble schizophrenia in some respects and yet do not meet the criteria for
diagnosis, either because of the duration or the absence of some common
symptoms. Schizophrenia-like disorders can be divided into four groups:
• Delusional or paranoid disorder;
• Brief disorders (at least one of the acute phase positive symptoms /
Short duration);
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• Disorders accompanied by prominent affective symptoms (reversible);
• Disorders without all required symptoms for schizophrenia.
14.4 Social Factors Modifying the Clinical Fea-
tures
The amount of social stimulation has a considerable effect on the clinical
picture. Under-stimulation increases ’negative’ symptoms such as poverty
of speech, social withdrawal, apathy, and lack of drive. Over-stimulation
precipitates ’positive’ symptoms such as hallucinations, delusions, and rest-
lessness. Modern treatment is designed to avoid under-stimulation, and as a
result ’negative’ features are less frequent than in the past.
The social background of the patient may effect the content of some
symptoms. Age also seem to modify the clinical features of schizophrenia.
In adolescents and young adults the clinical features often include thought
disorder, mood disturbance, passivity phenomena, and thought insertion.
With increasing age paranoid symptomatology is more common, with more
organized delusions (Ha¨fner et al. 1993).
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